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Th is doctoral thesis describes the infl uence of diff erent growth patterns during childhood 
on determinants of adult disease, like cardiovascular disease, type 2 diabetes mellitus and 
osteoporosis, in healthy young adults. Additionally, diff erences in these determinants are 
described between four clinically relevant subgroups; young adults born small for gestational 
age (SGA), with and without catch-up growth and young adults born appropriate for 
gestational age with short and normal adult height. Finally, the relation between early growth 
and determinants of adult disease, and the relation between nutrient intakes and body size in 
infancy are discussed. Th is chapter describes several hypotheses with regard to the infl uence 
of birth size and childhood growth on adult diseases and their determinants. In addition, the 
defi nitions, prevalence and etiologies of SGA and idiopathic short stature (ISS) are discussed 
together with the study design. Finally, the aims and outline of the thesis are presented.
1. Relations between low birth weight, childhood growth and adult disease
Hypotheses
In the early 1990s, several epidemiological studies showed an inverse relationship between 
birth weight and the risk for cardiovascular events, type 2 diabetes, hypertension, insulin 
resistance, adverse lipid profi le and reduced bone mass density in elderly subjects (1-11). Th e 
exact mechanism underlying these associations are yet unknown, but several hypotheses have 
been postulated over time.
Fetal origin hypothesis: Barker et al. were the fi rst to formulate a hypothesis based on the 
inverse association found between birth weight and adult disease. Th ey suggested that events 
during pregnancy leading to fetal malnutrition could result in permanent endocrine and 
metabolic changes in the fetus, called re-programming (Figure 1) (6,12). At fi rst, the fetus would 
benefi t from the adaptations, as it would remain alive during fetal life, but in the long-term, this 
re-programming would result in diseases in later adulthood.
Low birth weight
Development of adult disease
Low intrauterine nutrient supply
re-programming
Maternal factors
Fetal factors 
Placental factors
Environmental factors
Figure 1. Representation of the fetal origin hypothesis. Adapted from Barker et al. (6,8,12).
Fetal insulin hypothesis: Th is hypothesis was generated in 1999 and states that the inverse 
association between birth weight and adult insulin resistance is principally genetically mediated 
(Figure 2) (13). Parental genes involved in insulin resistance which are passed to the fetus could 
result in low-insulin-mediated fetal growth and in insulin resistance leading to type 2 diabetes 
in later life.
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Maternal glucose concentration
(in the third trimester) 
Glucose sensing by fetal pancreas
Insulin secretion by fetal pancreas
Insulin mediated fetal growth 
Birth weight
Fetal genetics
Fetal insulin resistance
+
_
Insulin resistance in later life 
Figure 2. Simplifi ed representation of the fetal insulin hypothesis. Adapted from Hattersley et al. (13).
Growth acceleration hypothesis: Singhal and Lucas postulated in 2004 the hypothesis that 
not low birth weight per se, but growth acceleration during childhood is responsible for the 
increased risk for adult diseases in later life (14). Almost every child is genetically determined 
to grow to their growth potential. Th us, children born aft er fetal growth restriction, thus below 
their genetic growth potential, will experience postnatal catch-up growth. According to the 
hypothesis this postnatal catch-up growth, which might be stimulated by nutrient-enriched 
diets, will lead to the development of adult diseases in later life (Figure 3).
 
Fetal growth restriction 
Development of adult disease 
Postnatal growth acceleration 
Relative to their  
growth potential 
Nutrient-enriched 
diets + 
Figure 3. Representation of the growth acceleration hypothesis. Adapted from Singhal et al. (14).
2. Adult diseases and their determinants
Th e studies described in this thesis investigated determinants of 3 adult diseases, cardiovascular 
disease, type 2 diabetes and osteoporosis, in young adults. 
Cardiovascular disease and type 2 diabetes
Although mortality of coronary heart disease has declined since the 1970s, the decline in 
mortality becomes less and might even reverse in the upcoming years (15,16). Cardiovascular 
disease (CVD) is still the primary cause of death. Obesity is a leading factor in the development 
of CVD and type 2 diabetes. Th e prevalence of obesity is rising in both children and adults, 
especially in developing countries (17-19). Th e exact factors involved in the development of 
CVD and type 2 diabetes are still unknown. Several studies have indicated that the development 
of CVD might start in childhood or even in infancy (20-22). It is therefore relevant to investigate 
whether diff erent growth patterns during childhood infl uence determinants for CVD and type 
2 diabetes in early adulthood.
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Insulin sensitivity
To maintain a healthy glucose homeostasis, insulin sensitivity and insulin secretion should be 
balanced. A decline in insulin sensitivity is normally compensated by an increase in insulin 
secretion to maintain glucose tolerance. When insulin secretion does not change appropriately, 
impaired glucose tolerance and eventually type 2 diabetes will develop (23). Glucose homeostasis 
can be measured by Frequent Sampling Intravenous Glucose Tolerance test (FSIGT), which 
is explained in Appendix A. Low birth weight has consistently been associated with a higher 
prevalence of type 2 diabetes in later life, and some calculations indicated that low birth weight 
might be responsible for 35% of the type 2 diabetes cases (3,24,25). However, as low birth weight 
subjects show catch-up growth during childhood, it remains diffi  cult to determine whether 
birth size is directly linked to the prevalence of type 2 diabetes, or that catch-up growth in early 
life determines the increased risk for type 2 diabetes. Our research group previously reported 
that a group of prepubertal short small for gestational (SGA) children had a reduced insulin 
sensitivity compared to age and height matched AGA born controls (26). Glucose homeostasis 
was still balanced by the compensatory increase of insulin secretion. Th is suggests that birth 
size might infl uence the development of type 2 diabetes in later life, but prior to the start of our 
studies no data in young adults were available.
Body composition
Body composition can be measured by Dual Energy X-ray Absorptiometry (DXA), which 
is explained in Appendix A, and gives more insight in the total amount of lean body mass 
(LBM) and fat mass (FM) of the body. It is well-known that a higher fat percentage results in an 
increased risk for type 2 diabetes and cardiovascular events. Studies investigating whether low 
birth size results in a diff erent body composition were inconsistent and diffi  cult to compare, 
mainly due to diff erent ways of measuring LBM and FM as well as a wide variation in age of the 
various study groups (27-30). Short children born SGA have a typical lean appearance, which 
was confi rmed by one study showing a low body mass index (BMI) and low sum of skin folds 
SDS (31). However, in children born SGA with catch-up growth in weight, early development 
of adiposity has been reported (32). Whether these diff erences in body composition would 
persist into early adulthood was unknown. Population-based studies showed that obesity 
during infancy tracked into adulthood (33,34). Understanding the mechanisms underlying the 
development of adult diseases in later life could lead to specifi c preventive interventions during 
childhood (33,35).
Lipid metabolism and Acylation Stimulating Protein (ASP)
Raised serum levels of total cholesterol (TC), low-density lipoprotein (LDLc), apolipoprotein 
B (apoB) and lipoprotein a (Lp(a)) together with reduced levels of high-density lipoprotein 
(HDLc) and apolipoprotein A-I (apoA-I) increase the risk for cardiovascular disease (36-39). 
Although the association between birth weight and serum lipid levels had been investigated in 
several studies, no consistency was found (40,41). If low birth weight would aff ect lipid levels in 
later life, this should be present in SGA subjects. Our research group has investigated lipid levels 
in prepubertal SGA children and found no abnormalities (26). Th is was consistent with other 
literature, but no study diff erentiated between SGA children with or without catch-up growth 
during childhood (42-44).
Apolipoprotein E (apoE) is an important regulator of serum lipid levels because it aff ects 
hepatic binding and uptake of several lipoproteins (45). Th ere are six apoE genotypes which all 
have specifi c affi  nity for the LDLc receptor. ApoE genotype ε3/ε3 is most common and subjects 
with an ε2 allele have a reduced risk for CVD, while subjects with an ε4 allele have a higher risk 
for CVD (46,47). No study evaluated the prevalence of the diff erent ApoE genotypes in subjects 
born SGA and if it has an eff ect on their serum lipid levels.
Acylation stimulating protein (ASP) is a relatively new hormone generated through the 
activation of the alternative complement pathway proteins C3, B and adipsin and produced by 
adipocytes (48). Th e function of ASP is to stimulate uptake of glucose and free fatty acid (FFA) 
in adipocytes (49,50). By increasing chylomicron derived FFA incorporation into triglycerides 
(TG) in adipocytes, ASP prevents inhibition of lipoprotein lipase (LPL) by FFA and therefore 
helps to maintain normal serum FFA levels (51). Additionally, ASP inhibits TG lipolysis in 
adipocytes by reducing the activity of hormone-sensitive lipase (HSL), resulting in lower serum 
FFA levels. By controlling the storage of TGs, ASP helps to keep lipid levels in the normal range. 
Because it is a relatively new hormone, clinical data on ASP are limited. High fasting levels of 
TG and ASP have been associated with obesity, insulin resistance, cardiovascular disease and 
dyslipidemia. Th is resulted in the hypothesis that higher ASP levels in the presence of higher 
TG might indicate ASP resistance (48,52). Cianfl one et al. showed that ASP as a predictor of 
delayed TG clearance might predict postprandial hypertriglyceridemia, which is an early stage 
of dyslipidemia (52,53). Th us, the ASP level might actually predict a very early stage of CVD. 
It might therefore be interesting to investigate which factors are related to fasting ASP levels 
in early adulthood and whether diff erent growth patterns during childhood are related to a 
diff erent fasting ASP level in early adulthood.
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Blood pressure and carotid intima media thickness (carotid IMT)
Blood pressure is an important determinant of cardiovascular events and is the most investigated 
determinant regarding the relationship between birth size and the risk for development of CVD 
in later life (2,5,7,54,55). Despite this extensive research, several reviews concluded that clarity 
was lacking because the results remained inconclusive (56,57). Other reports stated that subjects 
on nutrient enriched diets had rapid weight gain in early life and that this was related with 
increased blood pressure in later life (58). For that reason, it was relevant to investigate whether 
prenatal or postnatal growth infl uences blood pressure in later life.
Eventually, cardiovascular events are caused by occlusion of arteries at the site of 
atherosclerotic plaques. Th e presence of atherosclerotic plaques in the carotid arteries can be 
determined by investigating the intima media thickness in the vessel wall of the carotid arteries 
by non-invasive ultrasound measurements (Appendix A) (59). A greater thickness is associated 
with the development to atherosclerotic plaques and is positively correlated with cardiovascular 
events (60, 61). As development of atherosclerosis already starts in childhood, determining 
carotid IMT in early adulthood might give more insight in the risk of cardiovascular events 
later in life and early factors infl uencing carotid IMT might be found. No study had investigated 
carotid IMT in SGA subjects, either with or without catch-up growth.
Osteoporosis
Birth size, childhood growth and bone mineral density
Osteoporosis is a condition characterized by reduced bone mineralization, resulting in an 
increased fracture risk. Bone mineral density (gr/cm2) (BMD) can be measured by Dual Energy 
X-ray Absorptiometry (DXA) (Appendix A). In young adults, total body BMD and BMD of the 
lumbar spine were measured. To evaluate BMD, it is important to take body size into account 
as BMD is a measure for aerial bone density instead of volumetric bone density, otherwise 
BMD will be underestimated in short subjects (62,63). For bone density of the vertebra, apparent 
BMD (BMAD) is calculated to take body size into account (64). Th e prevalence of osteoporosis 
varies in developed countries between 8-18% in elderly women and 3-6% in elderly men; the 
prevalence in elderly women is higher due to their lower estrogen levels aft er the menopause 
(65,66). 
Several studies found a positive association between birth size and BMD in adults, indicating 
that subjects with a low birth weight had an increased risk for development of osteoporosis in 
later life (1,11,67,68). However, adult size had hardly been taken into account and most studies 
were performed in elderly subjects. Th erefore, additional data regarding the association between 
birth size and BMD in later life were required.
Growth in early life
Timing and tempo of early growth and determinants of cardiovascular disease
Some studies reported that rapid weight gain in early life might have adverse eff ect on 
determinants of CVD (35,69-71). Especially fi rst year growth seemed to be an important period 
and it was suggested that in this period a special ‘time window’ might be applicable (72). However, 
whether slow or rapid growth is deleterious for later outcome of CVD was unclear (73). Studies 
from the Helsinki Birth Cohort concluded that growth retardation in the fi rst year followed 
by rapid growth between 2 and 10 years is related to an increase in cardiovascular events (74). 
In contrast, several other studies reported that rapid weight gain in the fi rst few months of life 
are related to increased fat mass in childhood and a disadvantageous metabolic profi le in early 
adulthood (70,75). As most low birth weight subjects will show catch-up growth in early life, 
which is to a certain extend wished for, it is relevant to investigate if tempo of postnatal weight 
gain has an infl uence on determinants of CVD in early adulthood. 
Nutrition in early life and the relationship with body size and body composition at 12 
months
As catch-up growth during childhood seems to result in an increased fat mass which is being 
tracked into adulthood (70,76), factors infl uencing catch-up growth need to be established. 
Nutrition is one of these infl uencing factors (77). For instance, breast-fed children grow at 
a slower rate, and accumulate less fat during this period (78,79). One explanation might be 
the lower content of protein in breast milk compared to formula milk (80). Rolland-Cachera 
et al formulated an early protein hypothesis, suggesting that high protein intake early in life 
leads to increased secretion of insulin-like-growth factor I and insulin (81). Th ese hormones 
trigger multiplication of adipocytes and therefore stimulate fat accumulation. Reports of the 
DONALD study support this hypothesis while several other studies found no relation between 
protein intake and adiposity in early life (82-84). A possible explanation might be that proteins 
of diff erent nutritional sources have a diff erent infl uence on body composition in early life. 
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3. Small for gestational age (SGA) and idiopathic short stature (ISS)
To investigate the infl uence of diff erent growth patterns during childhood on determinants of 
adult disease, we included subjects with extreme variants of normal growth, like subjects born 
small for gestational age (with and without catch-up growth) and subjects with unknown growth 
retardation during childhood (idiopathic short stature). Th is design created greater contrast in 
the study population, which contributed to a better statistical model in which relationships 
between various factors could be detected with more statistical power.
Defi nition of SGA
In 2001, the International SGA Advisory Board Panel formulated a consensus statement on the 
defi nition of SGA, by defi ning SGA as a birth length and/or birth weight below –2 standard 
deviation score, adjusted for gestational age and gender (85). Data from an appropriate reference 
population are necessary to take diff erences in race and ethnicity into account.
SGA is a term used for size at birth and does not refer to intra-uterine growth. Intra-uterine 
growth is used to describe growth velocity in fetal life, which is determined by at least two 
ultrasound measurements. A child born SGA might have been small from the beginning of fetal 
life, or could have experienced intra-uterine growth retardation later in gestation, resulting in a 
small size at birth. However, children with intra-uterine growth retardation late in gestation can 
be born with a normal birth size. Figure 4 shows these diff erent growth patterns in fetal life.
Prevalence and etiology of SGA
When SGA is defi ned as a birth length and/or birth weight below –2 standard deviation score, 
2.3% of all live-born children are born SGA. For the Netherlands this means that in 2005, of all 
187,910 live-born children, 4322 were born SGA (Central Bureau of Statistics, Voorburg, the 
Netherlands). 
Several factors infl uence intra-uterine growth and may therefore cause SGA, including fetal, 
maternal, placental and demographic factors (86-89). Although many factors are known, in 40% 
of the cases, no cause can be found. Identifi cation of the cause of SGA is important as underlying 
mechanisms may infl uence the prognosis and treatment. Table 1 lists factors associated with 
intrauterine growth retardation.
+2 SD
-2 SD
0 SD
LGA
AGA
SGA
SGA and IUGR
IUGR but not SGA
SGA but not IUGR
le
ng
th
/w
ei
gh
t
gestation birth
Figure 4. Fetal growth chart showing diff erent growth patterns in IUGR and SGA newborns.
Short stature and SGA
Approximately 85% of the SGA children show catch-up growth in the fi rst two years of life to 
a height above –1.88 SDS (91-93). Recently, de Ridder et al showed that 91% of SGA children 
reached a normal height, 6% achieved this between 2 and 8 years of age (94). Catch-up growth is 
most pronounced in the fi rst 6 months of life, but this might be prolonged in prematurely born 
SGA children. Although subjects born SGA with catch-up growth (SGA-CU) attain an adult 
height which is within the normal ranges of the population, they remain signifi cantly smaller 
than AGA born subjects (91).
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Table 1. Factors associated with intrauterine growth retardation.
Fetal factors 
Multiple births  
Congenital malformations  
Chromosomal anomalies Turner syndrome −
Down syndrome −
Inborn errors of metabolism   −
Intrauterine infections TORCHES (Toxoplasmosis, Rubella, Cytomegalovirus, Herpes simplex,  −
Syphilis)
Maternal factors 
Medical conditions Hypertension −
Pre-eclampsia −
Severe chronic disease or infections −
Systemic lupus erythematosus −
Antiphospholipid syndrome −
Anemia −
Malignacies −
Abnormalities of the uterus −
Social conditions Maternal nutrition −
Low prepregnancy BMI −
Low maternal weight gain −
Delivery at <16 or >35 years −
Low social economic status −
Use of drugs −
Placental factors 
Reduced blood fl ow   −
Reduced area for exchange of 
nutrients and oxygen
Infarcts −
Hematomas −
Partial abruption −
Environmental factors 
High altitude
Toxic substances   −
Adapted from Bryan and Hindmarch (90).
SGA children without catch-up growth to a height above –2 SDS during childhood will 
attain an average adult height of –2.1 SDS for boys and –2.8 SDS for girls (95). If catch-up growth 
in height to >–2 SDS is not achieved at 2 years, these children have a 7-fold increase risk for 
short stature (93). Th erefore, SGA born children with short stature at the age of 3 years should 
be referred to a pediatrician with expertise in endocrinology (85). Th e pediatrician should 
investigate whether short adult stature could be prevented by growth hormone treatment. 
Growth hormone treatment has shown to be eff ective and safe for preventing short adult stature 
(96-99).
Defi nition of idiopathic short stature (ISS)
ISS is defi ned as a condition in which postnatal height of an individual is < –2 SDS of the 
corresponding mean height for a given age, sex and population group without evidence of 
systemic, endocrine, nutritional, or chromosomal abnormalities (100). Th ese subjects have a 
normal size at birth and do not have growth hormone defi ciency. A subcategorization can be 
made based on the expectance of achieving target height range based on fi nal height of the 
parents. A second criterion for subcategorization is the presence of delayed bone maturation, 
which suggests delayed growth and puberty. 
Prevalence and etiology of idiopathic short stature
Th e group of ISS subjects is a heterogeneous group of subjects with an unknown cause of 
short stature. Familial short stature is a common feature in this group. It is estimated that 
approximately 60-80% of all short children at or below –2 SDS do fi t the defi nition of ISS (100). 
Th e frequency of referral of these children is dependent on the socioeconomic environment 
and boys have a greater perceived disability of short stature compared with girls.
4. Th e PROGRAM-study
To investigate the relationship between birth size, childhood growth and determinants of 
adult disease in early adulthood, the PROgramming factors for GRowth And Metabolism 
(PROGRAM) study was started. Th e inclusion and exclusion criteria are described in Appendix 
B. Th e study consists of a cohort of 322 healthy young adults with diff erent growth patterns 
during fetal life and childhood. Th e association between birth size, childhood growth and 
determinants of adult disease were analysed in two ways.
First, multiple regression analyses were used to investigate the association between birth 
size, childhood growth and determinants of adult disease. Th e wide range in birth size and 
childhood growth patterns increases the contrast in the study population, which increase the 
statistical power to detect relationships between various factors.
Secondly, the total study population was divided into four clinically relevant subgroups 
based on birth length and adult height. Th e criteria for being included into one of the subgroups 
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are described in Appendix C. Two subgroups consisted of small for gestational age (SGA) born 
adults, one without catch-up growth (SGA-short) and another one with catch-up growth (SGA-
CU). Th e last two subgroups consisted of young adults born appropriate for gestational age. 
Th e fi rst subgroup experienced growth retardation during childhood without a known reason 
(idiopathic short stature (ISS)). Th e second one had normal growth during childhood and 
attained a normal adult height (controls). Th e growth patterns during childhood of each of the 
subgroups are displayed in Figure 5. 
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Figure 5. Growth patterns of the four subgroups. SGA-S: born SGA and short as adults, SGA-CU: born 
SGA with catch-up growth in childhood, ISS: born AGA and short as adults, Controls: born AGA with 
normal adult height.
5. Aims of the study
Th is thesis describes results of seven studies performed in 322 young adults, aged 18-24 years, 
who participated in the PROGRAM-study and of one study performed in 396 infants from the 
Cambridge Baby Growth Study. Th e PROGRAM-study was started to investigate if size at birth 
and diff erent growth patterns during childhood infl uence determinants of adult disease in early 
adulthood. Also, eff orts were made to investigate if there were other factors infl uencing these 
determinants. Finally, this thesis describes the infl uence of various nutritional factors on fi rst 
year growth in 396 infants participating in the Cambridge Baby Growth Study.
Determinants of metabolic and cardiovascular disease
We investigated if size at birth and growth patterns during childhood were related to insulin 
sensitivity (measured by Frequent Sampling Intravenous Glucose Tolerance test), body 
composition (measured by Dual Energy X-ray absorptiometry), serum lipid and ASP levels, 
blood pressure and carotid intima media thickness (IMT), in young adults. In addition, we 
also investigated whether other factors infl uenced these determinants in early adulthood. 
With regard to all these determinants, subgroup analyses were performed to evaluate whether 
determinants diff ered between the subgroups.
Determinants of bone mineral density (BMD)
Bone mineral density of the total body and lumbar spine was measured by DXA to investigate 
the relation between size at birth and growth patterns and BMD. Additionally, subgroup 
analyses were performed to investigate whether there were diff erences in bone mass density 
between the subgroups.
Growth in early life
In 217 young adults, fi rst year growth data was collected to investigate if growth during a specifi c 
time period in the fi rst year had an infl uence on determinants of cardiovascular disease in early 
adulthood. Additionally, we investigated if fast catch-up in weight during the fi rst year of life 
had a more adverse eff ect on these determinants than slow fi rst year catch-up in weight. Finally, 
the relation between nutrient intake and fi rst year growth was investigated in infants of the 
Baby Growth Study from Cambridge, United Kingdom. Fat mass was determined by skinfold 
thickness and extensive nutritional data at 12 months of age were collected.
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6. Outline of the thesis
Chapter 1 gives an introduction in the topics described in this thesis. 
Chapter 2 presents which growth patterns and factors infl uence insulin sensitivity in young 
adults and based on the fi ndings, a new hypothesis could be formulated.
Chapter 3 reports the relation between size at birth and lean body mass as well as fat mass 
in early adulthood. Additionally, diff erences in lean body mass and fat mass between the four 
subgroups are described.
Chapter 4 describes the infl uence of environmental and genetic factors on serum lipid 
profi les in young adults. In addition, subgroup analyses have been performed to investigate 
diff erences in lipid profi le with regard to diff erent growth patterns.
Chapter 5 reports the relation between growth during childhood and fasting serum ASP 
levels in young adults and the four subgroups.
Chapter 6 depicts the relation between size at birth and blood pressure and carotid IMT 
in early adulthood. Additionally, diff erences between the four subgroups are described with 
regard to blood pressure and carotid IMT.
Chapter 7 depicts the relation between size at birth and bone mineral density in young adult 
and the four subgroups.
Chapter 8 reports which period of postnatal growth has an infl uence on determinants of 
cardiovascular disease in early adulthood. In addition, it describes whether diff erences in tempo 
of postnatal weight gain have diff erent infl uences on determinants of cardiovascular disease.
Chapter 9 describes the infl uence of various nutrient intakes on body size and body 
composition in infants at 12 months of age. Th is study was performed in the Cambridge Baby 
Growth Study.
Chapter 10 discusses the results of the studies in relation to the current literature and gives 
conclusions and clinical implications of the study results.
Chapter 11 summarizes the fi ndings of the study in English.
Chapter 12 provides a Dutch summary.
Appendix A
Frequent Sampling Intravenous Glucose Tolerance test (FSIGT-test)
Several values regarding glucose homeostasis can be measured by FSIGT; insulin sensitivity 
index, which is the ability of insulin to increase net glucose disposal; glucose eff ectiveness, which 
is the ability of glucose to increase its own disposal and reduce its own production; acute insulin 
response to glucose (AIRg), which is the integrated insulin release during the fi rst 10 minutes 
aft er the glucose infusion; and the disposition index (DI), the product of insulin sensitivity and 
acute insulin response indicating the degree of glucose homeostasis. Th ese indicators of glucose 
regulation were determined by the Bergman’s minimal model (MINMOD 6.01 copyright RN 
Bergman) calculating paired glucose and insulin data obtained by frequent measurements 
during an intravenous glucose tolerance test (FSIGT) (101-103) with Tolbutamide (104).
When insulin sensitivity varies in healthy subjects, these changes are compensated 
proportionally by insulin secretion; reduced insulin sensitivity leads to increased insulin 
secretion by the beta cells (Figure 6) (105). If insulin secretion does not change appropriately, 
impaired glucose tolerance and eventually type 2 diabetes mellitus will develop (23).
Figure 6. Hyperbolic association between insulin secretion and insulin sensitivity. Adapted from Kahn et 
al. (106). IGT: impaired glucose tolerance, T2DM: type 2 diabetes mellitus.
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Dual Energy X-ray Absorptiometry (DXA)
Dual Energy X-ray Absorptiometry (DXA) is a machine used to measure bone mineral density 
and body composition (fat mass and lean body mass). Th e person being assessed lies still for 
about 15 minutes while a scanner slides over the participant. DXA uses X-rays to assess these 
measures, but the radiation dose is about 1/10 of a chest X-ray. 
Carotid intima media thickness (IMT)
Intima media thickness is the thickness of the two inner layers of an arterial wall. Th e thickness 
of the intima media of the carotid artery is related to cardiovascular events in later life (60). 
Carotid IMT was measured in supine position by recording of ultrasonographic images of both 
left  and right carotid artery, using the same 7.5 MHz linear array transducer (ATL Ultramark IV, 
Advanced Tech. Laboratories, Bethel Washington, USA). On the R wave of the electrocardiogram, 
three longitudinal images of the near and far wall of the common carotid artery were frozen 
and stored on videotape. Th ese frozen images were digitalized and displayed on the screen of a 
computer using a frame grabber (VP 1400-KIT-512-E-AT, Imaging Technology). Th e common 
carotid IMT was determined as the mean of the mean near and far wall measurements of both 
the left  and right side common carotid artery.
Appendix B
Inclusion criteria of the PROGRAM-study:
Chronological age at inclusion: 18.00-23.99 years, −
Neonatal period without signs of severe asphyxia (defi ned as Apgar score < 3 aft er 5  −
minutes), no other serious diseases such as long-term artifi cial ventilation and oxygen 
supply, broncho-pulmonary dysplasia or other chronic lung disease,
Gestational age of 36 weeks or more, −
Well documented growth data, −
Caucasian, −
Born singleton, −
Signed informed consent. −
Exclusion criteria of the PROGRAM-study:
Chromosomal disorders, known syndromes and serious dysmorphic symptoms suggestive  −
for a yet unknown syndrome, except Silver-Russell Syndrome,
Any disease, endocrine or metabolic disorder that could interfere with growth during  −
childhood (like diabetes mellitus, growth hormone defi ciency, malignancies, severe chronic 
disease, emotional deprivation),
Treatment that could have interfered with growth (like radiotherapy or growth hormone  −
treatment),
Serious suspicion of psychosocial dwarfi sm (emotional deprivation) during childhood. −
Appendix C
Additional criteria for inclusion into one of the four subgroups:
Normal birth length and adult height were set at an SDS> –1 (± 0.1 SDS),
Born small for gestational age (<–2 SDS) with a short adult height (<-2 SDS) (SGA-short,  −
SGA-S),
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>-1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (controls).
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Background/Objectives: Low birth weight and postnatal catch-up growth has been associated 
with an increased risk for diabetes mellitus type II (DMII). We evaluated the contribution of 
birth- and adult size, body composition and waist to hip ratio to DMII risk factors in young 
adulthood.
Methods: In a group of 136 young adults, aged 18-24 years, insulin sensitivity and disposition 
index were determined by Frequent Sampling Intravenous Glucose Tolerance test (FSIGT). Th e 
association of clinical parameters with these variables was analyzed with multiple regression 
modeling. In addition, diff erences in insulin sensitivity and disposition index, a measure for 
beta cell function, were analyzed in 4 subgroups, young adults either born Small for Gestational 
Age with short stature (SGA-S) (n= 25) or with catch-up growth (SGA-CU) (n= 23) or, born 
Appropriate for Gestational Age (AGA) with Idiopathic Short Stature (ISS) (n= 23) or with 
normal stature (controls) (n= 26). 
Results: Fat mass (FM) was the only signifi cant predictor of insulin sensitivity, whereas birth 
length and birth weight were not signifi cant. Aft er correction for age, gender and adult body 
size, insulin sensitivity was signifi cantly lower in SGA-CU subjects compared to controls. None 
of the variables had a signifi cant infl uence on disposition index and there was no signifi cant 
diff erence in disposition index between the subgroups. 
Conclusions: Our data show that a higher body fat mass at 21 years is associated with reduced 
insulin sensitivity, independent of birth size. Th ese fi ndings have important implications for 
public health practice. 
Introduction
Size at birth has been inversely associated with adult diseases, such as diabetes mellitus type II 
(DMII) and cardiovascular diseases (1-3). A meta-analysis estimated that low birth weight was 
responsible for 35% of cases of DMII(4). Reduced insulin sensitivity is a well recognised, early 
determinant of DMII and cardiovascular disease, and it usually precedes clinical symptoms (5,6). 
Several studies found an association between low birth weight and reduced insulin sensitivity 
(1,7), but these studies did not correct for adult weight. 
Unfortunately, many study populations were heterogeneous with regard to gestational 
age, parity, ethnicity, used tests and age at evaluation. Also, many studies did not diff erentiate 
between height and weight, neither at birth nor in adulthood. Oft en insulin sensitivity is 
described, whereas actually the disposition index (insulin sensitivity x insulin secretion) is 
a better determinant of DMII (8). Th e disposition index refl ects how well the beta cells can 
compensate for a reduction in insulin sensitivity by increasing their insulin secretion (9). 
At this moment it is not clear who is most at risk for DMII, the subject born small for 
gestational age (SGA) with persistent short stature or the one born SGA with a normal stature 
aft er postnatal catch-up growth. We recently reported lower insulin sensitivity in 8 year olds 
born SGA with persistent short stature (SGA-S) compared to age-matched short children who 
were born appropriate for gestational age (AGA-Idiopathic Short Stature (ISS)) (10). Comparable 
results were found in another group of short prepubertal SGA children (11). Postnatal catch-up 
growth in weight and height is found in approximately 85% of SGA subjects (12,13). Catch-
up in height has been associated with increased insulin secretion, whereas catch-up in weight 
with reduced insulin sensitivity (14). In young adulthood, comparison of insulin sensitivity and 
secretion between SGA subjects with short stature and subjects with catch-up growth has not 
been performed. 
We hypothesized that both pre- and postnatal factors associate with insulin sensitivity. We 
therefore evaluated the relative contribution of birth length, birth weight, adult height, adult 
weight, fat mass (FM), lean body mass (LBM) and waist to hip ratio to insulin sensitivity and 
disposition index in young adulthood. In addition, we evaluated if there were diff erences with 
regard to insulin sensitivity and disposition index between 4 clinically recognizable subgroups 
of young adults, born SGA with either short adult height (SGA-S) or normal adult height (SGA-
CU), or born AGA with either idiopathic short stature (ISS) or normal adult height (controls).
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Subjects
Th e total population consisted of 136 healthy subjects with an age between 18 and 24 years. Th ey 
were randomly selected from hospitals in the Netherlands, were they had been registered because 
of their being small at birth (SGA with a birth length <–2SD) (15) or showing short stature (aft er 
being born SGA or appropriate for gestational age (AGA) with an adult height <–2SD) (16) 
or having a minor accidental health problem, but otherwise being normal. Only those born 
at 36 weeks or more of gestation, being singleton and Caucasian, were invited to participate 
in order to exclude a potential infl uence of prematurity, parity and ethnicity, respectively. All 
subjects fulfi lled the same inclusion criteria: an uncomplicated neonatal period without signs 
of severe asphyxia (defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-
term complications of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects 
were excluded if they had been suff ering from any serious condition or had been receiving 
any treatment known to interfere with growth (e.g. growth hormone defi ciency, severe chronic 
illness, emotional deprivation, growth hormone treatment, treatment with glucocorticosteriods, 
radiotherapy) or if they had endocrine or metabolic disorders, chromosomal defects, syndromes 
or serious dysmorphic symptoms suggestive for a yet unknown syndrome. Birth data were 
taken from hospital records, community health services and general practitioners. Th e Medical 
Ethics Committee of Erasmus Medical Centre, Rotterdam Th e Netherlands, approved this 
study. Written informed consent was obtained from all the participants.
Based on SD-scores of birth length and adult height, the subjects were also assigned to one 
of four subgroups. In order to increase the statistical power for subgroup comparison, the cut-
off  value was set at –1 SDS (± 0.1 SDS). 
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (short-SGA,  −
SGA-S),
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height  −
(>–1 SDS) (controls).
Th e number of males and females per subgroup are shown in Table 1. Of the 136 subjects, 
97 were included in one of the subgroups.
Assessments
All subjects were invited to the Erasmus University Medical Centre aft er a 12-h overnight fast and 
had abstained from smoking and alcohol for 16 hours. At this visit, in all subjects anthropometry 
was recorded, blood was drawn for fasting lipids, body composition was determined using Dual 
Energy X-ray Absorptiometry (DXA) and a Frequent Sampling Intravenous Glucose Tolerance 
test (FSIGT) with Tolbutamide was performed (17). All women were tested between 3-5 days 
before their expected menstrual period. A questionnaire concerning subject’s medical history 
and that of their relatives, use of contraceptives, physical activity and their substance use 
including smoking was completed. Adult height was measured using a Harpenden stadiometer, 
whereas weight in kilograms was measured to the nearest 0.1 kg on a digital scale (Servo Balance 
KA-20-150S). Waist and hip circumference were measured at the level of the umbilicus and 
greater trochanters with a non-extendable measuring tape. One trained investigator performed 
all measurements according to standardised methods. Body composition was assessed on 
the same DXA machine (Lunar Prodigy, GE Healthcare, Chalfont St Giles, UK) and quality 
assurance was performed daily. Indicators of glucose regulation were determined by the 
Bergman’s minimal model (MINMOD 6.01 copyright RN Bergman) calculating paired glucose 
and insulin data obtained by frequent measurements during an intravenous glucose tolerance 
test (FSIGT) (17-19) with Tolbutamide (9). Values derived were insulin sensitivity index (Si), 
which is the ability of insulin to increase net glucose disposal, glucose eff ectiveness (Sg), which 
is the ability of glucose to increase its own disposal and reduce its own production, acute insulin 
response to glucose (AIRg), which is the integrated insulin release during the fi rst 10 minutes 
aft er the glucose infusion, and the disposition index (DI), the product of insulin sensitivity 
and acute insulin response indicating the degree of glucose homeostasis. Blood samples were 
centrifuged directly aft er withdrawal and serum and plasma were immediately frozen at –80 °C 
for later analyses. 
Assays
All plasma glucose levels were determined on a VITROS analyser 750 (Orthoclinical Diagnostics, 
Johnson&Johnson Company, Beerse, Belgium). All plasma insulin levels were measured 
by IRMA (Medgenix; Biosource Europe, Nivelles, Belgium). Th e intra-assay coeffi  cient of 
variation (CV) was 2% to 4.7% (19-405 pmol/l) and the inter-assay CV was 4.2% to 11.3% (32-
375 pmol/l). All assays were performed in one central laboratory. 
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SD-scores for birth length, birth weight, adult height and adult weight were calculated in order 
to correct for gestational age, gender and age (15,16). Multiple linear regression (MR) analysis 
was performed to determine which variables contribute to insulin sensitivity and disposition 
index. First, we entered age, gender, height SDS, birth length SDS and birth weight SDS to the 
model (model A). Th e interaction term birth length SDS * adult height SDS was added to all 
MR models because the study group had been selected on birth length and adult height, in 
order to ensure that the eff ect of these variables was modeled correctly. Secondly, weight SDS 
and waist-to-hip ratio were added (model B). Th irdly, lean body mass (LBM) and fat mass (FM) 
were added as independent variables instead of adult weight SDS and waist-to-hip ratio was 
removed (model C). Finally, we added waist-to-hip ratio again to the model (model D). 
Prior to the study, a power analysis with a level of signifi cance (α) of 0.05 and a chosen 
power of 80% estimated that there should be at least 17 subjects in each subgroup to enable 
detection of relevant diff erences in insulin sensitivity (10). ANOVA was used to determine 
if there were diff erences between the subgroups with regard to the group characteristics. 
Bonferroni correction was used for pair wise group comparisons. To determine diff erences 
between the groups aft er correction for age, gender, adult size and adult fat mass, an ANCOVA 
model was used, with controls as reference group and SGA-S, SGA-CU and ISS as dummy 
variables. Statistical package SPSS version 11.0 (SPSS, Inc., Chicago, IL) was used for analysis. 
Results were regarded statistically signifi cant if p was < 0.05.
Results
Th e clinical characteristics of the study population are shown in Table 1. Th e total population 
consisted of 136 subjects with a mean (SD) age of 21 (1.5) years. We evaluated the relative 
contribution of several variables to insulin sensitivity in a multiple linear regression analysis. 
Th e initial analysis with insulin sensitivity as dependent variable included age, gender, adult 
height SDS, birth length SDS, birth weight SDS and the interaction term birth length SDS x 
adult height SDS (Table 2). Only gender and birth weight were signifi cant determinants of 
insulin sensitivity (Model A, adjusted R2= 0.06, p= 0.03). However, when we added adult weight 
SDS and waist-to-hip ratio to the regression model, gender, adult height SDS, adult weight SDS 
and waist-to-hip ratio were signifi cant determinants of insulin sensitivity, whereas birth weight 
was no longer signifi cant (Model B, adjusted R2= 0.17). Aft er specifi cation of adult weight in 
fat mass and lean body mass, measured by DXA, fat mass appeared to be the only signifi cant 
determinant of insulin sensitivity (Model C, adjusted R2= 0.23), even aft er adding waist-to-hip 
ratio to the model (Model D, adjusted R2= 0.24). Th ere were no signifi cant interactions between 
birth weight or -length and fat mass or lean body mass with regard to insulin sensitivity.
For disposition index as dependent variable, no signifi cant determinants were found.
Table 1. Clinical characteristics of the total study group and the 4 subgroups.
Total group 
(n= 136)
SGA-S 
(n=25)
SGA-CU 
(n=23)
ISS 
(n=23)
Controls 
(n=26)
Gender (M/F) 68/68 11/14 12/11 11/12 14/12
Gestational age (wk) 39.1 (1.5) 39.4 (1.3) 38.1 (1.3) ‡ 39.4 (1.6) 39.0 (1.6)
Birth length (cm) 47.5 (2.78) 45.6 (1.31) #* 44.7 (1.68) #* 49.7 (1.43) 50.6 (1.58)
Birth length (SDS) –1.58 (1.36) –2.73 (0.57) #* –2.75 (0.76) #* –0.46 (0.46) § 0.08 (0.70) §
Birth weight (kg) 2.76 (0.63) 2.50 (0.37) #* 2.16 (0.28) #* 3.29 (0.63) 3.27 (0.53)
Birth weight (SDS) –1.28 (1.34) –1.96 (0.72) #* –2.39 (0.63) #* –0.04 (1.38) –0.12 (1.12)
Age (years) 21.0 (1.5) 20.9 (1.6) 21.1 (1.4) 21.0 (1.5) 20.9 (1.6)
Height (m) 1.68 (0.11) 1.59 (0.07) ^* 1.75 (0.07) 1.60 (0.06) ^* 1.78 (0.08)
Height (SDS) –1.39 (1.32) –2.57 (0.56) ^* –0.28 (0.77) –2.50 (0.41) ^* 0.13 (0.91)
Weight (kg) 64.1 (13.8) 56.6 (9.1) ^* 73.7 (14.0) 56.6 (13.3) ^* 71.5 (14.4)
Weight (SDS) –0.80 (1.56) –1.68 (1.42) ^* 0.31 (1.20) –1.88 (1.64) ^* 0.11 (1.22)
Adult Fat% 24.6 (10.0) 24.9 (8.6) 25.9 (10.9) 24.6 (9.8) 23.2 (9.9)
Adult Fat (kg) 16.0 (8.4) 14.1 (5.7) 19.5 (10.2) 14.5 (8.8) 16.8 (9.5)
Adult LBM (kg) 45.2 (10.3) 40.0 (7.7) ^* 51.0 (9.7) 39.8 (7.9) ^* 51.3 (10.8)
Waist/Hip ratio 0.84 (0.07) 0.84 (0.08) 0.87 (0.08) 0.83 (0.08) 0.85 (0.06)
Values are given as means (sd). M: Male, F: Female,
$: p< 0.001 compared with the other subgroups, §: p<0.05 compared with the other subgroups, 
‡: p< 0.02 compared with SGA-S and ISS, *: p<0.001 compared with controls, #: p<0.001 compared with ISS,
^: p< 0.001 compared with SGA-CU.
Comparison of the subgroups
Ninety-seven subjects were eligible for the analysis of diff erences between the four clinically 
relevant groups. Th ere was a signifi cant diff erence in gestational age between the SGA-CU 
group and the SGA-S and ISS group (p< 0.02) and a signifi cant diff erence in birth length SDS 
between ISS and AGA subjects (p< 0.05) (Table 1). Other diff erences were due to the selection 
criteria. Th ere was a tendency for a higher weight and FM in SGA-CU subjects but weight and 
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2absolute or relative FM were not signifi cant between groups. Physical activity, alcohol use and 
smoking were not signifi cantly diff erent between the subgroups. 
Table 2. Multiple regression for Si in young adulthood
Si
Model A Model B Model C Model D
Variables β p-value β p-value β p-value β p-value
Age (yrs) –0.21 0.389 –0.15 0.516 –0.13 0.543 –0.11 0.620
Gender –1.84 0.013 –2.75 0.001 –0.13 0.927 –0.79 0.614
Height SDS 0.34 0.381 0.87 0.038 0.47 0.314 0.49 0.305
Birth length SDS 0.01 0.987 0.001 0.998 0.12 0.801 0.12 0.791
BL*AH (SDS) 0.19 0.369 0.16 0.413 0.14 0.464 0.14 0.464
Birth weight SDS 0.89 0.040 0.66 0.116 0.55 0.169 0.51 0.209
Weight SDS –0.74 0.018
W/H ratio –13.8 0.026 –7.70 0.210
Fat mass (kg) –0.24 < 0.0005 –0.21 < 0.0005
LBM (kg) 0.02 0.758 0.02 0.799
Overall 0.026 < 0.0005 < 0.0005 < 0.0005
R2 0.10 0.22 0.28 0.29
R2 adjusted 0.06 0.17 0.23 0.24
BL: Birth length SDS; AH: Adult height SDS
Table 3 shows the results of the FSIGT tests. Th e SGA-CU group had the lowest insulin 
sensitivity and highest insulin secretion of the four groups, but this diff erence was not statistically 
signifi cant before correction for possible confounders. In order to correct for age, gender, 
adult height and adult weight, we additionally performed multiple linear regression analyses. 
Aft er correction, the SGA-CU group appeared to have a signifi cantly lower insulin sensitivity 
compared to the controls (p= 0.01). Since fat mass is an important factor in determining insulin 
sensitivity, we also corrected for adult fat mass (Table 4, model 2). Th e explained variance rose 
from 0.17 to 0.30, indicating the relevance of FM. Th e diff erence in insulin sensitivity between 
the three subgroups and controls tended to become less signifi cant, but the diff erence between 
SGA-CU and controls remained signifi cant (p= 0.02). 
Table 3. FSIGT results of the total study group and the 4 subgroups*.
Total group 
(n= 136)
SGA-S
(n= 25)
SGA-CU
(n= 23)
ISS
(n= 23)
Controls
(n= 26)
Si *10-4/min (μU/ml) 6.9 (4.3) 6.3 (3.9) 4.9 (3.1) 6.7 (4.1) 8.0 (4.0)
Sg *10-2/min (mg/d) 0.02 (0.01) 0.02 (0.01) 0.02 (0.01) 0.02 (0.00) 0.02 (0.00)
AIRg (mU/l) 540 (509) 615 (703) 782 (777) 401 (261) 456 (283)
DI (Si*AIRg) 2833 (1818) 2698 (1618) 2716 (1908) 2264 (1306) 3208 (2242)
Fasting glucose (mmol/l) 4.9 (0.51) 5.0 (0.45) 4.9 (0.50) 4.8 (0.5) 4.9 (0.4)
Fasting insulin (mU/l) 10.2 (4.7) 10.2 (5.1) 11.5 (4.1) 9.1 (3.9) 10.1 (5.0)
*Not corrected for age, gender and adult size.
Values are given as means (sd).
Si: insulin sensitivity; Sg: sensitivity of glucose disposal by glucose,
AIRg: acute insulin response to glucose ; DI: disposition index.
Table 4. Diff erence in insulin sensitivity of the subgroups versus controls*.
Model 1 Model 2
Variables β p-value β p-value
Age (yrs) –0.33 0.177 -0.23 0.316
Gender –1.88 0.13 0.01 0.988
Height SDS 0.32 0.570 -0.19 0.723
Weight SDS –0.94 0.001 0.89 0.077
FM (kg) -0.33 < 0.0005
SGA-S1 –2.25 0.214 -1.34 0.421
SGA-CU1 –2.66 0.013 -2.28 0.021
ISS1 –2.13 0.237 -0.60 0.720
Overall 0.001 < 0.0005
R2 0.23 0.36
R2 adjusted 0.17 0.30
*After correction for age, gender, adult height and adult weight.
1: The control group is the reference group.
Aft er correction for age, gender, adult height and adult weight, the acute insulin response 
(AIR) was signifi cantly higher in all three subgroups compared to controls (Table 5). Aft er an 
additional correction for fat mass, the AIR was only signifi cantly higher in the SGA-S and SGA-
CU groups, compared to controls. 
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2Multiple regression analysis showed, however, no signifi cant diff erence in disposition index 
between the four groups aft er correction for age, gender, adult height and adult weight. 
Table 5. Multiple regression for AIRg in various subgroups.
Model 1 Model 2
Variables β p-value β p-value
Age (yrs) –60.0 0.077 –65.2 0.055
Gender 167.3 0.104 71.0 0.556
Height SDS 93.5 0.222 120.0 0.125
Weight SDS 169.7 < 0.0005 75.3 0.309
FM (kg) 17.5 0.138
SGA-S1 702.4 0.005 659.0 0.009
SGA-CU1 345.4 0.019 328.9 0.025
ISS1 526.8 0.034 451.3 0.073
Overall < 0.0005 < 0.0005
R2 0.32 0.33
R2 adjusted 0.26 0.27
1: The control group is the reference group.
Discussion
Our study in 136 young adults shows that adult fat mass is the main predictor of insulin 
sensitivity in young adulthood, whereas birth length and birth weight were not. When data on 
body composition are not available, gender, adult height, adult weight and waist-to-hip ratio 
appear to be signifi cant determinants. None of these variables had a signifi cant infl uence on the 
disposition index. Analysis in four clinically relevant subgroups showed that, aft er correction 
for age, gender, adult height and adult weight, SGA-CU subjects had signifi cantly lower insulin 
sensitivity compared to controls. Th is diff erence remained signifi cant even aft er an additional 
correction for fat mass. Th ere were no signifi cant diff erences between the subgroups with regard 
to disposition index.
Our data, measured by FSIGT and DXA, show a strong infl uence of fat mass on insulin 
sensitivity in young adults whereas birth size had no infl uence on insulin sensitivity. Th ese 
fi ndings are in line with a previous study in 25 years old adults born SGA, which showed that 
lower insulin sensitivity coincided with weight gain rather than with birth weight(20). Due to 
the DXA measurements, we could specify weight gain as accumulation of fat. Our data imply 
that all individuals, regardless of their size at birth, should try to achieve or maintain a normal 
fat mass for their body size.
Our fi rst model showed that birth weight and gender were signifi cant determinants of 
insulin sensitivity. Th is is consistent with studies of Barker, who showed an inverse association 
between birth size and adult diseases, like DM II and cardiovascular diseases (1,3). However, 
when we added adult weight and waist-to-hip ratio to the model, birth weight was no longer a 
signifi cant determinant of insulin sensitivity, whereas adult size (height, weight and waist-to-hip 
ratio) was signifi cant (Model B). Th is is in line with other studies demonstrating weight gain or 
growth acceleration during childhood as a signifi cant factor (14,21-23). When we specifi ed adult 
weight into FM and LBM, FM was the only signifi cant determinant of insulin sensitivity (Model 
C). Th e regression model shows that, given a similar birth length or birth weight, the fat mass 
in young adults, accumulated from birth to 21 years, determines insulin sensitivity. Th us, an 
additional accumulation of 10 kilograms of fat will reduce insulin sensitivity by 2.42*10–4/min 
(μU/ml). Our last model showed that waist-to-hip ratio had no additional value in determining 
insulin sensitivity (Model D). Th is is probably due to the prior correction for FM, because in 
Model B, W/H ratio is a signifi cant determinant. Another reason might be the small variation 
of W/H ratio at this age.
Th e “growth acceleration hypothesis’, as suggested by Singhal and Lucas, in which fetal 
growth restriction relative to genetic growth potential could result in deleterious growth 
acceleration postnatally (24), can be taken a step further. In our study, we had the opportunity 
to correct for birth-, adult size and adult body composition. As fat accumulation appeared to 
be the only signifi cant factor in the determination of insulin sensitivity, we therefore propose 
to specify growth acceleration by increased accumulation of fat mass. One may call this the “fat 
accumulation hypothesis”, indicating that an increased accumulation of fat during childhood, 
independent of birth size, will result in reduced insulin sensitivity. Increased fat mass is 
associated with changes in levels of free fatty acids and adipocytokines (e.g. adiponectin, leptin) 
(25), which aff ect insulin sensitivity and action. Th ese changes might, in time, lead to adult 
diseases like DMII and cardiovascular diseases. Growth acceleration in height and weight as 
such is not a problem as long as a normal amount of fat is accumulated. 
We analysed if there were diff erences in insulin sensitivity and disposition index between 
four clinically relevant groups of young adults (SGA-S, SGA-CU, ISS and controls) because 
some investigators, including ourselves, described reduced insulin sensitivity in prepubertal 
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subjects born SGA when they had reached young adulthood. Our study revealed no diff erence 
between the SGA-S subjects compared to the other subgroups. Th e diff erence with the studies in 
prepubertal children might be due to puberty, when insulin sensitivity decreases in all children 
(27). Th e explanation might be that the decline in insulin sensitivity in SGA-S children is less 
during puberty, which would result in almost the same values as the ISS and controls in young 
adulthood.
Aft er correction for age, gender, adult height and adult weight, we found signifi cantly lower 
insulin sensitivity in SGA-CU compared to controls. As fat mass is a signifi cant determinant of 
insulin sensitivity, a diff erence in fat mass might explain the lower insulin sensitivity in SGA-
CU. Th is would be in line with data in 4 year old SGA-CU subjects who already had a higher fat 
mass and a lower insulin sensitivity compared to age-matched AGA subjects (23). We, therefore, 
performed an additional correction for fat mass. Th e diff erence in insulin sensitivity became 
less, but remained signifi cant, indicating that also other factors contribute to the reduced insulin 
sensitivity in SGA-CU subjects compared to controls. Diff erences in IGF-I have been described 
but are controversial (23,28). Another factor that has been suggested is the amount of LBM. 
Decreased muscle mass might lead to more insulin resistance (29,30). However, in our total 
study population, LBM had no signifi cant association with insulin sensitivity (Table 2). Other 
relevant factors might be genetic factors (31), such as a higher allele frequency of polymorphism 
in the glucocorticoid receptor gene (32), leading to increased glucocorticoid sensitivity, which 
might contribute to the lower insulin sensitivity in SGA-CU subjects. 
Several studies concluded that intra-uterine growth retardation (IUGR) has an independent 
eff ect on insulin sensitivity, but they did not take adult size or weight gain into account (1,22,33). 
We have studied two SGA subgroups, with one group having lower insulin sensitivity and 
the other group having similar insulin sensitivity compared to controls. In our opinion, this 
supports our conclusion that birth size as such is not a relevant factor in determining insulin 
sensitivity.
ISS subjects had the same insulin sensitivity compared to controls. Aft er correction for 
adult height and adult weight, their insulin sensitivity was non-signifi cantly lower compared to 
controls, but this disappeared aft er correction of fat mass, indicating a relatively higher fat mass 
percentage in ISS subjects than controls. Insulin sensitivity of young adults with ISS has never 
been described. 
Aft er correction for age, gender, adult height, adult weight and fat mass, SGA-S subjects 
had a signifi cantly higher AIR compared to controls, whereas their insulin sensitivity was 
comparable. Th e reason for this is unknown, but an increased sensitivity of the beta cells for 
glucose might be a reason, or a reduced insulin clearance by the liver. SGA-CU subjects also 
had a signifi cantly higher AIR compared to controls aft er the corrections, but their insulin 
sensitivity was signifi cantly lower. Th is is a known compensation mechanism to maintain 
glucose tolerance (9). Th e signifi cantly higher AIR in ISS subjects might be due to a diff erence 
in fat mass, because aft er the additional correction for fat mass, the signifi cance disappeared.
We determined which factors infl uence disposition index, because the most important 
determinant of DM II is beta cell function (8). We applied the MR models on disposition index, 
but none of the variables appeared to be a signifi cant factor. Also our subgroups comparison 
showed no diff erence in disposition index. It has been shown that a reduction in disposition 
index and not reduced insulin sensitivity relates to an increased risk of DM II(34). Normally, the 
beta cells will increase their insulin secretion when insulin sensitivity declines. When the beta 
cells start to fail, the disposition index, which stands for insulin sensitivity x insulin secretion, 
will decline. Two studies in SGA-S and SGA subjects showed a reduced insulin sensitivity, but 
recalculations show that the disposition index was normal, indicating an increased insulin 
secretion (10,35). Our present study shows that all four groups had a normal disposition index 
indicating that all groups had normal functioning beta cells at the age of 21 years. Th us the fear 
that SGA subjects might be at a higher risk of DM II at the age of 21 years compared to those 
born AGA, could not be substantiated by our study. 
We have chosen for a study population, which consisted for a relative large percentage of 
subjects born small for gestational age and of short adults, compared to the normal population. 
Th is results in a better statistical model because there is more contrast in the study population, 
so relationships between various factors can be detected with more statistical power. Another 
advantage of this study population is that it allows comparison between clinically relevant 
subgroups. Better insight could be obtained in the diff erences between the subgroups with 
regard to insulin sensitivity and disposition index, aft er correction for age, gender, adult size 
and fat mass.
In conclusion, our study in 136 young adults shows that adult fat mass is the main predictor 
of insulin sensitivity in young adulthood, whereas birth length and birth weight had no 
signifi cant infl uence on insulin sensitivity. None of these variables had a signifi cant infl uence on 
the disposition index. SGA-CU subjects had signifi cantly lower insulin sensitivity compared to 
controls, aft er correction for age, gender, adult height, adult weight and fat mass. No diff erences 
in disposition index were found between the subgroups. As a result of our fi ndings, we propose 
to introduce the “fat accumulation hypothesis”. For public health practice this means, that 
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2parents of all children, independent of birth size or growth during childhood, should be aware 
of the risks of fat accumulation in their children. Children at risk for fat accumulation, like 
SGA-CU subjects, need to be controlled on a regular basis by primary health workers.
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Abstract
Background / Objectives: Several studies have investigated the relationship of birth size with 
fat mass (FM) and lean body mass (LBM), but the fi ndings diff ered greatly due to diff erent ways 
of measuring FM and LBM, diff erent study populations and age groups. We hypothesized that 
birth size has no infl uence on adult body composition, whereas weight gain during childhood 
has.
Methods: In the PROGRAM-study, a cohort of 312 young adults, aged 18-24 years, FM and 
LBM were determined by Dual Energy X-ray Absorptiometry (DXA). Subsequently, diff erences 
in FM and LBM were analyzed in 4 subgroups, young adults either born Small for Gestational 
Age with short stature (SGA-S) or with catch-up growth (SGA-CU), or born Appropriate for 
Gestational Age (AGA) with Idiopathic Short Stature (ISS) or with normal stature (controls). 
Results: Age, gender, adult height SDS and adult weight SDS were signifi cant positive 
determinants of FM and LBM, whereas weight gain during childhood was positively signifi cant 
for FM and negatively for LBM. Birth weight SDS tended to be signifi cant and birth length SDS 
was not. Weight gain during childhood was positively correlated with waist/hip ratio and trunk 
fat/total fat ratio. SGA-CU subjects had signifi cantly higher FM and signifi cantly lower LBM 
than controls. 
Conclusion: Weight gain during childhood is an important determinant of body composition 
in young adulthood, whereas birth size is less important. In clinical practice, too much weight 
gain in childhood should be prevented as it results in a relatively high fat mass, especially in 
children with catch-up growth in weight, like SGA-CU subjects.
Introduction
Birth size, especially birth weight, has been associated with adult diseases like diabetes mellitus 
type II (DMII) and cardiovascular diseases (1). Some studies showed a signifi cant association 
between low birth weight and an increased risk for cardiovascular diseases (2,3), but other 
studies found controversial results with regard to the relationship between birth weight and 
BMI (4-6), whereas BMI was recognized as an important predictor for cardiovascular disease 
(7,8). As a higher BMI might be due to either a higher fat mass (FM) or more lean body mass 
(LBM) or both, BMI is an inappropriate measure for explaining the risk of cardiovascular 
disease in adulthood.
Some studies have investigated the relationship of birth weight with FM and LBM separately 
(9-16). Th ese studies are inconsistent with each other due to diff erences in measuring FM and 
LBM. Various methods have been used like skinfold-thickness measurements, bioelectrical-
impedance analysis, hydrostatic weight measurements and Dual Energy X-ray Absorptiometry 
(DXA) measurements. Th ese studies have been performed in diff erent age groups. Additionally, 
not all studies corrected for adult size (height and weight). For this reason, it is diffi  cult to 
compare these studies and to draw conclusions with regard to the relationship between birth 
size and body composition in adulthood. Based on recent literature, we hypothesized that birth 
size has no infl uence on adult body composition, whereas weight gain during childhood has 
(6,17). 
We therefore investigated in a cohort of 312 young adults (PROGRAM-study), the infl uence 
of birth length and birth weight on FM and LBM measured by DXA, with and without correction 
for adult size. Additionally, we investigated if there were diff erences in FM and LBM between 
four clinically recognizable subgroups of young adults, born SGA with either short adult height 
(SGA-S) or normal adult height (SGA-CU), or born AGA with either idiopathic short stature 
(ISS) or normal adult height (controls).
Subjects and Methods
Subjects
Th e PROgramming factors for GRowth And Metabolism study (PROGRAM) investigated a 
cohort of 323 healthy subjects with an age between 18 and 24 years. Th ey were randomly selected 
from hospitals in the Netherlands, were they had been registered because of their being small 
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at birth (SGA with a birth length <–2SD) (18) or showing short stature (aft er being born SGA 
or appropriate for gestational age (AGA) with an adult height <–2SD) (19). In addition, healthy 
subjects of diff erent schools were randomly asked to participate as controls. Only those born at 
36 weeks or more of gestation, being born singleton and Caucasian, were invited to participate 
in order to exclude a potential infl uence of prematurity, parity and ethnicity, respectively. All 
subjects fulfi lled the same inclusion criteria: an uncomplicated neonatal period without signs 
of severe asphyxia (defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-
term complications of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects 
were excluded if they had been suff ering from any serious condition or had been receiving 
any treatment known to interfere with growth (e.g. growth hormone defi ciency, severe chronic 
illness, emotional deprivation, growth hormone treatment, treatment with glucocorticosteriods, 
radiotherapy) or if they had endocrine or metabolic disorders, chromosomal defects, syndromes 
or serious dysmorphic symptoms suggestive for a yet unknown syndrome. Birth data were 
taken from hospital records, community health services and general practitioners. Th e Medical 
Ethics Committee of Erasmus Medical Centre, Rotterdam Th e Netherlands, approved this 
study. Written informed consent was obtained from all the participants.
Of the 323 participants who entered the study, 11 were excluded from analysis because of 
incomplete data, resulting in a total number of 312 subjects eligible for the multiple regression 
analyses in the total group. Based on SD-scores of birth length and adult height, the subjects 
were also assigned to one of four subgroups. Normal birth length and adult height were set at an 
SDS> –1 (± 0.1 SDS), in order to increase the statistical power to identify diff erences between 
subgroups. Of the 312 subjects, 217 were included in one of the subgroups:
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (SGA-short,  −
SGA-S),
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (controls).
Methods
All participants were invited to visit the Erasmus Medical Centre in Rotterdam. Th ey had been 
fasting for 12-hours and had abstained from smoking and alcohol for 16 hours. Height was 
measured to the nearest 0.1 cm by a Harpenden stadiometer and weight to the nearest 0.1 kg by 
a scale (Servo Balance KA-20-150S). All anthropometric measurements were performed twice 
and the mean value was used for analysis. 
All participants had FM and LBM measured by one DXA machine (Lunar Prodigy, GE 
Healthcare, Chalfont St Giles, UK). Quality assurance was daily performed. Th e intra-essay 
coeffi  cient of variation for lean tissue and fat tissue has been reported to be 1.57-4.49% and 
0.41-0.88%, respectively (20).
Statistical analysis
In order to correct for gestational age, gender and age, SD-scores for birth length, birth weight, 
adult height and adult weight were calculated (18,19). Because of a skewed distribution, FM was 
log transformed. Multiple linear regression (MR) analyses, as suggested by Lucas et al (21), were 
performed to determine the association between birth size and FM and LBM, correcting for 
age, gender, and adult size. Firstly, we entered age, gender, adult height SDS, birth length SDS 
and birth weight SDS to the model, to investigate the infl uence of birth size on the outcomes 
(model A). Th e interaction term birth length SDS * adult height SDS was added to all MR 
models because the study group had been selected on birth length and adult height in order 
to ensure that the eff ect of these variables was modeled correctly. Secondly, birth weight SDS 
was replaced by adult weight SDS, to relate adult size to FM and LBM (model B). Th irdly, birth 
weight SDS was added to the model. When birth size and adult size are shown in one model, it 
is possible to investigate if the change in weight (centile crossing) between birth and adulthood 
is related to the outcomes (model C). Finally, we added the interaction term birth weight SDS 
* adult weight SDS to investigate whether birth weight modifi es the eff ect of adult weight on 
outcome. Th is means that we can answer the question whether being growth retarded at birth 
and having weight gain during childhood is more serious in terms of outcome than having 
a normal birth size and an equivalent weight gain during childhood (model D). To analyze 
associations between fat distribution and weight gain SDS aft er correction for age and gender, 
partial correlations were used.
For the subgroup comparisons, FM and LBM were expressed as percentage of bodyweight 
to correct for weight and subsequently as SD-scores with controls as reference group. ANOVA 
was used to determine if there were diff erences between the subgroups with regard to the group 
characteristics. Bonferroni correction was used for pair wise group comparisons. To determine 
diff erences between the groups corrected for age, gender and adult size, an ANCOVA model 
was used, with controls as reference group and SGA-S, SGA-CU and ISS as dummy variables. 
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Statistical package SPSS version 11.0 (SPSS, Inc., Chicago, IL) was used for analysis. Results 
were regarded statistically signifi cant if p was < 0.05.
Results
Th e clinical characteristics of our study group are shown in Table 1. Mean (SD) age was 20.9 
(1.67) years. 
Table 1. Clinical characteristics of the total study group and the 4 subgroups.
Total group 
(n= 312)
SGA-S 
(n=44)
SGA-CU 
(n=56)
ISS 
(n=38)
Controls
(n=79)
Male (n) (%) 122 (39.1) 15 (34.1) 23 (41.1) 16 (42.1) 29 (36.7)
Birth length (cm) 47.6 (3.08) 45.2 (1.98)* 44.6 (1.9)* 49.6 (1.4)§ 50.8 (1.7)
Birth length (SDS) –1.5 (1.48) –2.90 (0.79)* –2.86 (0.80)* –0.53 (0.47)$ 0.08 (0.75)
Birth weight (kg) 2.78 (0.67) 2.50 (0.48)§ 2.19 (0.33)§ 3.25 (0.56) 3.30 (0.62)
Birth weight (SDS) –1.2 (1.39) –1.94 (0.94)*# –2.36 (0.70)* –0.17 (1.14)^ –0.09 (1.27)
Age (years) 20.9 (1.68) 20.7 (1.76) 21.0 (1.5) 21.0 (1.7) 20.8 (1.71)
Height (cm) 168.2 (10.7) 157.3 (6.7)*^ 174.7 (7.8) 159.3 (6.7)*^ 176.8 (7.7)
Height (SDS) –1.1 (1.37) –2.63 (0.55)*^ –0.14 (0.77)§ –2.48 (0.40)*^ 0.24 (0.90)
Weight (kg) 63.8 (12.5) 56.7 (11.4)*^ 70.5 (14.4) 56.5 (12.2)*^ 68.8 (11.0)
Weight (SDS) –0.6 (1.42) –1.55 (1.54)*^ 0.12 (1.17) –1.77 (1.67)*^ 0.07 (0.98)
Delta weight SDS 0.57 (1.99) 0.39 (1.76) 2.48 (1.33)$ –1.60 (2.22)$ 0.16 (1.43)
BMI 22.5 (3.9) 22.9 (4.6) 23.1 (4.5) 22.2 (4.7) 21.9 (2.9)
Waist/Hip Ratio 0.88 (0.07) 0.87 (0.08) 0.90 (0.07) 0.87 (0.08) 0.89 (0.06)
FM (kg) ** 15.7 (8.73) 15.7 (8.88) 18.7 (10.7) 14.7 (9.10) 15.6 (8.71)
FM (SDS) ** 0.01 (1.02) 0.35 (1.23) –0.10 (1.05) 0.00 (1.00)
Trunk fat / total fat ratio 0.48 (0.06) 0.47 (0.06) 0.49 (0.06) 0.47 (0.07) 0.48 (0.05)
LBM (kg) ** 45.1 (9.85) 38.3 (7.28)*^ 48.5 (9.86) 39.1 (7.17)*^ 50.0 (9.78)
LBM (SDS) ** –1.20 (0.74)*^ –0.16 (1.01) –1.11 (0.73)*^ 0.00 (1.00)
Values are given as means (sd). **Not corrected for age, gender, adult height and adult weight.
$: p< 0.001 compared with the other subgroups, §: p< 0.02 compared with the other subgroups, 
*: p< 0.001 compared with controls, #: p<0.001 compared with ISS, ^: p< 0.001 compared with SGA-CU.
Fat mass
Table 2 shows the results of the multiple regressions for FM. Model A shows the infl uence of 
birth length and birth weight on FM aft er correction for age, gender and adult height SDS. 
In this model, birth length SDS was no signifi cant determinant for adult FM, whereas birth 
weight SDS was borderline signifi cant (β= -0.057, p= 0.082) and age and gender were strong 
signifi cant determinants (adjusted R2= 0.23). Th e second model shows the infl uence of adult 
weight SDS on FM. Adult weight SDS was a strong signifi cant determinant of FM, next to age, 
gender and adult height SDS (Model B, adjusted R2= 0.71). Model C demonstrates that both 
birth weight and adult weight were signifi cant factors, but the beta and the level of signifi cance 
were reasonably higher for adult weight than for birth weight. In addition, when birth weight is 
related to FM aft er adjustment for adult weight, this indirectly demonstrates change in weight 
during childhood (see Methods). Th is model shows that the subjects with the highest weight 
gain had relatively more FM (adjusted R2= 0.72). Th e fi nal model shows no signifi cant infl uence 
of the interaction term BW*AW, meaning that having weight gain from a lower birth weight has 
no extra eff ect on FM in young adulthood than having weight gain from a higher birth weight. 
Th e last three models showed that age, gender and adult height SDS were also signifi cant 
determinants of FM.
Table 2. Multiple regression for log transformed FM.
Log transformed FM
Model A Model B Model C Model D
Variables β1 p-value β1 p-value β1 p-value β1 p-value
Age (yrs) 4.36 0.011 3.40 0.001 3.50 0.001 3.53 0.001
Gender 52.1 < 0.0005 52.1 < 0.0005 52.9 < 0.0005 52.7 < 0.0005
Height SDS 5.00 0.083 –13.9 < 0.0005 –14.6 < 0.0005 –14.8 < 0.0005
Birth length SDS 1.11 0.753 –1.27 0.397 1.66 0.436 2.19 0.341
BL*AH (SDS) 0.68 0.631 0.49 0.598 0.32 0.709 0.81 0.446
Birth weight SDS –5.65 0.082 –3.89 0.048 –4.28 0.046
Weight SDS 33.7 < 0.0005 33.4 < 0.0005 33.2 < 0.0005
BW*AW (SDS) –0.23 0.810
Overall < 0.0005 < 0.0005 < 0.0005 < 0.0005
R2 adjusted 0.23 0.71 0.72 0.72
1: refers to the unstandardized regression coeffi  cients (1/100).
BL: Birth length SDS, AH: Adult height SDS, BW: Birth weight, AW: Adult weight.
Lean body mass
Th e results of the MR analysis are shown in Table 3. Model A showed that birth length SDS was 
not signifi cant, aft er correction for age, gender and adult height. Birth weight SDS and age were 
58
Infl uence of Birth Size on Body Composition
59
Chapter
3
borderline signifi cant (β= 0.55, p= 0.06 and β= 0.33, p= 0.03, respectively), whereas gender 
and adult height SDS were strong signifi cant determinants of LBM (adjusted R2= 0.79). Model 
B shows that adult weight was a strong signifi cant determinant of LBM (Model B, adjusted 
R2= 0.86). Model C demonstrates that both birth weight and adult weight were signifi cant 
factors, but the beta and the level of signifi cance were reasonably higher for adult weight than 
for birth weight. In addition, when birth weight is related to LBM aft er adjustment for adult 
weight, this indirectly demonstrates change in weight during childhood. Th is model shows that 
subjects with the highest weight gain had relatively less LBM (adjusted R2= 0.86). Th e fi nal 
model shows that the interaction term was not signifi cant, which indicates that weight gain 
from a lower birth weight has no extra eff ect on LBM in young adulthood than having weight 
gain from a higher birth weight. All models show that age, gender and adult height SDS were 
also signifi cant determinants of LBM.
Table 3. Multiple regression for LBM (kg)
LBM
Model A Model B Model C Model D
Variables β p–value β p–value β p–value β p–value
Age (yrs) 0.33 0.031 0.29 0.020 0.28 0.030 0.27 0.032
Gender –15.6 < 0.0005 –15.5 < 0.0005 –15.5 < 0.0005 –15.6 < 0.0005
Height SDS 3.69 < 0.0005 2.35 < 0.0005 2.44 < 0.0005 2.45 < 0.0005
Birth length SDS –0.39 0.223 0.19 0.287 –0.35 0.180 –0.29 0.303
BL*AH (SDS) –0.04 0.723 0.04 0.737 0.02 0.833 0.05 0.691
Birth weight SDS 0.55 0.061 0.66 0.006 0.60 0.020
Weight SDS 2.09 < 0.0005 2.12 < 0.0005 1.99 < 0.0005
BW*AW (SDS) –0.084 0.456
Overall < 0.0005 < 0.0005 < 0.0005 < 0.0005
R2 adjusted 0.79 0.86 0.86 0.86
BL: Birth length SDS, AH: Adult height SDS, BW: Birth weight, AW: Adult weight.
Fat distribution
As weight gain appeared to be an important determinant of adult body composition, we 
additionally investigated if weight gain during childhood was associated with waist / hip ratio 
and trunk fat / total fat ratio, aft er correction for age and gender. Weight gain during childhood 
was strongly correlated to waist / hip ratio (r= 0.20, p< 0.0005), but especially to trunk fat / total 
fat ratio (r= 0.42, p< 0.0005). 
Comparison of the subgroups
Th e clinical characteristics of the subgroups are shown in Table 1. ISS subjects had a signifi cantly 
lower birth length SDS than controls (p< 0.001) and SGA-CU subjects had signifi cantly shorter 
adult height than controls (p< 0.02). SGA-CU subjects had the highest FM (kg) of the 4 
subgroups, but this diff erence did not reach signifi cance. Further, LBM (in kg and SDS) was 
signifi cantly lower in SGA-S and ISS subjects than in SGA-CU subjects and controls (p< 0.001). 
However, these data were not corrected for confounders like age, gender, adult height and adult 
weight. Other diff erences were due to the selection criteria.
To determine possible diff erences between the subgroups with regard to FM and LBM, 
corrections for age, gender and adult height were made. We used percentage of FM (%FM) 
and LBM (%LBM) as outcome parameters. Figure 1 shows the corrected diff erences in %FM 
between the subgroups. SGA-CU subjects had signifi cantly higher %FM than controls, aft er 
correction for age, gender and adult height SDS (p= 0.026). Th e other subgroups did not 
signifi cantly diff er from controls.
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SGA-S:     small for gestational age with short stature 
SGA-CU: small for gestational age catch-up growth 
ISS:           idiopathic short stature 
Figure 1. Diff erence in %FM SD-score between the 3 subgroups compared to controls (with 95% CI), aft er 
correction for age, gender and adult height. # p= 0.026
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Corrected diff erences in %LBM are shown in Figure 2. SGA-CU subjects had a signifi cantly 
lower %LBM than controls (p= 0.018). Th e other subgroups did not signifi cantly diff er from 
controls. 
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Figure 2. Diff erence in %LBM SD-score between the 3 subgroups compared to controls (with 95% CI), aft er 
correction for age, gender and adult height. * p= 0.018
Fat distribution was not signifi cantly diff erent between the subgroups aft er correction for age 
and gender, although the trunk fat / total fat ratio was highest in SGA-CU subjects (diff erence 
with controls was 0.012 (p= 0.187)). Weight gain during childhood was not signifi cantly 
correlated with parameters of fat distribution in the subgroups (data not shown).
 
Discussion
Our study in 312 young adults shows that age, gender, adult height SDS and adult weight SDS 
as well as weight gain during childhood are signifi cant determinants of FM and LBM, whereas 
birth weight SDS tends to be. Comparison of the subgroups showed that SGA-CU subjects had 
a signifi cantly higher %FM and a signifi cantly lower %LBM than controls, aft er correction for 
age, gender and adult height.
Th e fi rst MR models showed that birth weight was borderline signifi cant for adult FM as 
well as adult LBM, whereas adult weight was a strong signifi cant determinant of both FM and 
LBM, next to age, gender and adult height. Th e third model showed that adult weight was a 
reasonably stronger determinant of adult FM and LBM than birth weight. Th e model indirectly 
showed that the gain in weight during childhood was a signifi cant positive determinant of FM 
and a signifi cant negative determinant of LBM, indicating that of two subjects, the one with 
the greatest change in weight during childhood will gain relatively more FM than LBM. Th e 
fi nal model answered the question whether a certain weight gain aft er low birth weight gives a 
diff erent body composition than a similar weight gain aft er normal birth weight. Because the 
interaction term BW*AW was not signifi cant, our data show that birth size has no additional 
eff ect on body composition when subjects have the same weight gain. We therefore conclude 
that adult weight and weight gain during childhood are determinants of body composition and 
that subjects with more catch-up growth in weight during childhood gain relatively more FM 
than LBM.
Our results are in line with other reports showing a positive association between birth 
weight and LBM (9,10,12-16,22,23). With regard to FM, there was no conclusive answer in recent 
studies (12-16,22,23). Our study shows that birth weight has opposite eff ects on FM and LBM. 
One explanation might be that subjects who were born aft er fetal growth retardation use their 
energy for their vital organs and do not use their spare energy for accumulation of LBM, but 
rather for FM as a buff er for diffi  cult periods later in life.
It remains diffi  cult to determine whether prenatal or postnatal growth is the most important 
determinant of long-term outcome parameters. Catch-up growth in weight can only be 
measured indirectly by subtracting early weight SDS of later weight SDS. Nevertheless, with 
the MR models suggested by Lucas et al (21), we were able to assess the infl uence of weight 
gain during childhood on FM and LBM. Because the time span between birth and adulthood is 
large and we have no growth data within this period, we could not defi ne in which period this 
catch-up in weight took place. It would be interesting to collect data on growth in infancy and 
during childhood as it might specify the time period wherein catch-up in weight takes place. 
Some reports showed that infancy is an important period for catch-up in weight, especially the 
fi rst few months aft er birth (24-26). However, other investigators reported that the association 
between catch-up in weight and later blood pressure becomes only detectable aft er a longer 
period of time (27). We were able to demonstrate that catch-up in weight, somewhere during 
childhood, had an eff ect on FM and LBM at the age of 18-24 years.
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Fat distribution had a strong correlation with weight gain during childhood. Th is indicates 
that persons with higher weight gain during childhood accumulate relatively more central fat 
than peripheral fat. Too much weight gain will result in a relatively large amount of central fat. 
Th is has serious consequences for later life as central fat distribution has been associated with 
cardiovascular risk factors, like dyslipidemia and hyperglycemia. (28,29) On the other hand, 
specifi cation in visceral or subcutaneous fat is necessary (30).
Short SGA subjects (SGA-S) had similar %LBM and %FM as controls, aft er correction for 
age, gender and adult height. Previous fi ndings reported that prepubertal SGA-S subjects had a 
lower fat percentage and a lower BMI compared to controls, but no corrections for height and 
weight were made (31,32). Another explanation might be that SGA-S subjects accumulate more 
fat during puberty, which results in a similar BMI and %FM as controls. 
SGA-CU subjects had a signifi cantly higher %FM and a signifi cantly lower %LBM than 
controls, which is in line with the literature (11,33,34). While their low birth weight might 
explain some of this diff erence, their weight gain during childhood explained most of this 
diff erence, because SGA-S subjects had a similar size at birth but less catch-up growth. Th us, 
SGA-CU subjects accumulated more FM. Th ey also increased their LBM, but to a lower extend 
than FM. 
Högler et al showed that growth retardation during childhood resulted in a reduced LBM 
when no correction for weight was made (35). We corrected for adult size and our results in 
ISS subjects show that their body composition in young adulthood is equal to controls. Th eir 
reduced weight gain during childhood will lead to a reduced amount of LBM and FM, but not 
to a diff erent body composition (%LBM and %FM).
Our study population consisted of a relative high percentage of subjects born small for 
gestational age and of short adults. Th is created greater contrast in the study population, which 
contributed to a better statistical model in which relationships between various factors could 
be detected with more statistical power. In addition, this study population allowed comparison 
between clinically relevant subgroups.
In conclusion, our hypothesis that birth size has no association with adult body composition, 
whereas weight gain during childhood has, is only partially correct. Our study in 312 young 
adults showed that adult weight SDS as well as weight gain during childhood are strong 
signifi cant determinants, next to age, gender and adult height. In contrast, birth length SDS 
is not a signifi cant factor and birth weight SDS was borderline signifi cant. Th us, weight gain 
during childhood is a strong determinant of body composition in young adulthood, whereas 
birth size is less important. For clinical practice it means that too much weight gain in childhood 
should be prevented as it results in a relatively high fat mass, especially in children with catch-
up growth in weight, like SGA-CU subjects.
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Abstract
Background / Objectives: An association between an unfavourable lipid profi le and low birth 
weight has been reported, although this association remains controversial. We hypothesized 
that birth size does not have any infl uence on serum lipid levels but fat accumulation during 
childhood has.
Methods: In the PROGRAM-study, a cohort of 297 young adults, aged 18-24, the infl uence of 
clinical parameters on total cholesterol (TC), triglycerides, low-density lipoprotein, high-density 
lipoprotein, lipoprotein a, apolipoprotein A-1 and B (apoA-1 and apoB) were analyzed with 
multiple regression modeling. In addition, diff erences in these lipid levels and apolipoprotein E 
(ApoE) genotype prevalence were analyzed in 4 subgroups, young adults either born Small for 
Gestational Age with short stature (SGA-S) or with catch-up growth or, born Appropriate for 
Gestational Age with Idiopathic Short Stature or with normal stature (controls).
Results: Birth length SDS and birth weight SDS were no signifi cant determinants of the serum 
lipid levels, while gender, ApoE genotype, adult height SDS, adult weight SDS and fat mass were. 
Comparison of the subgroups showed that SGA-S subjects had a signifi cantly higher apoB than 
controls. Th ere were no other signifi cant diff erences in lipid levels or ApoE genotype prevalence 
between the four subgroups.
Conclusion: ApoE genotype is an important genetic determinant of lipid levels in young 
adulthood. Furthermore, fat accumulation during childhood signifi cantly determines serum 
lipid levels, whereas birth size has no signifi cant contribution. For public health practice this 
means, that parents and their children need to be informed about the risks of fat accumulation 
during childhood.
Introduction 
Raised levels of total cholesterol (TC), low-density lipoprotein (LDLc), apolipoprotein B (apoB) 
and lipoprotein a (Lp(a)) together with reduced levels of high-density lipoprotein (HDLc) and 
apolipoprotein A-I (apoA-I) increase the risk for cardiovascular disease (1-4). In the literature, 
there is an ongoing discussion whether low birth weight has a signifi cant infl uence on various 
lipid levels, like TC, LDLc, HDLc, apoA-I and apoB. Some reports found an association between 
low birth weight and high TC levels (5-8), indicating that subjects born with a low birth weight 
would have an increased risk for cardiovascular disease due to an unfavourable lipid profi le. 
Conversely, systematic reviews showed no associations between serum birth weight and lipid 
levels (9,10). Also in subjects born small for gestational age (SGA), normal lipid profi les were 
found, although a distinction between SGA subjects with or without catch-up growth was 
seldom made (11-16).
Apolipoprotein E (ApoE) is an important regulator of serum lipid levels because it aff ects 
hepatic binding and uptake of several lipoproteins (17). Th e affi  nity for the LDLc receptor is 
diff erent for the six ApoE genotypes. ApoE genotype ε3/ε3 is most common. Subjects carrying 
the ε2 allele have a lower affi  nity for the LDLc receptor, which results in an up-regulation of 
the LDLc receptor. Th is leads to more uptake of lipoproteins and thus lower serum lipid levels. 
In contrast, subjects carrying the ε4 allele have a higher affi  nity for the LDLc receptor, which 
results in higher lipid levels (17,18). Th e ε4 genotype is associated with higher coronary disease 
risk (18,19). So far, no study has investigated the infl uence of the ApoE genotype in subjects 
born SGA and subjects with idiopathic short stature (ISS).
Recently, we demonstrated in young adults of the PROGRAM study, that birth size had 
no infl uence on insulin sensitivity in young adulthood, whereas fat accumulation during 
childhood had (20). Th erefore, we hypothesized that prenatal growth, refl ected by size at birth, 
has no infl uence on serum lipid levels in young adulthood, whereas postnatal growth and 
genetic factors have. To test our hypothesis, we investigated the infl uence of birth length, birth 
weight, adult size, body composition and ApoE genotype on TC, triglycerides (TG), HDLc, 
LDLc, apoA-I, apoB and Lp(a) in 297 young adults. In addition, we investigated if there were 
diff erences in the prevalence of ApoE genotype and serum lipid levels between four clinically 
relevant subgroups of young adults: born SGA with either short adult height (SGA-S) or normal 
adult height (SGA-CU), or born AGA with either idiopathic short stature (ISS) or normal adult 
height (controls).
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Subjects and Methods
Subjects
Th e PROgramming factors for GRowth And Metabolism (PROGRAM) study cohort consists 
of 323 healthy subjects with an age between 18 and 24 years. Th ey were randomly selected 
from hospitals in the Netherlands, were they had been registered because of their being small 
at birth (SGA with a birth length <–2SD) (21) or showing short stature (aft er being born SGA 
or appropriate for gestational age (AGA) with an adult height <–2SD) (22). In addition, healthy 
subjects of diff erent schools were randomly asked to participate as controls. Only those born 
at 36 weeks or more of gestation, born singleton and Caucasian, were invited to participate 
in order to exclude a potential infl uence of prematurity, parity and ethnicity, respectively. All 
subjects fulfi lled the same inclusion criteria: an uncomplicated neonatal period without signs 
of severe asphyxia (defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-
term complications of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects 
were excluded if they had been suff ering from any serious condition or had been receiving 
any treatment known to interfere with growth (e.g. growth hormone defi ciency, severe chronic 
illness, emotional deprivation, growth hormone treatment, treatment with glucocorticosteriods, 
radiotherapy) or if they had endocrine or metabolic disorders, chromosomal defects, syndromes 
or serious dysmorphic symptoms suggestive for a yet unknown syndrome. Birth data were 
taken from records of hospitals, community health services and general practitioners. Th e 
Medical Ethics Committee of Erasmus Medical Centre, Rotterdam Th e Netherlands, approved 
this study. Written informed consent was obtained from all participants.
Of the 323 participants who entered the study, complete data on lipid levels, body composition 
and anthropometry were obtained in 297 subjects. Based on the SD-scores of birth length and 
adult height, the subjects were also assigned to one of four subgroups. Normal birth length 
and adult height were set at an SDS> –1 (± 0.1 SDS), in order to increase the contrast between 
the subgroups. Th is resulted in an increased statistical power to identify diff erences between 
subgroups. Of the 297 subjects, 208 fulfi lled the inclusion criteria for the subgroup analyses: 
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (SGA-S), −
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (Controls).
Measurements
All participants were invited to visit Erasmus Medical Centre in Rotterdam. Th ey had been 
fasting for 12-hours and had abstained from smoking and alcohol for 16 hours. Height was 
measured to the nearest 0.1 cm by a Harpenden stadiometer and weight to the nearest 0.1 kg by 
a scale (Servo Balance KA-20-150S, Katwijk, Netherlands). All anthropometric measurements 
were performed twice and the mean value was used for analysis. 
In all participants, lean body mass (LBM) and fat mass (FM) were measured on one DXA 
machine (Lunar Prodigy, GE Healthcare, Chalfont St Giles, UK). Quality assurance was daily 
performed. Th e intra-assay coeffi  cient of variation for lean tissue and fat tissue was 1.57-4.49% 
and 0.41-0.88%, respectively (23).
Laboratory methods
Fasting levels of TC, TG, HDLc, apoA-1, apoB and Lp(a) were measured. Low-density 
lipoprotein cholesterol (LDLc) was calculated using the Friedewald formula: LDLc (mmol/l) = 
total cholesterol – HDLc – 0.45 x triglycerides. 
Total cholesterol and TG were measured using an automated enzymatic method with the 
CHOD-PAP reagent kit and with the GPO-PAP reagent kit, respectively (Roche Diagnostics, 
Mannheim, Germany). HDLc was measured using a homogenous enzymatic colorimetric 
assay (Roche Diagnostics). ApoA-1, apoB and Lp(a) were determined by rate nephelometry on 
the Image Immunochemistry System, according to the manufacturers instructions (Beckman 
Coulter, Mijdrecht, the Netherlands). Th e intra-assay variations of measurements of TC, TG 
and HDLc were 2.9, 3.3 and 3.9%. Between-run coeffi  cients of variation for apoA-1, apoB and 
Lp(a) were 4.2%, 2.8% and 6.9% at levels of 0.94 , 0.53 and 0.35 g/l, respectively.
ApoE genotype was analyzed in 246 of the 297 subjects. Th ere were no diff erences in clinical 
characteristics between the 246 with ApoE genotyping and the 51 without. Th e ApoE genotype 
was determined on DNA samples using a polymerase chain reaction followed by enzymatic 
digestion using methods previously described (24).
Statistical analysis
SD-scores for birth length, birth weight, adult height and adult weight were calculated, in order 
to correct for gestational age, gender and age (21,22). Percentage of body fat was calculated as 
[body fat (kg) / weight (kg)] x 100%. Due to a skewed distribution, TG, LDLc, apoB and Lp(a) 
were log transformed. Multiple linear regression (MR) analysis was performed to determine 
the association between birth size and the lipid variables, correcting for age, gender and adult 
size. First, we entered age, gender, birth length SDS, birth weight SDS and adult height SDS 
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(Model 1). Th e interaction term birth length SDS e adult height SDS, birth length SDS and adult 
height SDS were added to all following MR models because the study cohort had been selected 
on birth length and adult height. Th is ensured that the eff ect of these variables was modeled 
correctly. Secondly, we added adult weight SDS to the model (Model 2). Th irdly, weight SDS 
was replaced by fat mass (FM) and lean body mass (LBM) to specify weight (Model 3). Th e 
interaction term gender e LBM was added to the model to investigate if the eff ect of LBM 
on women was diff erent than the eff ect of LBM on men. Finally, we added ApoE genotype to 
investigate if this had a signifi cant infl uence on serum lipid levels (Model 4). ApoE genotype 
was added with ApoE ε3/ε3 as reference group and the other 5 genotypes as dummy variables. 
Th e model assumptions independence, linearity, normality and homoscedasticy were examined 
in a histogram of the residuals, and subsequently by plotting the residuals against each predictor 
and against predicted values.
Diff erences in prevalence of ApoE genotype between the subgroups were analyzed with 
the Fisher’s exact test. ANOVA was used to determine if there were diff erences between the 
subgroups with regard to the group characteristics. Bonferroni correction was used for pair wise 
group comparisons. To determine diff erences between the groups corrected for age, gender, 
%body fat and ApoE genotype, an ANCOVA model was used, with controls as reference group 
and SGA-S, SGA-CU and ISS as dummy variables. Statistical package SPSS version 11.0 (SPSS, 
Inc., Chicago, IL) was used for analysis. Results were regarded statistically signifi cant if p was 
< 0.05.
Results
Total study population
Th e clinical characteristics and lipid levels of the total study population are shown in Table 1. 
Th e mean (sd) age at time of measurement was 20.9 (1.7) years. Th e data on body composition 
and lipid concentrations presented in Table 1 are not yet corrected for age, gender and adult 
size. Table 2 shows the prevalence of ApoE genotypes in the total study population. 
By multiple linear regression, we evaluated the contribution of birth size to the serum lipid 
levels in young adulthood. Firstly, a multiple regression was performed with birth length SDS 
and birth weight SDS aft er correction for age, gender and adult height SDS (model 1). Secondly, 
adult weight SDS was added (model 2). Subsequently, we replaced weight SDS for fat mass (FM) 
and lean body mass (LBM) (model 3). Finally, ApoE genotype was added (model 4). Th e results 
are shown in Table 3. Ta
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Table 2. Prevalence of the 6 genotypes of ApoE (%) in the total study population, the 4 subgroups and the 
unclassifi ed group.
ApoE 
genotype
Total group 
(n= 246)
SGA-S 
(n= 33)
SGA-CU 
(n= 44)
ISS 
(n= 26)
Controls
(n= 70)
Unclassifi ed
 (n= 73)
2/2 0.8 (2) 0 (0) 0 (0) 0 (0) 2.8 (2) 0 (0)
2/3 11.7 (29) 3.0 (1) 15.9 (7) 19.2 (5) 14.3 (10) 8.2 (6)
2/4 3.7 (9) 0 (0) 2.3 (1) 3.8 (1) 4.3 (3) 5.5 (4)
3/3 58.1 (143) 72.7 (24) 45.5 (20) 50 (13) 54.3 (38) 65.8 (48)
3/4 24.0 (59) 24.2 (8) 31.8 (14) 26.9 (7) 22.9 (16) 19.2 (14)
4/4 1.6 (4) 0 (0) 4.5 (2) 0 (0) 1.4 (1) 1.4 (1)
Data is given in percentages (n).
Th e fi rst model showed that gender had a signifi cant infl uence on all serum lipid levels, 
whereas birth length and birth weight had not. Th e second model showed that shorter adult 
height SDS and higher adult weight SDS resulted in a signifi cantly higher TC, TG, LDLc and 
apoB. For HDLc the relation was inversed, a higher adult height SDS and a lower adult weight 
SDS resulted in a signifi cantly higher level of HDLc. For apoA-1 this was not signifi cant. Birth 
length SDS and birth weight SDS remained not signifi cant.
Aft er replacement of adult weight SDS by FM and LBM, FM was a signifi cant determinant 
for all lipid variables, except for HDLc and apoA-1 (Model 3). Th e signifi cance of gender 
disappeared for most lipid variables, but adult height SDS remained a signifi cant determinant 
of lipid levels aft er correction for FM and LBM, except for apoA-1. LBM, birth length SDS and 
birth weight SDS were no signifi cant determinants for any lipid variable. 
Finally, several ApoE genotype were signifi cant determinants for total cholesterol, LDLc 
and apoB. Subjects carrying a ε2 genotype have lower levels, while subjects carrying a ε4 
genotype have higher levels. In these models, the explained variance rose by 6%, 10% and 7%, 
respectively. Th e rise in explained variance established by fat mass was less, 1%, 2% and 2%, 
respectively. For Lp(a), none of the variables had a signifi cant infl uence (data not shown). An 
additional correction for smoking did not change the results in the models of Table 4 (data not 
shown).
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Table 3. Multiple linear regression of the lipid variables.
Variables Model Gender Birth 
length 
SDS
Birth 
weight 
SDS
Adult height
SDS
Adult 
weight
SDS
Fat mass
(kg)
LBM
(kg)
ApoE genotype Adj R2
ε2/ε2 ε2/ε3 ε2/ε4 ε3/ε4 ε4/ε4
β P P P β P β P β P β P β P β P β P β P β P
TC (mmol/l) 1 0.68 <0.001 n.s. n.s. –0.06 n.s. 0.12
2 0.68 <0.001 n.s. n.s. –0.13 0.023 0.11 0.008 0.14
3 1.48 0.051 n.s. n.s. –0.10 n.s. 0.01 0.049 0.01 n.s 0.13
4 1.15 n.s. n.s. n.s. –0.07 n.s. 0.01 n.s. 0.02 n.s –0.74 n.s. –0.42 0.019 –0.44 n.s 0.35 0.011 0.65 n.s. 0.19
TG (log) 1 0.22 <0.001 n.s. n.s. –0.04 n.s. 0.08
2 0.22 <0.001 n.s. n.s. –0.08 0.003 0.08 <0.001 0.12
3 0.49 n.s. n.s. n.s. –0.08 0.024 0.01 0.005 0.01 n.s 0.11
4 0.70 0.092 n.s. n.s. –0.06 0.093 0.01 0.017 0.02 n.s 0.23 n.s. 0.15 0.082 0.20 n.s 0.02 n.s. 0.03 n.s. 0.12
LDLc (log) 1 0.12 <0.001 n.s. n.s. –0.02 n.s. 0.04
2 0.12 <0.001 n.s. n.s. –0.04 0.020 0.04 0.008 0.06
3 0.33 n.s. n.s. n.s. –0.04 0.056 0.00 0.044 0.01 n.s 0.06
4 0.11 n.s. n.s. n.s. –0.03 n.s. 0.01 0.083 0.00 n.s –0.41 0.035 –0.18 0.001 –0.16 0.078 0.11 0.007 0.22 n.s. 0.16
ApoB (log) 1 0.18 <0.001 n.s. n.s. –0.04 0.014 0.12
2 0.18 <0.001 n.s. n.s. –0.06 0.001 0.04 0.002 0.15
3 0.42 0.056 n.s. n.s. –0.05 0.007 0.00 0.018 0.01 n.s 0.14
4 0.27 n.s. n.s. n.s. –0.04 0.043 0.01 0.073 0.01 n.s –0.31 0.077 –0.15 0.003 –0.13 n.s 0.08 0.026 0.28 0.023 0.21
HDLc (mmol/l) 1 0.23 <0.001 n.s. n.s. 0.03 n.s. 0.10
2 0.22 <0.001 n.s. n.s. 0.05 0.021 –0.04 0.026 0.11
3 0.43 n.s. n.s. 0.069 0.10 0.001 –0.00 n.s. 0.00 n.s 0.14
4 0.49 n.s. n.s. n.s. 0.11 0.001 –0.01 n.s. –0.01 n.s –0.09 n.s. –0.05 n.s. –0.07 n.s –0.01 n.s. 0.04 n.s. 0.15
ApoA-1 (g/l) 1 0.20 <0.001 n.s. n.s. –0.02 n.s. 0.17
2 0.20 <0.001 n.s. n.s. 0.01 n.s. –0.01 n.s. 0.17
3 0.39 0.026 n.s. n.s. 0.02 n.s. 0.00 n.s. 0.00 n.s 0.19
4 0.39 n.s. n.s. 0.070 0.01 n.s. 0.00 n.s. 0.00 n.s –0.07 n.s. –0.04 n.s. –0.09 n.s –0.04 n.s. 0.11 n.s. 0.20
Signifi cant p-values are given in bold, n.s.: not signifi cant (p >0.10). β: regression coeffi  cient, P : p-value.
All models include a correction for age (n.s.). ApoE genotype ε3/ε3 is the reference group in model 4.
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Comparison of subgroups
Of the 297 subjects, 208 could be included in one of the four subgroups. Th eir clinical 
characteristics and serum lipid levels are shown in Table 1. Th e signifi cant diff erences in birth 
size and adult size between the subgroups are due to the selection criteria. SGA-S and ISS 
subjects had a signifi cantly lower lean body mass than the other subgroups, when no corrections 
were made for age, gender and adult weight. Almost all uncorrected lipid levels were higher in 
the SGA and ISS groups compared to those of controls. However, levels were not signifi cantly 
diff erent and within the normal range. 
Table 2 and Figure 1 show the prevalence of ApoE genotype in the subgroups. In SGA-S 
subjects, the prevalence of the ε3/ε3 genotype was higher and the favourable ε2/ε3 genotype was 
lower than in controls, while the SGA-CU subjects had a higher prevalence of the unfavourable 
ε3/ε4 genotype than controls, but these diff erences were not signifi cant.
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Figure 1. Prevalence of ApoE genotype per subgroup.
We also analyzed if there were diff erences in lipid levels between the subgroups, aft er 
correction for age and gender. Th ese analyses showed that SGA-S subjects had signifi cantly 
higher LDLc and apoB than controls (p= 0.014 and p= 0.006, respectively) (Table 4). SGA-CU 
subjects almost had a signifi cantly higher ApoB than controls (p= 0.051). Th ere were no other 
signifi cant diff erences in lipid levels between the four subgroups aft er correction for age and 
gender. Because of diff erences in fat mass and the prevalence of ApoE genotype between the 
subgroups, an additional correction for %body fat and ApoE genotype was performed. Only 
the diff erence in apoB levels remained signifi cant between the SGA-S subjects and controls 
(p= 0.034).
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Discussion
Our study in 297 young adults shows that birth length SDS and birth weight SDS were no 
signifi cant determinants of serum lipid levels, whereas gender, adult height SDS, adult weight 
SDS, fat mass and ApoE genotype were. ApoE genotype was the most important determinant. 
Th ere was no diff erence in ApoE genotype prevalence between the subgroups, although the 
SGA-S group had a lower prevalence of the favourable ε2 allele. Aft er correction for age, gender, 
%body fat and ApoE genotype, comparison of the subgroups showed that only apoB was 
signifi cantly higher in SGA-S subjects than in controls.
Birth weight SDS was not a signifi cant determinant in any of the models. Some studies 
found a negative correlation between birth weight and cholesterol aft er correction for adult 
weight, but this might have occurred because they did not adjust birth weight for gestational age 
(25-27). Two reviews concluded that there was no relationship between birth weight and adult 
lipid profi le (9,10). Birth length SDS was also not a signifi cant determinant in any of the models. 
In other reports, the relationship between birth length and lipid levels remained unclear (28-30). 
Our study results showed no signifi cant relation between birth weight as well as birth length 
and adult serum lipid levels, aft er correction for age, gender, ApoE genotype and adult size. 
All serum lipid levels were higher in young women than in men aft er correction for birth 
size and adult size, as shown by model 1 and 2. However, aft er correction for fat mass this 
signifi cant diff erence between women and men disappeared. Th is indicates that for serum lipid 
levels, gender related body composition is an important factor in young adulthood.
Th e fi rst model showed, that for all lipid variables, except HDLc and apoA-1, a shorter adult 
height and a higher adult weight resulted in signifi cantly higher serum lipid levels. It is likely 
that this refl exes fat mass as subjects with a similar adult weight, but a shorter adult height have 
a higher fat mass. Th e same accounts for HDLc, but inversely.
Several reports have indicated that weight gain during life might result in an unfavourable 
lipid profi le (31,32). While it has been suggested that this is due to an increase in fat mass, none 
of the studies could substantiate this theory because fat mass had not been measured. Our third 
model showed that an increase in fat mass resulted in higher serum levels of TC, TG, LDLc 
and apoB. Only HDLc and apoA-1 were not related to fat mass. Th e latter might indicate that 
HDLc and apoA-1 are not directly infl uenced by fat or fat accumulation, but more by other 
mechanisms like an impaired lipolysis of triglyceride-rich lipoproteins. Th is would lead to a 
decreased transfer of apolipoproteins and phospholipids from triglyceride-rich lipoproteins to 
HDLc (33).
Next to fat mass, other factors determine serum lipid levels, like genetic factors (34,35). In 
our total study population, the prevalence of ApoE genotypes was comparable with that of 
86,000 disease-free adults (18). ApoE genotype is an important gene in the determination of 
especially TC, LDLc and apoB as shown by the last MR model. Not all ApoE genotypes were 
signifi cant, but this might be due to the relatively small number of subjects in these subgroups. 
Th e explained variance rose from 6-16% to 14-21% when only ApoE genotype was added to 
the model. Th is may suggest that ApoE genotype is more important than body composition in 
determining lipid levels in young adulthood.
Comparison of the subgroups showed a signifi cant diff erence in LDLc and apoB between 
SGA-S subjects and controls, aft er correction for age, gender and %body fat. Aft er an additional 
correction for ApoE genotype the diff erence in LDLc disappeared. Various studies investigated 
lipid profi les in SGA subjects because it is thought that subjects born SGA have an increased risk 
for an unfavourable lipid profi le, due to their low birth size. One study found a less favourable 
lipid profi le in 3 days old SGA infants (36), but most studies showed no increased lipid levels in 
children born SGA, although they did not diff erentiate between SGA children with or without 
catch-up growth (11-15). Several studies Only Arends et al investigated various lipid variables 
in prepubertal SGA-S subjects but did not fi nd any diff erences compared to age and height 
matched controls (11). 
Only one study was performed in young adults. Th ey found signifi cantly lower levels of 
HDLc and higher levels of TG in a mixed group of SGA-S and SGA-CU subjects (16). Our 
present study specifi ed the SGA population and in contrast to our expectations, not SGA-CU 
but SGA-S subjects had higher apoB in early adulthood, although all lipid levels were still in 
the normal range. Th e reason for these higher levels remains unknown, but a reduced amount 
of LDLc receptors might be an explanation, because this leads to increased levels of apoB. In 
SGA-CU subjects, ApoB was borderline signifi cantly higher than controls, but this diff erence 
disappeared aft er an additional correction for %body fat and ApoE genotype. Th e reason that 
SGA-CU subjects did not have a signifi cant diff erence in lipid levels might be due to the fact 
that the diff erence in FM SDS between the SGA-CU and other subgroups is not large enough. 
Only one study reported lipid levels in ISS children, which were normal (37). Our results in the 
adult ISS group are in line with that study.
ApoE genotype did not diff er between the subgroups, although SGA-S subjects had a lower 
prevalence for the advantageous ε2 allele (ε2/ε2 and ε2 /ε3). Infante-Rivard et al concluded that 
the ε2 allele might protect from IUGR (38). Our results showed that SGA-CU subjects had the 
same prevalence of the ε2 allele, so we could not confi rm their results. 
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Our study population consisted of a relative high percentage of subjects born small for 
gestational age and of short adults. Th is created greater contrast in the study population, which 
contributed to a better statistical model in which relationships between various factors could 
be detected with more statistical power. In addition, this study population allowed comparison 
between clinically relevant subgroups. Better insight could be obtained in the diff erences 
between the subgroups, with regard to serum lipid levels aft er correction for age, gender, ApoE 
genotype and adult size. Although a larger sample size in our subgroup analyses might reveal 
smaller signifi cant diff erences in lipid levels, this sample size revealed signifi cant diff erences in 
two lipid variables between the subgroups and controls. Th erefore we state that our negative 
results in the subgroup analyses are justifi ed. 
In conclusion, our study demonstrates that prenatal growth has no infl uence on serum 
lipid levels in young adulthood, whereas postnatal growth, specifi ed as fat accumulation 
during childhood, and genetic factors have. For public health practice this means, that parents 
of all children, regardless of size at birth, should be aware of the risks of fat accumulation in 
their children. Th erefore, health care workers need to inform parents about the risks of fat 
accumulation during childhood.
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Abstract
Background / Objectives: Acylation stimulating protein (ASP) is an adipose tissue-derived 
hormone, which stimulates glucose and free fatty acid (FFA) uptake into adipocytes. Changes 
in ASP metabolism are associated with alterations in lipid metabolism. As postnatal catch-
up growth has been associated with dyslipidemia in later life, we investigated the association 
between ASP and birth size, adult size and diff erent growth patterns during childhood.
Methods: Th e associations were investigated by multiple regression analyses in 285 young 
adults, aged 18-24 years. Subsequently, diff erences in ASP were analyzed in 4 clinically relevant 
subgroups, young adults either born Small for Gestational Age with short stature (SGA-S) 
or with catch-up growth (SGA-CU), or born Appropriate for Gestational Age (AGA) with 
Idiopathic Short Stature (ISS) or with normal stature (controls). 
Results: Weight gain during childhood, particularly fat accumulation, was positively related to 
ASP levels in early adulthood, independent of birth size, age and gender. Fetal growth, refl ected 
by birth size, was not related to ASP levels. Between the subgroups, no diff erences in ASP were 
found, but SGA-CU and ISS subjects had signifi cantly higher levels of FFA.
Conclusion: Not fetal growth, but exaggerated weight gain during childhood contribute to 
alteration in ASP metabolism and might therefore lead to impairment of FFA uptake, which 
results in delayed TG clearance. Th erefore, exaggerated weight gain during childhood should 
be prevented. 
Introduction 
Acylation stimulating protein (ASP), also known as C3adesArg, is a relatively new hormone 
generated through the activation of the alternative complement pathway proteins C3, B and 
adipsin, and produced by adipocytes (1). ASP stimulates glucose and FFA uptake into adipocytes 
by increasing membrane glucose transport (2) and by increasing triacylglycerol synthesis in the 
adipocytes (3). By increasing incorporation of chylomicron-derived FFA into triglycerides (TG) 
in adipocytes, ASP prevents inhibition of lipoprotein lipase (LPL) by FFA and therefore helps to 
maintain normal serum FFA levels (4). In addition, ASP inhibits TG lipolysis in adipocytes by 
reducing the activity of hormone-sensitive lipase (HSL), resulting in lower serum FFA levels (5). 
By controlling the storage of TG, ASP helps to keep lipid levels in the normal range.
Normally, higher ASP levels should lead to lower TG levels and more accumulation of fat. 
However, in obesity, insulin resistance, cardiovascular disease and dyslipidemia, plasma ASP 
and TG levels are both increased, indicating reduced ASP activity, also called ASP resistance 
(6-10). In vitro studies have shown that cells from subjects with high ASP levels have reduced 
specifi c binding and response to ASP (11,12), which is partially induced by FFA (13). Higher 
ASP levels may be indicative for ASP resistance in the same way as higher insulin levels are 
indicative for insulin resistance, even with normal or near normal glucose (14). Th ese fi ndings 
resulted in the postulated hypothesis that higher ASP levels are related to ASP resistance, even 
when TG levels are normal (1,15).
Previous research showed that high fasting ASP predicts delayed clearance of TG in healthy 
men and women (15). Subsequently, postprandial hypertriglyceridemia has been associated 
with early dyslipidemia (16), which is a risk factor for cardiovascular disease. Th erefore, fasting 
ASP levels might predict dyslipidemia. Alterations in ASP metabolism might already begin at a 
young age as seen in 2-6 year-old obese children who had higher ASP levels and a small increase 
in plasma TG in absence of other lipid changes than controls (17). 
Postnatal catch-up growth in weight is related to determinants of cardiovascular disease 
(CVD) and type 2 diabetes in later life, such as reduced insulin sensitivity, adverse lipid profi les 
and higher fat mass in early adulthood, even when later BMI and percentage of body fat remain 
in normal range (18-21). Ninety percent of subjects born small for gestational age (SGA) show 
catch-up growth in the fi rst two years of life (22,23). Th ese subjects have a higher percentage 
body fat and reduced insulin sensitivity in early adulthood and may be at risk of development 
of CVD or type 2 diabetes (18,19). Higher ASP levels, indicating ASP resistance, have been 
found in subjects with increased body fat and reduced insulin resistance (10). We therefore 
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hypothesized that subjects with catch-up growth in weight would have higher levels of ASP, and 
thus might be at risk for early dyslipidemia.
Our aims were to investigate whether diff erent growth patterns during childhood infl uence 
ASP levels in early adulthood. In addition, we evaluated if there were diff erences in serum ASP 
levels between 4 clinically recognizable subgroups of young adults, born SGA with either short 
adult height (SGA-S) or normal adult height (SGA-CU), or born AGA with either idiopathic 
short stature (ISS) or normal adult height (controls).
Subjects and Methods
Subjects
Th e PROgramming factors for GRowth And Metabolism (PROGRAM) study cohort consists 
of 323 healthy subjects with an age between 18 and 24 years. Th ey were randomly selected from 
hospitals in the Netherlands, where they had been registered because of their being small at 
birth (SGA with a birth length <–2SD) (24) or showing short stature (aft er being born SGA or 
appropriate for gestational age (AGA) with an adult height <–2SD) (25). In addition, healthy 
subjects of diff erent schools were randomly asked to participate as controls. Only those born 
at 36 weeks or more of gestation, born singleton and Caucasian, were invited to participate 
in order to exclude a potential infl uence of prematurity, parity and ethnicity, respectively. All 
subjects fulfi lled the same inclusion criteria: an uncomplicated neonatal period without signs 
of severe asphyxia (defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-
term complications of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects 
were excluded if they had been suff ering from any serious condition or had been receiving 
any treatment known to interfere with growth (e.g. growth hormone defi ciency, severe chronic 
illness, emotional deprivation, growth hormone treatment, treatment with glucocorticosteriods, 
radiotherapy) or if they had endocrine or metabolic disorders, chromosomal defects, 
syndromes or serious dysmorphic symptoms suggestive of a yet unknown syndrome. Birth 
data and childhood growth data were obtained from records of hospitals, community health 
services and general practitioners. Th e Medical Ethics Committee of Erasmus Medical Centre, 
Rotterdam the Netherlands, approved this study. Written informed consent was obtained from 
all participants. 
Of the 323 participants who entered the study, 38 were excluded from analysis because of 
incomplete data, resulting in a total number of 285 subjects eligible for the multiple regression 
analyses in the total group. Based on SD-scores of birth length and adult height, the subjects 
were also assigned to one of four subgroups. Normal birth length and adult height were set at an 
SDS> –1 (± 0.1 SDS), in order to increase the statistical power to identify diff erences between 
subgroups. Of the 285 subjects, 198 were included in one of the subgroups:
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (SGA-short,  −
SGA-S),
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (controls).
Measurements
All participants were invited to visit Erasmus Medical Centre in Rotterdam. Th ey had been 
fasting for 12-hours and had abstained from smoking and alcohol for 16 hours. Height was 
measured to the nearest 0.1 cm by a Harpenden stadiometer and weight to the nearest 0.1 kg by 
a scale (Servo Balance KA-20-150S). All anthropometric measurements were performed twice 
and the mean value was used for analysis. 
In all participants, lean body mass (LBM) and fat mass (FM) were measured on the same 
DXA machine (Lunar Prodigy, GE Healthcare, Chalfont St Giles, UK). Quality assurance 
was performed daily. Th e intra-assay coeffi  cient of variation for lean tissue and fat tissue was 
1.57-4.49% and 0.41-0.88%, respectively (26). Blood samples were drawn to determine serum 
ASP and lipid levels. In 105 of the 285 subjects insulin sensitivity index (Si) and acute insulin 
response to glucose (AIRg) were available (18). Th e variables were determined by the Bergman’s 
minimal model (MINMOD 6.01 copyright RN Bergman) calculating paired glucose and insulin 
data obtained by frequent measurements during an intravenous glucose tolerance test (FSIGT) 
(27-29) with Tolbutamide (30).
Laboratory methods
Plasma ASP concentration was measured using a sandwich ELISA immunoassay method as 
previously described in detail (7). Intra-assay coeffi  cient of variations was <4% and interassay 
coeffi  cient of variations was <8%. Free fatty acids, total cholesterol (TC) and TG were measured 
using an enzymatic colometric method (WAKO Chemicals, Germany), an automated enzymatic 
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method with the CHOD-PAP reagent kit, and with the GPO-PAP reagent kit, respectively 
(Roche Diagnostics, Mannheim, Germany). HDLc was measured using a homogenous 
enzymatic colorimetric assay (Roche Diagnostics). Low-density lipoprotein cholesterol (LDLc) 
was calculated using the Friedewald formula: LDLc (mmol/l) = total cholesterol – HDLc – 
0.45 x triglycerides. ApoA-1 and ApoB were determined by rate nephelometry on the Image 
Immunochemistry System, according to the manufacturers instructions (Beckman Coulter, 
Mijdrecht, the Netherlands). Th e intra-assay variations of measurements of TC, TG and HDLc 
were 2.9, 3.3 and 3.9%. Between-run coeffi  cients of variation for apoA-1 and apoB were 4.2% 
and 2.8% at levels of 0.94 and 0.53 g/l, respectively. Plasma glucose levels were determined 
on a VITROS analyzer 750 (Orthoclinical Diagnostics, Johnson&Johnson Company, Beerse, 
Belgium) and plasma insulin levels were measured by IRMA (Medgenix, Biosource Europe).
 
Statistical analysis
SD-scores for birth length, birth weight, adult height and adult weight were calculated, in order 
to correct for gestational age, gender and age (24,25). Because of a skewed distribution, ASP, 
TG, LDLc, ApoB, insulin sensitivity and AIRg were log transformed. Multiple linear regression 
(MR) analyses were performed to determine the association between birth size, adult size and 
ASP, correcting for age and gender. Th e fi rst model consisted of age, gender, adult height SDS, 
birth length SDS and birth weight SDS to investigate the infl uence of birth size on the outcome 
(model A). Th e interaction term birth length SDS * adult height SDS was added to all MR 
models because the study group had been selected on birth length and adult height in order 
to ensure that the eff ect of these variables was modeled correctly. Secondly, adult weight SDS 
was added to the model. When birth size and adult size are shown in one model, it is possible 
to investigate if the change in weight (centile crossing) between birth and adulthood is related 
to the outcomes (model B). Finally, adult weight SDS was replaced by fat mass (FM) and lean 
body mass (LBM) to specify weight (model C). Th e interaction term gender * LBM was added 
to the model to correct for the extra eff ect of gender on LBM. Partial correlations were used to 
determine the relationship between ASP, lipid variables and insulin sensitivity, aft er adjustment 
for age and gender. For the subgroup comparisons, ANOVA was used to determine if there 
were diff erences between the subgroups with regard to the group characteristics. Bonferroni 
correction was used for pair wise group comparisons. To determine diff erences between the 
groups corrected for age and gender, an ANCOVA model was used, with controls as reference 
group and SGA-S, SGA-CU and ISS as dummy variables (model A). Additional adjustment for 
% body fat was made (model B). Statistical package SPSS version 15.0 (SPSS, Inc., Chicago, IL) 
was used for analysis. Results were regarded statistically signifi cant if p was <0.05.
Results
Clinical characteristics
Th e clinical characteristics of the total study population are shown in Table 1. Th e mean (sd) age 
of the study population was 20.9 (1.7) years. 
Table 1. Clinical characteristics of the total study population and the 4 subgroups.
Variables Total group 
(n= 285)
SGA–S 
(n= 31)
SGA–CU 
(n= 58)
ISS 
(n= 30)
Controls 
(n= 79)
Males (%) 38 36 38 37 38
Age 20.9 (1.7) 20.6 (1.8) 21.1 (1.5) 20.8 (1.7) 20.8 (1.7)
Birth length (cm) 47.7 (3.1) 45.0 (2.2) 44.5 (2.0) 49.7 (1.1) 1 50.7 (1.7) 1
Birth length SDS –1.45 (1.4) –2.96 (0.85) –2.85 (0.83) –0.51 (0.5) 1 0.07 (0.7) 1
Birth weight (kg) 2.78 (0.7) 2.44 (0.50) 2.17 (0.35) 3.28 (0.6) 2 3.29 (0.6) 2
Birth weight SDS –1.19 (1.4) –2.04 (1.0) –2.36 (0.72) –0.15 (1.2) 2 –0.11 (1.2) 2
Adult height (m) 1.69 (10.4) 1.58 (6.8) 1.74 (7.7) 3 1.59 (6.4) 1.77 (7.8) 3
Adult height SDS –0.95 (1.3) –2.60 (0.6) –0.18 (0.7) 1 –2.44 (0.4) 0.23 (0.9) 1
Adult weight (kg) 64.2 (12.3) 57.0 (12.6) 69.8 (13.2) 3 55.0 (11.3) 68.7 (11.0) 3
Adult weight SDS –0.56 (1.4) –1.52 (1.5) 0.09 (1.1) 3 –1.90 (1.7) 0.05 (1.0) 3
BMI 22.4 (3.5) 23.0 (4.9) 22.9 (3.6) 21.8 (4.9) 21.9 (2.9)
ASP (nM)* 15.7 (11–21) 12.9 (9–21) 15.6 (11–21) 13.8 (10–18) 15.8 (11–21)
TC (mmol/l) 4.52 (0.93) 4.67 (0.95) 4.67 (1.05) 4.44 (0.98) 4.41 (0.85)
Triglycerides (mmol/l) 1.03 (0.52) 0.99 (0.56) 1.11 (0.53) 1.03 (0.53) 0.99 (0.48)
FFA (mmol/l) 0.61 (0.25) 0.60 (0.25) 0.67 (0.22) 0.69 (0.28) 0.53 (0.24) 4
LDL (mmol/l) 2.66 (0.81) 2.83 (0.83) 2.73 (0.95) 2.59 (0.83) 2.53 (0.72)
ApoB (g/l) 0.82 (0.23) 0.87 (0.25) 0.84 (0.25) 0.83 (0.26) 0.76 (0.22)
HDL (mmol/l) 1.39 (0.37) 1.34 (0.30) 1.43 (0.41) 1.39 (0.38) 1.42 (0.36)
ApoA1 (g/l) 1.31 (0.23) 1.29 (0.21) 1.32 (0.24) 1.36 (0.26) 1.28 (0.23)
Insulin sensitivity** 6.95 (4.40) 6.19 (3.97) 4.88 (3.11) 7.10 (4.49) 7.98 (4.05) 5
Acute insulin response** 556 (536) 686 (790) 782 (777) 415 (279) 456 (283)
Data given in mean (sd), * median (quartiles), ** Data of 105 subjects in the total study population, 16 SGA-S, 23 
SGA-CU, 16 ISS and 25 controls.
1 p< 0.05 compared with all other subgroups, 2 p< 0.05 compared with SGA-S and SGA-CU, 3 p< 0.05 compared with 
SGA-S and ISS, 4 p< 0.05 compared with SGA-CU and ISS, 5 p< 0.05 compared with SGA-CU.
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Relationship between ASP and growth patterns during childhood
Birth length as well as birth weight were no signifi cant determinants of serum fasting ASP levels 
in early adulthood, aft er adjustment of age, gender and adult height SDS (Table 2, Model A). 
Adding adult weight SDS to the model indirectly shows whether weight gain (centile crossing) 
from birth to early adulthood is related to later ASP levels (Model B). Adult weight SDS was 
a determinant of ASP (p< 0.0005), indicating that the attained weight in early adulthood 
infl uenced ASP levels, but Model B indirectly showed that in fact weight gain during childhood 
resulted in a higher ASP level in early adulthood. To specify adult weight SDS, we replaced adult 
weight SDS by fat mass (FM) and lean body mass (LBM) (Model C). FM tended to be a positive 
determinant for ASP levels in early adulthood (p= 0.06). Th e signifi cance of gender in the fi rst 
two models disappeared aft er adjustment for body composition, indicating that the higher level 
of ASP in women was explained by the diff erence in fat mass. 
Table 2. Multiple regression of ASP in early adulthood
ASP*
Model A Model B Model C
Variables β p-value β p-value β p-value
Age (yrs) –0.01 0.597 –0.01 0.518 –0.02 0.379
Gender 0.26 < 0.0005 0.26 < 0.0005 –0.83 0.102
Birth length SDS –0.04 0.291 –0.04 0.274 –0.04 0.279
Birth weight SDS 0.02 0.591 0.03 0.431 0.02 0.644
Height SDS 0.02 0.668 –0.05 0.197 –0.09 0.056
Weight SDS 0.11 < 0.0005
Fat mass (kg) 0.01 0.060
LBM (kg) –0.02 0.233
Overall 0.012 < 0.0005 < 0.0005
R2 adjusted 0.04 0.08 0.09
All models include the interaction term birth length x adult height. 
Model C includes the interaction term gender x LBM.
*: log transformed
Relationship between ASP, lipid levels and insulin sensitivity
Correlations between ASP, serum lipid levels and insulin sensitivity are shown in Table 3. Aft er 
adjustment for age and gender, positive but weak correlations were found between ASP and TG 
(p= 0.009), total cholesterol (p= 0.039), ApoB (p= 0.014), and acute insulin response (p= 0.048). 
ASP was negatively related to insulin sensitivity (r= –0.28, p = 0.007). FFA levels were also 
related to insulin sensitivity (r= –0.31, p= 0.002).
Table 3. Partial correlations between ASP, lipid levels and insulin sensitivity.
Variables ASP* FFA TG* TC LDLc* ApoB* HDLc ApoA1 Si*
FFA –0.06
TG* 0.16 1 0.11
TC 0.13 1 0.02 0.34 2
LDLc* 0.10 –0.01 0.18 2 0.86 2
ApoB* 0.15 1 0.02 0.41 2 0.87 2 0.90 2
HDLc 0.02 –0.04 –0.13 1 0.27 2 –0.11 –0.10
ApoA1 0.11 –0.13 0.10 0.27 2 –0.07 0.03 0.78 2
Si* –0.28 1 –0.31 2 –0.25 1 –0.25 1 –0.24 1 –0.26 1 0.14 0.06
AIRg* 0.19 1 –0.16 0.20 1 0.19 0.17 0.17 –0.03 –0.03 –0.41 2
Values given are regression coeffi  cients.
All correlations are corrected for age and gender. 
*: log transformed. 1: p <0.05, 2: p <0.005.
Comparison of subgroups
Of the total study population, 198 subjects were assigned to one of four subgroups and the 
clinical characteristics of the subgroups are shown in Table 1. ISS subjects had a signifi cantly 
lower birth length SDS than controls and SGA-CU subjects had signifi cantly shorter adult 
height SDS than controls. SGA-CU and ISS subjects had a signifi cantly lower FFA level than 
controls. However, these data were not corrected for confounders like age, gender and fat mass. 
Other diff erences between the subgroups were due to the selection criteria.
Comparison of the subgroups aft er adjustment for age and gender showed that fasting 
ASP levels did not signifi cantly diff er between the subgroups (Table 4). Even aft er additional 
adjustment for % body fat, SGA-CU and ISS subjects still had a signifi cantly lower FFA level 
than controls (model B). SGA-S subjects had a signifi cantly higher serum ApoB level, but 
this became non-signifi cant aft er adjustment for % body fat. Th ere were no other signifi cant 
diff erences between the subgroups.
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Table 4. Diff erences in ASP and lipid levels between the 4 subgroups.
SGA–S SGA–CU ISS
Variables Model A Model B Model A Model B Model A Model B
ASP* –0.12 (0.35) –0.16 (0.22) 0.01 (0.90) –0.03 (0.82) –0.17 (0.18) –0.19 (0.14)
FFA 0.07 (0.16) 0.07 (0.19) 0.15 (< 0.001) 0.15 (0.001) 0.17 (0.001) 0.17 (0.001)
TG* –0.03 (0.73) –0.07 (0.50) 0.12 (0.15) 0.09 (0.30) 0.01 (0.89) 0.00 (0.99)
TC 0.26 (0.18) 0.23 (0.24) 0.28 (0.09) 0.25 (0.13) 0.07 (0.71) 0.06 (0.75)
LDLc* 0.11 (0.09) 0.10 (0.13) 0.07 (0.22) 0.06 (0.31) 0.03 (0.63) 0.03 (0.68)
ApoB* 0.13 (0.03) 0.11 (0.06) 0.09 (0.07) 0.08 (0.12) 0.09 (0.16) 0.08 (0.18)
Data are given as mean diff erence (p-value) with controls. *: log transformed. 
Model A: After adjustment for age and gender. 
Model B: After adjustment for age gender and % body fat.
Discussion
Our study shows that adult weight is associated with fasting ASP levels in early adulthood, 
independent of birth size, age, gender and adult height. Weight gain from birth to early 
adulthood was positively associated with ASP levels in early adulthood and this might be due 
to the amount of fat that was accumulated during childhood. Our subgroup analyses showed 
that there were no signifi cant diff erences in ASP levels between the four subgroups, but FFA was 
signifi cantly higher in SGA-CU and ISS subjects than in controls.
Obesity or high % body fat has been related to higher ASP levels in children, adolescents 
and adults (1,6,7). Th is might suggest a state of ASP resistance which is clinically characterized 
by increased levels of both ASP and TG (1,15). Our study shows that ASP levels were higher in 
subjects who attained a higher adult weight in early adulthood. Specifi cation of adult weight 
showed that the association was mainly based on fat mass, indicating that subjects with more 
fat have a higher risk to develop ASP resistance and therefore delayed TG clearance in early 
adulthood. Th is is supported by our previous report showing that fat accumulation during 
childhood was related to higher TG levels in early adulthood (21). ASP was positively related 
to TG levels, indicating that fat accumulation during childhood could result in ASP resistance. 
Women had higher ASP levels but this was due to a higher % body fat in women because aft er 
adjustment for % body fat, the diff erence disappeared.
Higher levels of ASP are seen in obese subjects, consistent with production from fat tissue. 
However, metabolic dysfunction also leads to higher ASP levels, even in lean subjects, such 
as lean subjects with type 2 diabetes mellitus or lean women with polycystic ovary syndrome 
(10,31). Th is may be a consequence of increased insulin secretion in subjects with reduced 
insulin sensitivity, as in vitro studies demonstrate that insulin increases the production of C3, 
the precursor of ASP (8). Our results support this hypothesis as insulin sensitivity was negatively 
and insulin secretion positively related to ASP levels in the young adults. 
An explanation for the positive relationships between ASP and plasma lipids (total 
cholesterol, TG and ApoB) is twofold. Firstly, chylomicrons (dietary lipoproteins) increase 
adipocytes C3 and ASP production (8) and secondly, reduced ASP activity will lead to higher 
FFA levels. Th is results in increased FFA fl ux to the liver, leading to increased lipoprotein 
production by the liver.
To investigate whether diff erent growth patterns during childhood have an infl uence on 
fasting ASP levels in early adulthood, we analyzed four diff erent clinically relevant subgroups, 
based on size at birth and adult height. Aft er adjustment for age and gender, fasting ASP levels 
were similar between the four subgroups, even aft er an additional adjustment for % body 
fat. We had expected that SGA-CU subjects would have higher ASP levels because they have 
reduced insulin sensitivity and relatively more body fat than controls (18,19). Nevertheless, 
their ASP levels were comparable with the other subgroups. However, SGA-CU subjects had a 
signifi cantly higher FFA levels than controls, which might be explained by a reduced activity of 
HSL as SGA-CU are less insulin sensitive (18). Higher levels of FFA may result in an increased 
fl ux to the liver, causing increased production of ApoB by the liver. In early adulthood, this was 
not yet observed in SGA-CU subjects, but might develop later in adulthood. Serum TG levels 
were also similar between the subgroups and as serum TG levels infl uence ASP levels (15), this 
might explain why ASP levels were comparable between the subgroups. Also, ISS subjects had 
signifi cantly higher FFA levels while all other serum lipid levels were similar to controls. Insulin 
sensitivity was also similar to controls, so the reason for these higher FFA levels cannot be 
explained by the activity of HSL (18). ASP levels in ISS subjects were non-signifi cantly lower, so 
FFA trapping might be reduced in these subjects, what might have led to the higher serum FFA 
levels. SGA-S subjects had a signifi cantly higher ApoB level, which disappeared aft er adjustment 
for % body fat, while all other serum lipid levels were similar to controls. Th erefore, % body fat 
explained the diff erence in ApoB level between SGA-S subjects and controls. 
Although weight gain during childhood was a signifi cant determinant of ASP in the MR 
analyses, subjects with weight gain during childhood did not have higher ASP levels. Th is 
diff erence might be explained by two reasons; the MR analyses had a higher number of subjects 
leading to a higher statistical power than the subgroup analyses, and the explained variance 
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of ASP by weight gain was relatively small (4%). Studies showing diff erences in ASP had 
subgroups with large diff erences in BMI, while our subgroups had a relatively small variance 
in BMI (6,17).
In conclusion, this study showed that ASP levels in early adulthood were positively associated 
with weight gain during childhood, specifi ed as fat accumulation. Fetal growth, refl ected by 
birth size, was not related to ASP levels. For clinical practice, weight gain during childhood 
should be in proportion to height gain, otherwise ASP levels might rise and FFA trapping will 
be impaired, which might result in dyslipidemia in later life.
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Abstract
Background / Objectives: It remains unclear whether prenatal or postnatal growth infl uences 
determinants of cardiovascular disease. We investigated whether birth size or weight gain 
during childhood infl uenced blood pressure and carotid intima-media thickness (cIMT) in 
early adulthood.
Methods: Th e relationships between birth size and systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and cIMT were investigated in 243 young adults, aged 18-24 years. Additionally, 
diff erences in SBP, DBP and cIMT were analyzed in 4 subgroups, young adults either born Small 
for Gestational Age with short stature (SGA-S) or with catch-up growth, or born Appropriate 
for Gestational Age with Idiopathic Short Stature or with normal stature (controls).
Results: Birth size had no signifi cant association with blood pressure and cIMT in early 
adulthood. Fat mass was positively related to both SBP and DBP, next to male gender, alcohol use 
and heart rate, while social economic status was negatively related. Carotid IMT was positively 
related to SBP, artery diameter and female gender, aft er correction for age, birth size, adult size 
and lifestyle factors. Subgroup analyses showed no diff erence in blood pressure between the 
subgroups, but cIMT was signifi cantly greater in SGA-CU subjects than in controls, even aft er 
correction for age, gender, artery diameter, smoking and SBP.
Conclusion: Not birth size, but fat accumulation during childhood determines blood pressure 
in early adulthood. SGA-CU subjects had a greater cIMT than controls, while SGA-S subjects 
had similar cIMT as controls. Th erefore, postnatal catch-up growth is more important than 
prenatal growth in the development of atherosclerosis.
Introduction 
Vascular health deteriorates during life as cardiovascular risk factors induce changes in arteries 
leading to atherosclerosis, and this process starts already in childhood (1-3). Atherosclerosis 
can lead to cardiovascular events like myocardial infarction and stroke. Some studies reported 
that low birth weight is associated with an increased risk for cardiovascular diseases (CVD) (4). 
Recently, the role of postnatal catch-up in weight as a determinant of cardiovascular risk has 
been acknowledged (5-9). As 90% of subjects born small for gestational (SGA) show catch-up 
in weight and length during childhood (10-12), these subjects might be at risk for CVD later in 
life.
Th e relationship between birth weight and adult blood pressure is probably the most 
investigated association based on the ‘fetal origin’ hypothesis, but clarifi cation is still needed as 
several studies and reviews showed confl icting results (13-19). Th e most recent review concluded 
that the association might refl ect the impact of random error, selective emphasis of particular 
results and inappropriate adjustment for current weight and confounding factors (20). On the 
other hand, this has been opposed as well (21,22). 
We hypothesized that prenatal growth is not related with adult blood pressure and carotid 
intima media thickness (cIMT), while postnatal growth is an important determinant for these 
factors, especially weight gain during childhood. Both blood pressure and cIMT are accurate 
predictors of cardiovascular events later in life (23-26), and cIMT may be regarded as a valid 
marker for generalized atherosclerosis (27). We, therefore, investigated the infl uence of birth 
length, birth weight, adult size and body composition on systolic (SBP), diastolic blood pressure 
(DBP) and cIMT in 243 young adults. Additionally, we investigated if there were diff erences in 
SBP, DBP and cIMT between four clinically recognizable subgroups of young adults, born SGA 
with either short adult height (SGA-S) or normal adult height (SGA-CU), or born AGA with 
either idiopathic short stature (ISS) or normal adult height (controls).
Subjects and Methods
Subjects
Th e PROgramming factors for GRowth And Metabolism (PROGRAM) study investigates 
a cohort of 323 healthy subjects with an age between 18 and 24 years. Th ey were randomly 
selected from hospitals in the Netherlands, where they had been registered because of their 
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being small at birth (SGA with a birth length <–2SD) (28) or showing short stature (aft er 
being born SGA or appropriate for gestational age (AGA) with an adult height <–2SD) (29). In 
addition, a group of healthy controls was invited to participate. Only those born at 36 weeks or 
more of gestation, born singleton and Caucasian, were invited to participate in order to exclude 
a potential infl uence of prematurity, parity and ethnicity, respectively. All subjects fulfi lled the 
same inclusion criteria: an uncomplicated neonatal period without signs of severe asphyxia 
(defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-term complications 
of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects were excluded if they 
had been suff ering from any serious condition or had been receiving any treatment known 
to interfere with growth (e.g. growth hormone defi ciency, severe chronic illness, emotional 
deprivation, growth hormone treatment, treatment with glucocorticosteriods, radiotherapy) 
or if they had endocrine or metabolic disorders, chromosomal defects, syndromes or serious 
dysmorphic symptoms suggestive for a yet unknown syndrome. Birth data were taken from 
records of hospitals, community health services and general practitioners. Th e Medical Ethics 
Committee of Erasmus Medical Centre, Rotterdam the Netherlands, approved this study. 
Written informed consent was obtained from all participants.
Of the 323 participants who entered the study, 80 had incomplete blood pressure and cIMT 
data, resulting in a total number of 243 eligible subjects for analyses. Th ere were no diff erences 
in anthropometric and DXA measurements between the included and excluded participants. 
Based on SD-scores of birth length and adult height, the subjects were also assigned to one of 
four subgroups. In order to increase the statistical power for subgroup comparison, the cut-off  
values were set at –2 SDS and –1 SDS (± 0.1 SDS). Of the 243 subjects, 170 fulfi lled the inclusion 
criteria for the subgroup analyses: 
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (SGA-S), −
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (Controls).
Measurements
All participants were invited to visit Erasmus Medical Centre in Rotterdam. Th ey had been 
fasting for 12-hours and had abstained from smoking and alcohol for 16 hours. Height 
was measured to the nearest 0.1 cm by a Harpenden stadiometer and weight to the nearest 
0.1 kg by a scale (Servo Balance KA-20-150S, Servo Berkel Prior, Katwijk, Netherlands). All 
anthropometric measurements were performed twice and the mean value was used for analysis. 
All subjects fi lled out a questionnaire about their alcohol use, smoking habits and their social 
economic status (SES).
In all participants, lean body mass (LBM) and fat mass (FM) were measured by one DXA 
machine (Lunar Prodigy, GE Healthcare, Chalfont St Giles, UK). Quality assurance was daily 
performed. Th e intra-essay coeffi  cient of variation for lean tissue and fat tissue has been reported 
to be 1.57-4.49% and 0.41-0.88%, respectively (30).
Blood pressure was measured in sitting position aft er 5 minutes rest with an automatic 
device (Accutorr Plus, Datascope Corp., Montvale NJ, USA). Blood pressure was measured 
every 5 minutes for an hour and the average value of 13 measurements was taken to refl ect the 
24-hours blood pressure. 
IMT was measured in supine position by recording of ultrasonographic images of both left  
and right carotid artery, using the same 7.5 MHz linear array transducer (ATL Ultramark IV, 
Advanced Tech. Laboratories, Bethel Washington, USA). On the R wave of the electrocardiogram, 
three longitudinal images of the near and far wall of the common carotid artery were frozen 
and stored on videotape. Th ese frozen images were digitalized and displayed on the screen of a 
computer using a frame grabber (VP 1400-KIT-512-E-AT, Imaging Technology). Th e common 
carotid IMT was determined as the mean of the mean near and far wall measurements of both 
the left  and right side common carotid artery. 
Statistical analysis
In order to correct for gestational age, gender and age, SD-scores for birth length, birth weight, 
adult height and adult weight were calculated (28,29). Multiple linear regression (MR) analysis 
was performed to determine the association between birth size and SBP, DBP and cIMT. Firstly, 
we entered age, gender, adult height SDS, birth length SDS and birth weight SDS to the model, 
to investigate the infl uence of birth size on the outcomes (model A). Th e interaction term birth 
length SDS * adult height SDS was added to all MR models because the study group had been 
selected on birth length and adult height, in order to ensure that the eff ect of these variables was 
modeled correctly. Possible confounders like SES, smoking and alcohol use were also added to 
the models. Secondly, adult weight SDS was added for birth weight SDS, to relate adult size to 
the outcomes (model B). Th irdly, birth weight SDS was added again to the model. When birth 
size and adult size are shown in one model, it is possible to investigate if the change in weight 
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(centile crossing) between birth and adulthood is related to the outcomes (model C). For SBP 
and DBP, an additional model was made with fat mass (FM) and lean body mass (LBM) to 
specify adult weight SDS. For cIMT, corrections were made for SES, smoking, alcohol, SBP and 
artery diameter. Using a sample size of 243, we calculated that we could detect at least 2% extra 
variance in SBP, DBP and cIMT attributable to birth weight (with 80% power and a signifi cance 
level of 0.05). 
ANOVA was used to determine if there were diff erences between the subgroups with regard 
to the group characteristics. Bonferroni correction was used for pair wise group comparisons. 
An ANCOVA model was used to determine diff erences between the groups corrected for age, 
gender and for variables with a p-value < 0.1 in the MR analyses because they might act as 
confounders. Controls served as the reference group and SGA-S, SGA-CU and ISS were added 
as dummy variables. Statistical package SPSS version 15.0 (SPSS, Inc., Chicago, IL) was used for 
analysis. Results were regarded statistically signifi cant if p was < 0.05.
Results
Th e clinical characteristics of the total study population are shown in Table 1. Th e study 
population consisted of 243 subjects with a mean age (SD) of 20.9 (1.7) years. 
Relationship between birth size and blood pressure in early adulthood
To determine the infl uence of birth size on blood pressure, we used multiple regression (MR) 
models (Table 2). Th e fi rst model showed that male gender, alcohol use and heart rate were 
positively associated with SBP in early adulthood, while SES was negatively related. Birth length 
SDS and birth weight SDS were not related with SBP (Model A). In the second model, birth 
weight SDS was replaced by adult weight SDS to investigate the relationship between adult 
size and SBP (Model B). Adult weight SDS was a strong positive determinant of SBP in early 
adulthood. Birth weight SDS was added to Model B to determine whether weight gain from 
birth to early adulthood was related to SBP (Model C). Adult weight SDS remained signifi cant 
and birth weight SDS was not, indicating that more weight gain during childhood is related 
with a higher SBP in early adulthood, independently of birth weight. Finally, adult weight was 
specifi ed by fat mass and lean body mass (Model D). Fat mass was positively related to SBP and 
therefore indirectly showed that fat accumulation from birth to early adulthood was positively 
related to SBP. Furthermore, fat mass explained the gender diff erence in SBP. Alcohol use and 
heart rate remained other signifi cant positive determinants of SBP, while SES was negatively 
related.
Table 1. Clinical characteristics of the total study group and the 4 subgroups.
Variables Total group 
(n= 243)
SGA–S 
(n=35)
SGA–CU 
(n= 44)
ISS 
(n= 27)
controls 
(n= 64)
Male (%) 37.9 31.4 38.6 37.0 40.6
Age 20.9 (1.7) 20.6 (1.7) 21.4 (1.4) 20.8 (1.8) 20.7 (1.8)
Birth length (cm) 47.7 (3.1) 45.0 (2.2) 44.5 (2.0) 49.4 (1.2) 1 50.9 (1.8) 1
Birth length SDS –1.47 (1.48) –2.98 (0.87) –2.88 (0.85) –0.54 (0.48) 1 0.14 (0.73) 1
Birth weight (kg) 2.82 (0.69) 2.48 (0.51) 2.17 (0.38) 3.23 (0.61) 2 3.36 (0.58) 2
Birth weight SDS –1.12 (1.43) –1.96 (0.99) –2.38 (0.75) –0.16 (1.24) 2 0.08 (1.17) 2
Adult height (m) 1.69 (0.11) 1.57 (0.07) 1.75 (0.08) 3 1.59 (0.06) 1.78 (0.08) 3
Adult height SDS –1.03 (1.41) –2.62 (0.58) –0.09 (0.75) 1 –2.39 (0.37) 0.38 (0.91) 1
Adult weight (kg) 63.7 (12.4) 56.8 (12.1) 71.2 (13.2) 3 54.5 (10.5) 69.4 (11.1) 3
Adult weight SDS –0.63 (1.43) –1.52 (1.62) 0.21 (1.11) 3 –1.96 (1.69) 0.10 (0.93) 3
BMI 22.4 (3.5) 23.0 (4.9) 23.2 (3.6) 21.5 (4.1) 21.8 (2.8)
Fat mass (kg) * 15.2 (8.0) 15.9 (9.4) 18.3 (8.2) 14.0 (8.4) 15.0 (8.0)
Fat mass (SDS) * 0.12 (1.18) 0.40 (1.02) –0.13 (1.05) 0.00 (1.00)
Trunk fat/total fat ratio * 0.48 (0.06) 0.47 (0.06) 0.49 (0.07) 0.46 (0.06) 0.47 (0.05)
Lean body mass (kg) * 45.4 (10.1) 38.1 (7.8) 49.3 (9.9)3 37.6 (6.3) 51.2 (9.5) 3
Lean body mass (SDS) * –1.38 (0.82) –0.21 (1.04)3 –1.43 (0.66) 0.00 (1.00) 3
Alcohol users (%) 75.7 77.1 80.0 81.5 78.1
Smokers (%) 25.5 22.9 35.0 37.0 20.3
cIMT (mm)* 0.52 (0.05) 0.50 (0.04) 0.53 (0.06)4 0.50 (0.05) 0.52 (0.05)
Artery diameter (mm) * 6.66 (0.48) 6.37 (0.41) 6.76 (0.42)3 6.44 (0.46) 6.79 (0.48)3
cIMT/artery diameter ratio 0.078 (0.007) 0.078 (0.006) 0.079 (0.008) 0.077 (0.007) 0.076 (0.007)
Systolic BP (mmHg) * 110.0 (9.0) 108.0 (10.2) 112.6 (10.3) 107.3 (10.4) 110.0 (7.3)
Diastolic BP (mmHg) * 66.1 (5.9) 65.9 (8.2) 66.4 (6.0) 65.4 (6.8) 66.1 (5.0)
Heart rate (beats/min) * 65 (9.0) 71 (9.7)5 65 (9.1) 67 (7.6) 64 (8.4)
Values are given as means (sd). *Not corrected for age, gender and adult size.
1: p< 0.01 compared with the other subgroups, 2: p< 0.001 compared with SGA-S and SGA-CU, 
3: p< 0.05 compared with SGA-S and ISS. 4: p< 0.05 compared with SGA-S, 5: p< 0.05 compared with SGA-CU and 
controls.
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.
No relationships were found between DBP in early adulthood and birth length SDS as well 
as birth weight SDS, while alcohol use and heart rate were signifi cant positive determinants 
(Model A). Adult weight was a strong positive determinant of DBP (Model B), and aft er adding 
birth weight SDS to the model, the attained weight in early adulthood remained a signifi cant 
determinant of DBP independent of birth weight SDS. Aft er specifying adult weight in fat mass 
and lean body mass, fat mass appeared to be a strong positive determinant of DPB in early 
adulthood, next to alcohol use and heart rate. Th is indirectly indicates that fat accumulation 
from birth to early adulthood is positively related to DBP.
Relationship between birth size and cIMT in early adulthood
Table 3 shows the relationship between cIMT and birth size. Birth length SDS and birth weight 
SDS were no signifi cant determinants of cIMT in early adulthood. Female gender and artery 
diameter were signifi cant positive determinants, whereas adult height SDS was negatively 
related with cIMT (Model A). Birth weight SDS was replaced by adult weight SDS to investigate 
whether weight in early adulthood infl uenced cIMT, but this was not signifi cantly related (Model 
B). Weight gain from birth to early adulthood did not infl uence cIMT, while female gender, SBP 
and artery diameter remained positive determinants (Model C). Specifi cation of adult weight 
SDS in fat mass and lean body mass did not change the results (data not shown). 
Notably, women had a greater cIMT than men in the fi nal model, while it is generally known 
that men have greater cIMT. When we analyzed this gender diff erence without corrections, men 
had greater cIMT and larger artery diameter than women (0.53 mm vs. 0.51 mm, p= 0.006 and 
6.94 mm vs. 6.48 mm, p< 0.001, respectively). Nevertheless, the cIMT / artery diameter ratio 
was higher in women than in men (0.079 vs. 0.077, p= 0.006), indicating that women have a 
relatively thicker carotid arterial wall than men.
Comparison of subgroups
Th e clinical characteristics of the four subgroups are shown in Table 1. Diff erences between 
the subgroups with regard to anthropometric measurements and lean body mass were due 
to the selection criteria. Th ere were no diff erences in SBP and DBP between the subgroups. 
Carotid IMT was signifi cantly higher in SGA-CU subjects compared to SGA-S subjects. Carotid 
artery diameter was signifi cantly smaller in the subgroups with short adult height than those 
with normal adult height, indicating that adult stature infl uences carotid artery diameter. Th is 
is confi rmed by the fact that there was no diff erence in cIMT/artery diameter ratio between 
the subgroups. Heart rate was signifi cantly higher in SGA-S subjects than in SGA-CU and 
controls.
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Table 3. Multiple regression for cIMT in early adulthood.
cIMT (mm)
Model A Model B Model C
Variables β p-value β p-value β p-value
Age (yrs) 0.001 0.551 0.001 0.621 0.001 0.567
Gender 0.022 0.006 0.023 <0.001 0.023 0.004
SES –0.004 0.523 –0.004 0.491 –0.005 0.533
Smoking 0.013 0.075 0.013 0.087 0.013 0.094
Alcohol use –0.002 0.839 –0.002 0.803 –0.001 0.855
Systolic BP (mmHg) 0.001 0.057 0.001 0.033 0.001 0.036
Artery diameter (mm) 0.060 < 0.001 0.061 < 0.001 0.062 < 0.001
Adult height SDS –0.006 0.044 –0.005 0.152 –0.005 0.143
Birth length SDS 0.000 0.969 –0.002 0.453 0.000 1.000
Birth weight SDS –0.002 0.506 –0.003 0.500
Adult weight SDS –0.003 0.363 –0.003 0.360
Overall < 0.001 < 0.001 < 0.001
R2 adjusted 0.29 0.29 0.29
Gender : 1 = men, 2 = women; SES: social economic score. 
All models include the interaction term birth length SDS x adult height SDS.
Aft er correction for age and gender, there were no signifi cant diff erences between the 
subgroups with regard to SBP and DBP (Table 4). Additional corrections were made for variables 
with a p-value < 0.1 in the MR analyses because they might act as confounders. However, these 
corrections did not result in signifi cant diff erences in SBP or DBP between the subgroups. 
SGA-CU subjects had a higher cIMT than SGA-S and ISS subjects aft er correction for age 
and gender (Table 5). Additional correction for artery diameter resulted in a similar cIMT 
between subjects with short adult stature and subjects with normal adult stature, indicating 
that subjects with short stature have smaller carotid arteries and therefore a lower cIMT. SGA-
CU subjects had a signifi cantly higher cIMT than controls aft er correction for artery diameter 
(p= 0.017), which remained signifi cant aft er corrections for variables with a p-value < 0.1 in the 
MR analyses (smoking and SBP, p= 0.047).
Table 4. Subgroup analyses of SBP and DBP.
SBP (mmHg) DBP (mmHg)
Model 1 Model 2 Model 1 Model 2
Variables β p-value β p-value β p-value β p-value
SGA-S 0.15 0.948 –0.06 0.977 0.73 0.644 0.06 0.969
SGA-CU 1.84 0.362 –0.26 0.888 0.51 0.723 –0.40 0.757
ISS –2.79 0.217 –0.55 0.812 –0.66 0.678 0.44 0.793
Overall 0.001 <0.001 0.776 <0.001
R2 adjusted 0.12 0.33 0.00 0.21
Reference group is controls.
Model 1: corrected for age and gender.
Model 2: corrected for age, gender, heart rate, SES, smoking, alcohol use and adult weight SDS.
Table 5. Subgroup analyses of cIMT.
cIMT (mm)
Model 1 Model 2 Model 3
Variables β p-value β p-value β p-value
SGA-S –0.021 0.079 0.002 0.854 0.002 0.830
SGA-CU 0.020 0.058* 0.023 0.017 0.019 0.047
ISS –0.020 0.099 0.001 0.957 0.000 0.972
Overall 0.002 <0.001 <0.001
R2 adjusted 0.09 0.25 0.28
Reference group is controls.
Model 1: corrected for age, gender.
Model 2: corrected for age, gender, and artery diameter.
Model 3: corrected for age, gender, artery diameter, smoking and SBP.
*: p< 0.05 compared with SGA-S and ISS.
Discussion
 
Th is study shows that birth weight and birth length SDS had no signifi cant infl uence on blood 
pressure and cIMT in early adulthood. Fat mass was a positive determinant for both SBP and 
DBP in early adulthood, next to male gender, alcohol use and heart rate, while SES was negatively 
related. For cIMT, female gender, SBP and artery diameter were positive determinants. Subgroup 
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analyses showed that there was no diff erence in blood pressure between the subgroups, but 
cIMT was signifi cantly higher in SGA-CU subjects than in controls.
Th e relationship between birth size and subsequent blood pressure has been previously 
investigated (13-19), with controversial results. According to the most recent review, this was 
due to diff erent study designs, publication bias and diff erent statistical approaches (20). In 
order to investigate the relationship between birth size and blood pressure, we did not only use 
the statistical model of Lucas et al (31), but also adjusted for several important confounding 
factors. Our results indicate that increased fat accumulation from birth to early adulthood is a 
signifi cant risk factor for a higher blood pressure, independent of birth size. Although previous 
studies reported a positive association between weight gain in early life or childhood and later 
blood pressure (8, 9), no other study was able to specify weight gain as accumulation of fat.
Infant nutrition is an important determinant of weight gain in early life (32). SGA infants 
who received nutrient-enriched formulas during early life showed more catch-up in weight, 
which was associated with increased blood pressure in childhood (33). Particularly the fi rst fi ve 
months of life might be a critical period for the eff ect of weight gain on blood pressure in later 
life, as weight gain during that period was associated with blood pressure at the age of 25 years 
(8). In view of these and our results, nutritional intervention studies should be undertaken to 
investigate which feeding regimen provide the optimal growth in early life with regard to blood 
pressure in later life. Awaiting these results, it seems best to avoid an exaggerated catch-up in 
weight for height during early life.
Birth size had no infl uence on cIMT in early adulthood. Adult weight or fat mass were also 
no determinants of cIMT, which was in contrast to our expectations. Previous reports showed 
that an increase in BMI during childhood associated with cIMT in adulthood (3,34). However, 
we could not confi rm such a relation with either BMI or fat mass, and the small range of BMI in 
our study or the relatively young age might explain this diff erence. To our knowledge, no study 
has shown a direct relationship between cIMT and fat mass.
Men had greater cIMT than women when no corrections were made, however women 
had a higher cIMT/artery diameter ratio and female gender was positively related to cIMT 
in the MR analyses. Th is indicates that women have a relatively thicker carotid arterial wall. 
One explanation might be a diff erent composition of the arterial wall in women which might 
preclude a diff erent plaque phenotype in later life than men (35). Our data warrant further 
investigation.
Th e MR analyses and the subgroup analyses showed that artery diameter is a signifi cant 
factor for cIMT. Subjects with short adult height had smaller cIMT and smaller artery diameter. 
Th is suggests that they have smaller carotid arteries, which was confi rmed by a similar cIMT/
artery diameter ratio as controls. Th ese results might suggest that future studies investigating 
cIMT need to adjust for artery diameter, otherwise cIMT will be underestimated in short 
subjects. 
Subgroup comparison showed no diff erences in blood pressure in early adulthood between 
the four clinically relevant subgroups. We expected that SGA-CU subjects would have a higher 
blood pressure than controls, because they had more fat mass than controls (36). Although 
the MR analyses showed a positive relationship between fat mass and blood pressure, blood 
pressure was not signifi cantly diff erent between the subgroups. Th is is probably due to the 
relatively small diff erences in fat mass between the subgroups. Both subgroups born SGA did 
not have a higher blood pressure, which is in line with the MR analyses showing that a lower 
birth weight does not increase the risk for higher blood pressure. 
SGA-CU subjects had a greater cIMT than controls, even aft er correction for several 
confounders. In contrast, SGA subjects without catch-up growth had a similar cIMT as controls. 
Our results are in line with Oren et al., who previously reported that young adults with the 
lowest birth weight and the highest postnatal growth had a greater cIMT than young adults with 
normal birth size and postnatal growth (37). However, they were unable to make a distinction 
whether prenatal or postnatal growth infl uenced cIMT in later life. We show that not prenatal 
growth but postnatal growth infl uence cIMT in adulthood, as SGA-CU subjects and not SGA-S 
subjects have a greater cIMT in early adulthood. 
Our study population consisted of a relative high percentage of subjects born small for 
gestational age and of short adults. Th is created greater contrast in the study population, which 
contributed to a better statistical model in which relationships between various factors could 
be detected with more statistical power. In addition, this study population allowed comparison 
between clinically relevant subgroups. Th ereby, no other study refl ected the 24-hours blood 
pressure by 13 measurements, as most studies used two measurements.
In conclusion, our study shows that catch-up growth in weight during childhood, specifi ed 
as fat accumulation, infl uences blood pressure in later life. Birth size did not infl uence cIMT and 
blood pressure in early adulthood. Subgroup comparison showed that subjects born SGA with 
catch-up growth had a signifi cantly greater cIMT in early adulthood than controls. Th erefore, 
fat accumulation during childhood should be prevented to attain normal blood pressure in 
early adulthood and more research is warranted to investigate whether subjects born small for 
gestational age with catch-up growth have a higher risk for cardiovascular events in later life.
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Abstract
Background/Objectives: Low bone mineral density (BMD) may lead to osteoporosis and is 
associated with increased fracture risk. Associations between BMD and various factors have 
been reported. Our objective was to investigate whether birth size, lean body mass (LBM) and 
fat mass (FM) are determinants of BMDTB (total body) and BMDLS (lumbar spine).
Methods: In the PROGRAM-study, a cohort of 312 young adults aged 18-24, BMDTB and 
BMDLS were determined by Dual Energy X-ray Absorptiometry (DXA). Subsequently, 
diff erences in BMDTB and BMDLS were analyzed in 4 subgroups, young adults either born 
Small for Gestational Age with short stature (SGA-S) or with catch-up growth (SGA-CU), or 
born Appropriate for Gestational Age (AGA) with Idiopathic Short Stature (ISS) or with normal 
stature (controls). 
Results: Adult weight, LBM, FM as well as weight gain during childhood were the main positive 
determinants for BMDTB in early adulthood, whereas birth size had no infl uence (adjusted R2 
= 0.50). Gender, adult weight, LBM, FM and weight gain were the signifi cant determinants of 
BMDLS. In the subgroups, aft er correction for age, gender and adult body size, the ISS group 
had a signifi cantly lower BMDTB than controls but there was no diff erence in BMDLS between 
the subgroups.
Conclusions: Prenatal growth has no signifi cant infl uence on BMDTB and BMDLS in early 
adulthood. Gender and postnatal growth, particularly weight gain, are the main positive 
determinants. To achieve a normal BMD in adulthood, health-care workers should aim for a 
normal weight gain in children.
Introduction
Low bone mineral density (BMD) may lead to osteoporosis and is associated with an increased 
fractures risk (1-5). Th e etiology of a low BMD is thought to be genetically and environmentally 
(6-12). Several studies evaluated associations between various factors and BMD (11-23). Most 
studies were, however, performed in elderly and did not correct for adult body size. Correction 
for adult weight and height is necessary, because Dual Energy X-ray Absorptiometry (DXA) 
will underestimate BMD in short subjects because DXA measures areal rather than volumetric 
bone density (24,25).
Only one study evaluated the association between birth length and BMD of the lumbar 
spine (BMDLS) but not between birth length and BMD of the total body (BMDTB) (17). No 
corrections for gestational age, LBM, FM or weight were made. Several studies evaluated the 
association between birth weight and BMD, but did not correct for adult weight (11,13-16). 
Other studies evaluated whether lean body mass (LBM) and fat mass (FM) were associated with 
BMD (18-23). Most studies corrected only for weight, not for height, although LBM and height 
are highly associated.
Growth might also be a signifi cant factor in determining BMD (26,27). A lower growth 
velocity during childhood leads to an increased fracture risk in later life (28), whereas weight 
gain during childhood results in a higher BMD (29).
We therefore evaluated in a cohort of 312 young adults (PROGRAM-study) aged 18-24, the 
association between birth size and BMDTB and BMDLS, measured by DXA, aft er correction for 
age, gender, adult weight, adult height and body composition. Subsequently, we evaluated the 
infl uence of LBM and FM on BMDTB and BMDLS, aft er correction for adult size. In addition, 
we evaluated if there were diff erences with regard to BMDTB and BMDLS between four clinically 
recognizable subgroups: young adults, born short with either short adult height (SGA-S) or 
normal adult height (SGA-CU), or born AGA with either idiopathic short stature (ISS) or 
normal adult height (controls).
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Subjects and Methods
Subjects
Th e PROgramming factors for GRowth And Metabolism (PROGRAM) study investigated 
a cohort of 323 healthy subjects with an age between 18 and 24 years. Th ey were randomly 
selected from hospitals in the Netherlands, were they had been registered because of their being 
small at birth (SGA with a birth length <–2SD) (30) or showing short stature (aft er being born 
SGA or appropriate for gestational age (AGA) with an adult height <–2SD) (31). In addition, 
a group of healthy controls was invited to participate. Only those born at 36 weeks or more 
of gestation, being singleton and Caucasian, were invited to participate in order to exclude a 
potential infl uence of prematurity, parity and ethnicity, respectively. All subjects fulfi lled the 
same inclusion criteria: an uncomplicated neonatal period without signs of severe asphyxia 
(defi ned as an Apgar score below 3 aft er 5 minutes), without sepsis or long-term complications 
of respiratory ventilation, such as broncho-pulmonary dysplasia. Subjects were excluded if they 
had been suff ering from any serious condition or had been receiving any treatment known 
to interfere with growth (e.g. growth hormone defi ciency, severe chronic illness, emotional 
deprivation, growth hormone treatment, treatment with glucocorticosteriods, radiotherapy) 
or if they had endocrine or metabolic disorders, chromosomal defects, syndromes or serious 
dysmorphic symptoms suggestive for a yet unknown syndrome. Birth data were taken from 
hospital records, community health services and general practitioners. Th e Medical Ethics 
Committee of Erasmus Medical Centre, Rotterdam, Th e Netherlands, approved this study. 
Written informed consent was obtained from all the participants.
Of the 323 participants who entered the study, 11 were excluded from analysis because of 
incomplete data, resulting in 312 eligible subjects. Based on the SD-scores of birth length and 
adult height, the subjects were also assigned to one of four subgroups. Normal birth length 
and adult height was set at an SDS >–1 (± 0.1 SDS), in order to increase the statistical power to 
identify diff erences between subgroups (32). Of the 312 subjects, 217 were included in one of 
the following subgroups: 
Born small for gestational age (<–2 SDS) with a short adult height (<–2 SDS) (SGA-short,  −
SGA-S),
Born small for gestational age (<–2 SDS) with catch-up growth resulting in a normal adult  −
height (>–1 SDS) (SGA-CU),
Born appropriate for gestational age (birth length >–1 SDS) with growth retardation  −
resulting in a short adult height (<–2 SDS) (Idiopathic short stature (ISS)) and
Born appropriate for gestational age (birth length >–1 SDS) and a normal adult height (>–1  −
SDS) (controls).
Methods
All participants were invited to visit the Erasmus Medical Centre in Rotterdam. Height was 
measured to the nearest 0.1 cm by a Harpenden stadiometer and weight to the nearest 0.1 kg by 
a scale (Servo Balance KA-20-150S). All anthropometric measurements were performed twice 
and the mean value was used for analysis. A questionnaire concerning subject’s substance use 
including alcohol and smoking was completed.
In all participants, bone mass of total body (TB), lumbar spine (LS), lean body mass (LBM) 
and fat mass (FM) was measured by one DXA machine (Lunar Prodigy, GE Healthcare, Chalfont 
St Giles, UK). Quality assurance was daily performed. Th e coeffi  cient of variation was 0.64% for 
BMC, 1.04% for spine BMD and 0.64% for total body BMD (33). Th e coeffi  cient of variation for 
lean tissue and fat tissue has been reported to be 1.57-4.49% and 0.41-0.88%, respectively (34). 
To account for diff erences in bone size, we calculated apparent BMD (BMAD) of the lumbar 
spine with the model BMADLS = BMDLS x [4(π x width)], with the width as the mean width 
of the second to fourth lumbar vertebral body. Th is model was validated by in vivo volumetric 
data obtained from magnetic resonance imaging of the lumbar vertebrae (35). 
Statistical analysis
In order to correct for gestational age, gender and age, SD-scores for birth length, birth weight, 
adult height and adult weight were calculated (30,31). Multiple linear regression (MR) analyses 
were performed to determine the associations between birth size and BMDTB and BMDLS, with 
corrections for age, gender, adult size and body composition. Th ese corrections were made 
because these variables might act as possible confounders. Firstly, we entered age, gender, birth 
length SDS, adult height SDS and birth weight SDS to the model (model A). Th e interaction 
term birth length SDS * adult height SDS was added to all MR models because the study group 
had been selected on birth length and adult height, in order to ensure that the eff ect of these 
variables was modeled correctly. Secondly, weight was added, to correct for adult weight (model 
B). Th irdly, lean body mass (LBM) and fat mass (FM) were added as independent variables 
instead of adult weight (model C). Finally, we replaced FM and height by delta weight SDS 
during childhood (adult weight SDS – birth weight SDS) and delta height SDS during childhood 
(model D). 
BMD in SGA-short, SGA-CU and ISS
120 121
Chapter
7
Th e BMC, BMC/height, BMDTB, BMDLS and the BMAD of the subgroups were expressed 
as SD-scores with controls as reference. ANOVA was used to determine if there were diff erences 
between the subgroups with regard to the group characteristics. Bonferroni correction was 
used for pair wise group comparisons. To determine diff erences between the groups corrected 
for age, gender, adult size and LBM, an ANCOVA model was used, with controls as reference 
group and SGA-S, SGA-CU and ISS as dummies. Statistical package SPSS version 11.0 (SPSS, 
Inc., Chicago, IL) was used for analysis. Results were regarded statistically signifi cant if p was 
< 0.05.
Results
Clinical characteristics
Th e clinical characteristics of our study group are shown in Table 1. Mean (SD) age was 20.9 
(1.67) years and more women than men were included (191 vs. 121). Th e characteristics of men 
and women are given separately.
Due to the selection criteria of the subgroups, birth length, birth weight, height and weight 
were diff erent between the groups. Th e SGA-CU group had a lower birth weight than the SGA-S 
group, but this diff erence was not signifi cant when birth weight was expressed as SDS. Adult 
height SDS of the SGA-CU group was signifi cantly lower than controls. Th e gain in weight and 
height SDS of the SGA-CU group and the loss in weight and height SDS in the ISS group during 
childhood were signifi cantly diff erent compared to the other groups. Alcohol use and smoking 
were not signifi cantly diff erent between the subgroups.
Diff erences in bone mineral density between the subgroups
BMDTB and BMDLS of our study population are shown in Table 2. Th e diff erences between the 
subgroups are given aft er correction for age and gender. BMC and BMDTB were signifi cantly 
lower in the SGA-S and ISS groups than in controls and in the SGA-CU group. Aft er correction 
for height, the diff erence in BMC between the 2 shorter groups and the 2 taller groups became 
less, but remained signifi cant (BMC/height). BMDLS was signifi cantly lower in the SGA-S and 
ISS groups than in controls and in the SGA-CU group. However, when BMDLS was corrected 
for bone size (BMAD) in each subgroup, the signifi cant diff erences between the subgroups 
disappeared.
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Infl uence of birth size and body composition on bone mineral density
Bone mineral density of the total body (BMDTB)
Table 3 shows the results of the multiple regression for BMDTB. Th e fi rst model showed no 
signifi cant infl uence of birth length or birth weight on BMDTB, whereas age, and adult height 
were signifi cant determinants (Model A). Adding adult weight to the model showed that 
adult weight is also a signifi cant determinant, next to adult height (Model B). Adult weight 
increased the explained variance from 28% to 44%. When LBM and FM replaced weight, the 
model showed that female gender, LBM and FM were the signifi cant positive determinants of 
BMDTB, whereas birth length and birth weight remained not signifi cant (Model C, adjusted 
R2= 0.49). In Model D, the infl uence of weight gain and height gain during childhood on 
BMDTB is shown. Th is model showed that LBM and weight gain were signifi cant determinants 
of BMDTB (adjusted R2= 0.49). Th us, the signifi cant determinants of BMDTB were adult weight 
or LBM and FM, as well as weight gain during childhood. Birth length and birth weight were 
no signifi cant determinants of BMDTB.
Table 3. Multiple regression for BMDTB (g/cm2).
BMDTB
Model A Model B Model C Model D
Variables β 1 p-value β 1 p-value β 1 p-value β 1 p-value
Age (yrs) 0.62 0.026 0.30 0.236 0.30 0.205 0.45 0.055
Gender –1.66 0.178 –1.52 0.165 0.40 0.004 2.73 0.136
Height (cm) 0.48 < 0.0005 0.21 0.002 –0.32 0.686
Birth length SDS 0.42 0.467 0.45 0.364 0.67 0.166 0.29 0.648
BL*AH (SDS) 0.44 0.058 0.33 0.107 0.33 0.088 0.36 0.041
Birth weight SDS –0.38 0.471 –0.24 0.607 –0.66 0.145 1.17 0.068
Weight (kg) 0.38 < 0.0005
LBM (kg) 0.87 < 0.0005 0.67 < 0.0005
Fat mass (kg) 0.22 < 0.0005
Delta weight (SDS) 1.82 < 0.0005
Delta height (SDS) –0.42 0.345
Overall < 0.0005 < 0.0005 < 0.0005 < 0.0005
R2 0.30 0.45 0.50 0.51
R2 adjusted 0.28 0.44 0.49 0.49
1: refers to the unstandardized regression coeffi  cients (1/100). BL: Birth length SDS; AH: Adult height SDS
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Bone mineral density of the lumbar spine (BMDLS)
We applied the same models on BMDLS (Table 4). Th e fi rst model showed that age, adult height 
and birth weight SDS were signifi cant determinants of BMDLS, whereas birth length SDS was 
not (Model A). With adult weight in the model, gender, adult height, birth weight SDS and 
adult weight were signifi cant determinants and the adjusted R2 increased from 0.13 to 0.22 
(Model B). When we replaced adult weight by LBM and FM, gender, birth weight SDS, LBM 
and FM were signifi cant determinants (model C, adjusted R2= 0.25). Birth length SDS tended 
to be signifi cant (p= 0.054). To determine the infl uence of weight gain and height gain during 
childhood on BMDLS, we replaced FM and adult height by delta weight SDS and delta height 
SDS. Th is model showed that female gender, LBM and the gain in weight during childhood 
were signifi cant positive determinants of BMDLS (Model D, adjusted R2= 0.25). Th e signifi cance 
of birth weight SDS and the trend of birth length SDS disappeared completely. Th us, the most 
signifi cant determinants of BMDLS were gender, LBM and weight gain during childhood, 
whereas birth length and birth weight were no signifi cant determinants for BMDLS.
Table 4. Multiple regression for BMDLS (g/cm2).
BMDLS
Model A Model B Model C Model D
Variables β 1 p-value β 1 p-value β 1 p-value β 1 p-value
Age (yrs) 0.77 0.044 0.41 0.331 0.42 0.310 0.60 0.142
Gender 0.62 0.439 0.63 0.001 12.5 < 0.0005 9.78 0.002
Height (cm) 0.59 < 0.0005 0.29 0.013 0.02 0.861
Birth length SDS 1.35 0.119 1.39 0.104 1.63 0.054 1.49 0.176
BL*AH (SDS) 0.51 0.138 0.39 0.255 0.39 0.241 0.40 0.195
Birth weight SDS –1.80 0.026 –1.65 0.037 –2.11 0.007 0.19 0.866
Weight (kg) 0.42 < 0.0005
LBM (kg) 0.95 < 0.0005 0.70 < 0.0005
Fat mass (kg) 0.23 0.007
Delta weight (SDS) 2.25 0.001
Delta height (SDS) –0.15 0.850
Overall < 0.0005 < 0.0005 < 0.0005 < 0.0005
R2 0.14 0.24 0.27 0.27
R2 adjusted 0.13 0.22 0.25 0.25
1: refers to the unstandardized regression coeffi  cients (1/100). BL: Birth length SDS; AH: Adult height SDS
Comparison of subgroups aft er correction
 
Our results clearly demonstrate that correction for adult height and weight is warranted 
before BMDTB and BMDLS between groups with a diff erent body size can be compared. To 
determine the true diff erence between the four groups an analysis of covariance was performed 
with correction for body size. With an adjusted explained variance of 51%, it showed that 
the ISS group had a lower BMDTB than controls (p= 0.028), aft er correction for age, gender, 
height, weight and LBM. Th e mean diff erence was more than 0.5 SDS between the ISS group 
and controls (Figure 1). Th ere were no diff erences in BMDLS between the groups in young 
adulthood aft er correction for age, gender, adult size and LBM.
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Figure 1. Diff erence in BMDTB (SD-scores) between the subgroups, aft er correction for age, gender, adult 
height, adult weight and lean body mass. Controls are the reference group (0 SDS). SGA-S: SGA short, 
SGA-CU: SGA catch-up, ISS: idiopathic short stature. *: p< 0.03 compared to controls.
Discussion
Our study in 312 young adults showed that adult weight, LBM and FM, as well as weight gain 
during childhood had a signifi cant infl uence on BMDTB in young adulthood, whereas age, 
gender, birth length, birth weight, adult height and height gain during childhood did not have. 
BMDLS had gender, LBM and weight gain during childhood as most signifi cant determinants, 
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without age, height, birth length and birth weight as signifi cant factors. Analyses in four 
clinically relevant subgroups showed that aft er correction for age, gender, adult height, adult 
weight and LBM, ISS subjects had a signifi cantly lower BMDTB than controls. No signifi cant 
diff erences between the subgroups were found with regard to BMDLS.
Aft er correction for age, gender, adult height, adult weight, LBM and FM, there was no 
signifi cant association between birth length or birth weight and BMDTB in young adulthood. 
Cooper et al. showed that a lower birth length might lead to a higher fracture risk although this 
association did not reach statistical signifi cance (28). Th ere is no literature with regard to the 
relationship between birth length and BMDTB. Th e lack of association between birth weight and 
adult BMDTB is in line with previous reports (13-16).
Aft er correction for age, gender, adult height, adult weight or LBM and FM, there was a 
signifi cant association between birth weight and BMDLS in young adulthood. Surprisingly, the 
regression coeffi  cient of birth weight was negative. Th is indicated that of subjects with a similar 
adult weight, those with a lower birth weight had a higher BMDLS in adulthood. Th is suggested 
that subjects with more weight gain during childhood would reach a higher BMDLS because 
they started with a lower weight at birth. Several studies showed that subjects with a low birth 
weight had more weight gain during childhood (36-38). We therefore investigated if weight 
gain during childhood was a signifi cant factor by replacing adult weight by delta weight SDS. 
Model D showed that among subjects with a similar weight gain during life, birth weight was 
not a signifi cant determinant of BMDLS. For this reason we conclude that birth weight is not 
a signifi cant determinant of BMDLS, which is in line with the literature (10,13,15,16). Instead, 
age, gender, LBM and weight gain during childhood were the most signifi cant determinants of 
BMDLS. 
Birth length was not a relevant determinant of BMDLS when we replaced height by delta 
height SDS during childhood. Jones et al (17) showed an association between birth length and 
BMDLS, but no corrections were made for gestational age, LBM, FM or weight. Th us, postnatal 
growth defi ned as weight gain during childhood determines adult BMD (TB + LS), whereas birth 
length and birth weight, i.e. prenatal growth, has no infl uence on adult BMD.
Both LBM and FM were signifi cant determinants of BMDTB and BMDLS. Th e larger 
contribution of LBM compared to FM in determining BMDTB and BMDLS is indicated by the 
larger regression coeffi  cient of LBM. Th is has also been reported by Wang et al (20). Men have 
more LBM, so aft er correction for LBM female gender had a positive infl uence on BMDTB (Model 
C). With regard to BMDLS, the infl uence of female gender was already positive aft er correction 
for adult weight and this increased further aft er correction of LBM. A possible explanation for 
the positive infl uence of female gender might be the fact that women start puberty earlier than 
men. Th ey have been exposed to sex hormones like estrogens for a longer time, which has an 
positive infl uence on BMD. Th us, LBM and FM are signifi cant determinants of BMD(TB + LS), 
and LBM is a signifi cant factor in the gender diff erence with regard to BMD(TB + LS).
Short SGA subjects (SGA-S) had similar BMDTB and BMDLS as controls, aft er correction 
for age, gender, adult height, adult weight and LBM. Arends et al (39) investigated BMDTB and 
BMDLS in SGA-S children aged 3-8 before growth hormone was administered. Baseline BMDTB 
SDS and BMDLS SDS were lower in the SGA-S children than in the reference group. Th eir data 
was corrected for height, but not for weight, which might explain the diff erent results between 
their and our study. 
Th e SGA-CU subjects also had similar BMDTB and BMDLS as controls. Whereas SGA-
CU subjects remained somewhat shorter than controls, their weight was the same as that of 
controls. Because weight is such a signifi cant determinant of BMD, it might explain why we 
did not fi nd a diff erence between the 2 groups. To our knowledge no study on BMD has been 
performed in SGA-CU subjects.
ISS subjects had a signifi cantly lower BMDTB than controls aft er correction for age, gender, 
adult height, adult weight and LBM. Only two other studies evaluated BMD in ISS subjects 
(40,41) and showed a lower BMDLS in the ISS group but, unfortunately, no BMDTB was given. 
Th e reason for a lower BMD might be a reduced bone turnover in ISS subjects (40). Other 
reasons might be the low weight gain during childhood in ISS subjects, or a yet unknown 
genetic variation in this population. Our results are in line with a previous study demonstrating 
that children with a reduced growth rate during childhood had an increased risk for fractures 
in later life (28).
Some reports stated that age, gender, height, weight, LBM and FM were relevant determinants 
of BMD in childhood and adolescence (16,18-23,26,42). Th erefore, we selected them in our 
model. Th e limited infl uence of age and gender in the model compared to other studies 
(26,42) is explained by the use of SD-scores to correct for gestational age, age and gender. Th e 
explained variance of BMDTB (50%) and BMDLS (25%) might have been higher if variables like 
daily exercise and calcium intake would have been available. On the other hand, the reported 
infl uence of calcium intake and physical exercise is reported as small (26). Part of the variance 
might also be explained by genetic variations (6,7,12).
Our study population consisted of a relatively high percentage of subjects born small for 
gestational age and of short adults. Th is created greater contrast in the study population, which 
contributed to a better statistical model in which relationships between various factors could 
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be detected with more statistical power. In addition, this study population allowed comparison 
between clinically relevant subgroups. 
Based on our data, we conclude that size at birth is not a signifi cant determinant of BMD 
in later life whereas postnatal growth, especially weight gain, is. To achieve a normal BMD in 
adulthood, health-care workers should aim for a normal weight gain in children.
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Abstract
Content: Growth during infancy appears to be an important determinant of cardiovascular 
disease (CVD) and type 2 diabetes in later life.
Objectives: To specify which period in the fi rst year of life is related to determinants of CVD 
and type 2 diabetes in early adulthood. Additionally, the infl uence of tempo of early catch-up 
growth was investigated.
Design, setting and participants: Observational study with longitudinal data in a cohort 
(PROgramming factors for GRowth And Metabolism (PROGRAM) study) of 217 healthy 
young adults, aged 18-24 years, performed in the Erasmus Medical Centre, Rotterdam, the 
Netherlands, from August 2004 until September 2007.
Main outcome measures: An extensive set of determinants of CVD and type 2 diabetes in early 
adulthood, like body composition, insulin sensitivity, lipid levels and blood pressure.
Results: Increased weight gain relative to height gain in the fi rst three months of life was 
inversely associated with insulin sensitivity and serum HDL level and positively associated with 
waist circumference, acute insulin response, cholesterol / HDL ratio and triglycerides in early 
adulthood. Fast catch-up growth in weight in the fi rst three months resulted in a higher % body 
fat, more central adiposity and reduced insulin sensitivity in early adulthood than slower catch-
up growth which took place during the entire fi rst year. 
Conclusion: Fast catch-up growth in the fi rst three months of life is a risk factor for a higher 
% body fat in early adulthood. As this is associated with a worse cardiovascular and metabolic 
profi le in early adulthood, eff orts should be made to prevent rapid weight gain in early life.
Introduction 
Low birth weight has been associated with cardiovascular diseases (CVD) and type 2 diabetes 
in later life (1), but other studies showed that diff erent growth patterns in infancy and childhood 
might have more impact (2-5). Catch-up growth in the fi rst year of life is associated with 
determinants of CVD and type 2 diabetes (6-8), while other studies showed that poor growth 
in early life and catch-up growth aft er age 2 years is related with an increased risk to develop 
cardiovascular events in later life (9,10). So far, no study investigated the relationship between a 
broad cardiovascular and type 2 diabetes risk profi le and growth in early life. In addition, it is 
unclear whether there is a relationship between the tempo of early life growth and cardiovascular 
and metabolic risk in early adulthood. 
We investigated which period in the fi rst year of life is associated with determinants for 
CVD and type 2 diabetes in early adulthood. Th erefore, we evaluated a study population of 
217 young adults, which had a wide variation in growth in the fi rst year, resulting in increased 
power to identify relationships between growth in early life and metabolic risk factors. Th e 
investigated determinants were % body fat, body mass index (BMI), fat distribution, insulin 
sensitivity, lipid levels and systolic blood pressure. Additionally, we investigated whether tempo 
of catch-up growth has an infl uence on metabolic and cardiovascular determinants. 
Subjects and Methods
Subjects
Th e study cohort consists of 323 healthy subjects with an age between 18 and 24 years. Th ey 
were randomly selected from several hospitals where they had been registered because of their 
being small at birth (birth length <–2SD) (11) or showing short stature (adult height <–2SD) 
(12). In addition, healthy subjects of diff erent schools were randomly asked to participate. Th is 
increased the variation in growth patterns. A higher contrast in growth patterns increased the 
statistical power to fi nd a relationship between early growth patterns and determinants of CVD 
and type 2 diabetes. Th e inclusion and exclusion criteria have been previously described in 
detail (13,14). Briefl y, only Caucasians born singleton at 36 weeks or more of gestation, aft er 
an uncomplicated neonatal period without signs of severe asphyxia (defi ned as an Apgar score 
below 3 aft er 5 minutes), without sepsis or long-term complications of respiratory ventilation, 
such as broncho-pulmonary dysplasia were invited to participate. Subjects were excluded if 
they had been suff ering from any serious condition, or disorder, or had been receiving any 
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treatment known to interfere with growth. Birth data and childhood growth data were obtained 
from records of hospitals, primary health care centers and general practitioners. Th e Medical 
Ethics Committee of Erasmus Medical Centre, Rotterdam the Netherlands, approved the study. 
Written informed consent was obtained from all participants.
Of the 323 study participants, data on fi rst year growth were available for 217 subjects. Th ere 
were no signifi cant diff erences in clinical characteristics with regard to birth size, adult height 
and adult weight between the subjects with fi rst year growth data and the ones without. Weight 
and height at the age of 3, 6, 9 and 12 months were measured at primary health care centers or 
hospitals. 
Measurements
All participants were invited to visit Erasmus Medical Centre in Rotterdam. Th ey had been fasting 
for 12-hours and had abstained from smoking and alcohol for 16 hours. All anthropometric 
measurements were performed twice and the mean value was used for analysis. 
In all participants, lean body mass (LBM) and fat mass (FM) were measured on one DXA 
machine (Lunar Prodigy, GE Healthcare, Chalfont St Giles, UK). Insulin sensitivity index 
(Si), acute insulin response to glucose (AIRg) and the disposition index (DI), the product of 
insulin sensitivity and acute insulin response indicating the degree of glucose homeostasis, 
were determined by the Bergman’s minimal model (MINMOD 6.01 copyright RN Bergman) 
calculating paired glucose and insulin data obtained by frequent measurements during an 
intravenous glucose tolerance test (FSIGT) (15-17) with Tolbutamide (18). Blood pressure was 
measured in sitting position aft er 10 minutes rest in the none-dominant arm with an automatic 
device (Accutorr Plus, Datascope Corp., Montvale NJ, USA), every 5 minutes for one hour and 
the average value of 13 measurements was taken.
Laboratory methods
Blood samples were drawn to determine serum lipid levels. Th e assays have been previously 
described in detail (13,14). Briefl y, plasma glucose levels were determined on a VITROS analyzer 
750 (Orthoclinical Diagnostics, Johnson&Johnson Company, Beerse, Belgium) and plasma 
insulin levels were measured by IRMA (Medgenix, Biosource Europe). Total cholesterol and 
TG were measured using the CHOD-PAP and the GPO-PAP reagent kit (Roche Diagnostics, 
Mannheim, Germany). HDLc was measured using a homogenous enzymatic colorimetric assay 
(Roche Diagnostics). Low-density lipoprotein cholesterol (LDLc) was calculated using the 
Friedewald formula: LDLc (mmol/l) = total cholesterol – HDLc – 0.45 x triglycerides. ApoA-1 
and apoB were determined by rate nephelometry on the Image Immunochemistry System, 
according to the manufacturer’s instructions (Beckman Coulter, Mijdrecht, the Netherlands). 
 
Statistical analysis
SD-scores for birth length, birth weight, adult height and adult weight were calculated, in 
order to correct for gestational age, gender and age (11,12). First, we performed multiple linear 
regression (MR) analyses to investigate the infl uence of weight gain per three months in the fi rst 
year of life on several determinants in the total group of young adults. Adjustments were made 
for gestational age, age, gender, social economic status (SES), height gain per three months and 
% body fat. 
Additionally, the total study group was divided in 2 groups, one with catch-up growth in 
the fi rst year and one without (Figure 1). Catch-up was defi ned as more than 0.67 SDS weight 
gain in the fi rst year, because 0.67 SD scores represent the width of each percentile band on 
standard growth charts (second to ninth percentile, ninth to 25th percentile and so on) (2). 
Of the group with fi rst year catch-up growth, two subgroups were formed based on fast (> 0.5 
SDS) or slow (< 0.5 SDS) catch-up growth in weight in the fi rst three months. A cut-off  value 
of 0.5 SDS was chosen because it is clinically useful. Diff erences between these two subgroups 
were determined by regression analyses, with corrections for fi rst year height gain to investigate 
the infl uence of weight gain on the variables independently of height gain. Our study has 87 
eligible subjects and according to a power analysis performed prior to the study, with a level of 
signifi cance (α) of 0.05 and a chosen power of 80%, at least 72 subjects should be included in 
the regression analyses to enable detection of a R-square change of 0.10. Th e variables tested 
were adjusted for an additional 5 independent variables. Statistical package SPSS version 15.0 
(SPSS, Inc., Chicago, IL) was used for analysis. Results were regarded statistically signifi cant if 
p was < 0.05.
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Total study population 
(n= 217)
First year gain in weight 
> 0.67 SDS
n= 87
First year gain in weight
< 0.67 SDS
n= 130
Gain in weight
first 3 months
> 0.5 SDS
Gain in weight
first 3 months
< 0.5 SDS
Fast catch-up
n= 65
Slow catch-up
n= 22
Figure 1. Derivation of sample into subgroups.
Results
Clinical characteristics
Th e clinical characteristics of the study population are shown in Table 1. Th e average age in 
adulthood was 20.8 years. 
Relationship between growth in the fi rst year and determinants of CVD and type 2 
diabetes in early adulthood
Associations between fi rst year weight gain and several determinants in early adulthood are 
shown in Table 2. Adjustments were made for gestational age, gender, age, SES and height 
gain SDS. We adjusted for height gain to investigate the infl uence of weight gain on the 
outcome variables independently of height gain. Weight gain in the fi rst three months of life 
had an inverse association with insulin sensitivity and HDL levels in early adulthood. Positive 
associations were found between weight gain in the fi rst three months and waist circumference, 
acute insulin response, cholesterol / HDL ratio as well as triglycerides levels in early adulthood. 
Weight gain from three to six months was only positively related to acute insulin response. Th e 
other three-month periods in the fi rst year showed no signifi cant associations. Height gain in 
the fi rst year of life was not signifi cantly related with the outcomes (data not shown).
Table 1. Clinical characteristics of the study population
Clinical characteristics at birth
Variable N Mean SD
Males (%) 217 40.1
Gestational age 217 39.3 1.7
Birth length (cm) 217 47.6 3.2
Birth length (SDS) 217 –1.54 1.45
Birth weight (kg) 217 2.78 0.67
Birth weight (SDS) 217 –1.21 1.34
First year growth characteristics
Time period Gain in height SDS
N Mean SD
Birth - 3 months 214 0.42 1.04
3-6 months 212 0.10 0.53
6-9 months 210 0.08 0.35
9-12 months 207 –0.03 0.30
Gain in weight SDS
N Mean SD
Birth - 3 months 217 0.23 1.16
3-6 months 216 0.08 0.58
6-9 months 212 0.06 0.40
9-12 months 205 0.08 0.34
Clinical characteristics in early adulthood
Variable N Mean SD
Age (years) 217 20.8 1.67
Adult height (m) 217 1.68 0.11
Adult height (SDS) 217 –1.13 1.38
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Table 1. Continued
Clinical characteristics in early adulthood
Variable N Mean SD
Adult weight (kg) 217 63.9 12.6
Adult weight (SDS) 217 –0.63 1.43
BMI 217 22.5 3.4
% body fat 211 24.0 10.4
Trunk fat / total fat ratio 211 0.48 0.06
Waist circumference (cm) 216 77.2 9.8
Waist / hip ratio 214 0.89 0.07
Insulin sensitivity 96 6.82 4.33
Acute insulin response 95 571 560
Disposition index 95 2934 1812
Cholesterol (mmol/l) 205 4.53 0.94
HDL (mmol/l) 205 1.39 0.38
Cholesterol / HDL ratio 204 3.45 1.11
LDL (mmol/l) 204 2.67 0.84
ApoA1 (g/l) 206 1.30 0.22
ApoB (g/l) 206 0.82 0.24
ApoB / ApoA1 ratio 206 0.64 0.22
Triglycerides (mmol/l) 206 1.03 0.49
Systolic BP (mmHg) 159 110.1 9.0
Diastolic BP (mmHg) 159 66.1 6.1
To investigate whether the associations between weight gain in the fi rst three months and 
determinants of CVD and type 2 diabetes were explained by fat mass in early adulthood, an 
additional adjustment was performed for % body fat. Th e associations between weight gain in 
the fi rst three months and insulin sensitivity (p= 0.032), HDL (p= 0.007) as well as cholesterol 
/ HDL ratio (p = 0.013) remained signifi cant. Th e associations with waist circumference 
(p= 0.054), acute insulin response (p= 0.087) and triglyceride levels (p= 0.075) became trends. 
Acute insulin response in early adulthood remained signifi cantly related with weight gain from 
3 to 6 months (p= 0.008).
Table 2. Regression coeffi  cients for gain in weight SDS in the fi rst year of life and determinants of CVD 
and type 2 diabetes in early adulthood
Outcome in young adults Gain in weight 
SDS from 
0-3 months
Gain in weight 
SDS from 
3-6 months
Gain in weight 
SDS from 
6-9 months
Gain in weight 
SDS from 
9-12 months
β P-value β P-value β P-value β P-value
% body fat 0.639 0.275 –0.759 0.495 1.342 0.388 –3.149 0.082
BMI* 0.014 0.174 –0.021 0.312 0.033 0.241 –0.019 0.540
Trunk fat / total fat ratio 0.006 0.085 –0.005 0.463 0.007 0.481 0.004 0.756
Waist circumference 1.437 0.040 –0.098 0.942 1.995 0.293 0.082 0.968
Waist / hip ratio 0.002 0.718 0.009 0.345 0.000 0.993 0.017 0.261
Insulin sensitivity*# –0.223 0.008 –0.155 0.323 0.157 0.490 –0.021 0.936
Acute insulin response*# 0.210 0.028 0.403 0.019 0.307 0.219 –0.091 0.749
Disposition index*# –0.011 0.916 0.261 0.180 0.463 0.090 –0.140 0.641
Total cholesterol* –0.002 0.892 0.022 0.402 0.014 0.717 0.017 0.677
LDL* 0.013 0.538 0.008 0.836 0.017 0.784 0.017 0.790
HDL* –0.053 0.005 0.038 0.292 –0.025 0.626 0.081 0.142
Cholesterol / HDL ratio* 0.052 0.014 –0.020 0.625 0.040 0.497 –0.061 0.335
ApoB* 0.026 0.178 0.020 0.574 0.012 0.826 0.022 0.697
ApoA1 –0.019 0.194 0.029 0.300 –0.004 0.924 0.005 0.900
ApoB / ApoA1 ratio* 0.039 0.085 0.008 0.859 0.014 0.827 0.013 0.845
Triglycerides* 0.066 0.040 0.024 0.700 0.136 0.121 –0.069 0.460
Systolic BP –1.08 0.122 0.461 0.733 1.825 0.316 –2.704 0.176
All correlations were corrected for gestational age, age, gender, SES and height gain in the same period.
*Log transformed variables, # measured in 94 subjects.
Infl uence of tempo of catch-up growth in the fi rst year on determinants of CVD and 
type 2 diabetes in early adulthood
To assess if tempo of catch-up growth infl uences determinants in early adulthood, subgroups 
were formed based on fast or slow catch-up growth in the fi rst three months of life. Of all 
subjects with a clinically relevant weight gain of at least 0.67 SDS in the fi rst year, some had 
a weight gain of more than 0.5 SDS in the fi rst three months (fast catch-up (n= 65)), while 
others had a weight gain in the fi rst three months of less than 0.5 SDS (slow catch-up (n= 22)). 
Th e clinical characteristics of these two subgroups are shown in Table 3. Birth size was not 
signifi cantly diff erent between the subgroups. First year growth patterns are shown in Figure 
2. Both subgroups attained a similar adult height, which was signifi cantly shorter than average 
(p< 0.05). However, the fast catch-up group attained a higher adult weight than the slow catch-
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up group (p= 0.075). When weight for height was expressed as weight SDS - height SDS, the 
fast catch-up group had more weight than height gain in the fi rst three months, while the slow 
catch-up group had more height than weight gain (p= 0.1).
Table 3. Clinical characteristics of subjects with fast versus slow fi rst year catch-up growth in weight*
Variable Fast catch-up growth 
(n= 65)
Slow catch-up growth 
(n= 22)
p-value
Males (%) 35 50
Gestational age 38.5 (1.51) 39.0 (1.97) 0.164
Birth length SDS –2.22 (1.28) –2.13 (1.62) 0.777
Birth weight SDS –2.23 (0.74) –2.05 (1.04) 0.376
Height SDS at 3 months –1.13 (1.06) –1.66 (1.23) 0.058
Weight SDS at 3 months –0.76 (0.93) –2.12 (1.05) <0.001
Weight SDS - height SDS at 3 months 0.37 (0.82) –0.46 (0.54) <0.001
Delta length SDS from birth to 3 months 1.07 (1.02) 0.47 (1.01) 0.020
Delta weight SDS from birth to 3 months 1.47 (0.62) –0.07 (0.47) <0.001
Delta length SDS from 3 months to 1 year 0.58 (0.62) 0.57 (0.66) 0.962
Delta weight SDS from 3 months to 1 year 0.43 (0.67) 1.37 (0.57) <0.001
Height SDS at 1 year –0.55 (0.97) –1.08 (1.09) 0.033
Weight SDS at 1 year –0.33 (0.79) –0.74 (1.02) 0.054
Weight SDS – height SDS at 1 year 0.22 (0.77) 0.34 (0.77) 0.514
Delta length SDS from birth to 1 year 1.68 (1.17) 1.05 (1.11) 0.030
Delta weight SDS from birth to 1 year 1.90 (0.68) 1.31 (0.53) <0.001
Adult height SDS –0.74 (1.02) –0.79 (1.14) 0.833
Adult weight SDS –0.09 (1.16) –0.59 (1.05) 0.075
Weight SDS - height SDS 0.65 (1.25) 0.19 (0.91) 0.125
Adult BMI 23.2 (3.46) 21.7 (2.27) 0.0951
% body fat 27.4 (9.2) 19.4 (11.6) 0.0061
Waist circumference 80.6 (10.6) 75.0 (8.3) 0.0281
Trunk fat / total fat ratio 0.49 (0.05) 0.48 (0.07) 0.0401
Insulin sensitivity 5.38 (3.75) 8.13 (4.76) 0.0391
Data is given in mean (sd). 
*All subjects had a fi rst year catch-up growth in weight of more than 0.67 SDS. They were divided in two subgroups 
based on fast (> 0.5 SDS) or slow (< 0.5 SDS) catch-up growth in weight in the fi rst three months.
1: after correction for gestational age, gender, age, SES and height gain in the fi rst year.
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Figure 2. Height SDS, weight SDS and weight SDS relative to height SDS in the fi rst year of life and in early 
adulthood between subjects with slow and fast catch-up growth in the fi rst three months of life. Values are 
means (± SEM). *p< 0.05 between the two subgroups
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Interestingly, the fast catch-up group had a signifi cantly higher % body fat (β= 6.00, 
p= 0.006), a greater waist circumference (β= 6.19, p= 0.028), a higher trunk fat / total fat ratio 
(β= 0.029, p= 0.040) and a reduced insulin sensitivity (β= -3.54, p= 0.039) in early adulthood 
than the slow catch-up group, aft er adjustment for gestational age, gender, age, SES and 
height gain in the fi rst year. Th e diff erence in waist circumference, fat distribution and insulin 
sensitivity between the 2 subgroups disappeared aft er adjustment for adult % body fat, thus % 
body fat explained the diff erences. Additional adjustment for birth weight SDS and birth length 
SDS did not change these results. 
Discussion
Our study shows that increased weight gain relative to height gain in the fi rst three months 
of life is associated with reduced insulin sensitivity and serum HDL, and an increased waist 
circumference, acute insulin response, cholesterol / HDL ratio and serum triglyceride in early 
adulthood. Th ese are all important determinants of CVD and type 2 diabetes in later life. Even 
aft er adjustment for adult % body fat, the associations with insulin sensitivity, HDL levels and 
cholesterol / HDL ratio remained signifi cant. A subgroup analysis showed that of all subjects 
with fi rst year catch-up in weight (> 0.67 SDS), those with fast catch-up growth in weight in the 
fi rst three months of life had a higher % body fat, more central adiposity and reduced insulin 
sensitivity in early adulthood than those with slower catch-up growth. Percentage body fat 
explained the diff erences in central adiposity and insulin sensitivity in early adulthood between 
the two subgroups.
Low birth weight has previously been associated with an increased risk of CVD and type 2 
diabetes in later life (19-21). Although this was initially thought to be due to an unfavorable fetal 
environment (1), other studies reported that postnatal catch-up growth infl uenced the risk as 
well (6-8,22-24). Our study shows that increased weight gain in the fi rst three months of life had 
a signifi cant infl uence on several determinants for CVD and type 2 diabetes in early adulthood. 
Of all subjects born small for gestational age (SGA), ninety percent experience catch-up growth 
in the fi rst two years of life (25). We previously showed that young adults with catch-up growth 
between birth and adulthood had a higher risk for CVD or type 2 diabetes, while young adults 
born SGA without catch-up growth did not have an increased risk (13,14,26). Th is indicates 
that having a low birth weight for gestational age is not directly related with an unfavorable 
cardiovascular and metabolic profi le, but increased weight gain during early childhood is. 
Until now, it is unknown whether tempo of catch-up growth is of infl uence on cardiovascular 
or metabolic determinants. Of all subjects who showed postnatal catch-up growth in the fi rst 
year, the ones with fast catch-up growth had a higher % body fat, more central adiposity and 
reduced insulin sensitivity in early adulthood, while both subgroups reached a similar adult 
height. Th e fast catch-up group was fatter in early adulthood and this explains the diff erence in 
central adiposity and insulin sensitivity. Th erefore, it is important to investigate which factors 
determine weight gain in early life, because this might lead to intervention strategies to prevent 
cardiovascular events in later life. At this moment it is unclear whether (epi)genetic factors 
are involved. Early nutrition might be a major factor. Generally, nutrient-enriched diets lead 
to rapid weight gain in early life, and subsequently have adverse eff ects on cardiovascular risk 
factors in later life (6,27,28). Also, formula-fed infants grow at a faster rate than breast-fed infants 
and have a higher risk of being overweight later in life (29,30). Unfortunately, our study did not 
have nutritional data to investigate the relationship between early nutrition, growth in infancy 
and cardiovascular determinants later in life. Nevertheless, our fi ndings suggest that the use 
of nutrient-enriched formulas which induce rapid weight gain in early life might increase the 
risk for CVD and type 2 diabetes in later life (27). Nutritional intervention, like stimulating 
breastfeeding during the fi rst three months, might decrease the prevalence of CVD and type 2 
diabetes. 
In our study, we investigated the infl uence of early weight gain, but other periods in life might 
be important as well. As shown in reports of the Helsinki Birth Cohort Study, subjects with a 
slow gain in weight from birth to two years followed by catch-up in weight during childhood 
also had an increased risk for development of CVD and type 2 diabetes (10,31,32). Similar results 
have been found in a cohort study in India (33). Interestingly, these subjects experienced growth 
retardation in weight in early life before they showed catch-up growth during childhood. Th is 
might indicate that catch-up growth aft er a period of growth retardation, either during intra-
uterine or early life, increases the risk for the development of CVD and type 2 diabetes in later 
life. Our study suggests that the tempo of catch-up growth might be more relevant than the 
timing. Th is merits further study of factors infl uencing tempo of catch-up growth.
In conclusion, we found that increased weight gain relative to height gain in the fi rst three 
months of life is associated with an unfavorable cardiovascular and metabolic profi le in early 
adulthood. Furthermore, fast catch-up growth in early life is more detrimental than slow catch-
up growth. For clinical practice, the fi rst three months of life might provide a sensitive time-
window to apply intervention strategies to prevent fast catch-up growth and later cardiovascular 
events. Additionally, more studies are required to investigate which factors determine catch-up 
growth in early infancy. 
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Abstract
Background: Rapid weight gain and larger body size during infancy predict subsequent 
increased risk for childhood obesity. High protein intakes during infancy have been proposed 
to increase adiposity in early life, however previous studies have been inconsistent.
Objective: To investigate the associations between protein intake, and specifi cally dairy milk 
protein intakes (from dairy protein-based infant formula and cow’s milk), on body size and 
adiposity at age 12 months.
Design: Nutrient intakes at age 12 months, assessed by three-day diet records in 396 infants 
participating in the Cambridge Baby Growth Study, were related to length, weight, BMI and 
adiposity assessed by skinfold thickness at 12 months. Analyses were adjusted for age, sex, and 
maternal BMI, and also other nutritional factors (breast feeding at 3 months and total energy 
intake at 12 months).
Results: Total energy intake at 12 months was positively related to length, weight and BMI at 
12 months, but not to adiposity. Aft er adjustment for total energy intake, total protein intake 
was not related to any anthropometric outcome. However, specifi cally dairy milk protein intake 
was positively related to BMI (p=0.04) and adiposity (0.16 ± 0.06 SDS per 10g; P= 0.005) at 
12 months, and the association with adiposity persisted aft er adjustment for other nutritional 
factors (0.13 ± 0.06; P= 0.02).
Conclusion: Higher dairy milk protein intake, rather than total protein intake, at age 12 months 
appeared to be associated with greater adiposity. 
Introduction 
Rapid weight gain in the fi rst year of life has been related to increased adiposity in childhood 
and adverse cardiovascular risk profi les in young adults (1-5). Th erefore, early interventions to 
avoid excessive infancy weight gain could potentially prevent obesity and its co-morbidities. 
Various nutritional factors in early life have been shown to infl uence later obesity risk. Breast 
feeding is associated with both slower infant weight gain and lower risk of obesity (6,7). Among 
infants who are formula-fed, higher total energy intakes at age 4 months were associated with 
higher rates of infant weight gain and higher childhood BMI in a large UK study (8). Follow-
up of randomised trials of diff erent infant milk formulas in preterm infants also demonstrate 
the long-term body composition and metabolic outcomes related to early feeding (9-11). With 
regard to specifi c infant nutrients, protein intake at age 2 years was positively related to adiposity 
at 8 years in a study of 112 French children (12), leading to the proposal that higher protein 
intakes during infancy may increase adiposity and subsequent obesity risks. However, other 
studies did not confi rm this association (13,14). Recently, the DONALD study reported that 
the apparent eff ect of infant total protein intake on increased adiposity at age 7 years could be 
driven specifi cally by infant diary protein intake (15).
We therefore investigated the associations between infant energy, protein and fat intakes 
on body size and adiposity at age 12 months. In particular we tested the hypothesis that dairy 
milk protein intake (from dairy protein-based infant formula milk and cow’s milk) might be 
specifi cally associated with infant adiposity.
Subjects and Methods
Study design
Th e current study is part of a large ongoing birth cohort study. Inclusion criteria were mothers 
attending a single antenatal centre in Cambridge UK. Exclusion criteria were mothers aged 
< 16 years, or unable to give informed consent. Mothers were approached and recruited at 
their fi rst antenatal clinic appointment during early pregnancy by trained paediatric research 
nurses. Off spring were followed up during infancy. Weight, length, and skinfold thicknesses 
were measured at 0, 3, and 12 months by the research nurses.
At the time of the current analysis, the cohort included 1526 infants born between August 
2001 and July 2008. Th e current dataset was based on a sub-cohort of 431 infants born between 
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July 2004 and June 2007, with information on infant dietary intakes at age 12 months, which 
were introduced to the study protocol from 2004 onwards. Complete data were available in 
396 infants, including mother’s BMI and infant anthropometry at 3 and 12 months. Details 
of their birth weights and birth lengths and body size at 12 months are shown in Table 1. Th is 
sample was representative of the whole cohort with regard to birth weight, parity, mother’s BMI, 
mother’s age and type of milk feeding at age 3 months (data not shown).
Th e study was approved by the local Cambridge research ethics committee and all mothers 
gave informed written consent. 
Anthropometry 
Infant weight, length and skinfolds were measured at birth and at each research clinic visit by 
trained paediatric research nurses. Weight was measured to the nearest 1 g using electronic 
scales. Supine length was measured to the nearest 0.1 cm using a Kiddimeter (Holtain Ltd, 
Crosswell, Pembs., UK.). Skinfold thickness was measured in triplicate at four sites (triceps, 
subscapular, fl ank and quadriceps) using a Holtain Tanner/Whitehouse Skinfold Caliper 
(Holtain Ltd).
Dietary assessment
Mode of infant feeding (breast milk only or using formula milk) at age 3 months was assessed 
by questionnaire completed by the parents at that clinic visit.
At age 12 months, mothers were asked to record all food and drink consumed, in household 
measures, over a 3 day period. Th ese estimated (unweighed) dietary intakes were recorded by 
mothers and carers in diet diary booklets, which were sent by mail prior to the 12 month clinic 
visit, and collected at that visit. At the visit, the mothers were interviewed by one Research 
Assistant (FK) to clarify responses and portion sizes recorded in the diaries. Th ese diet diaries 
had been adapted from the ALSPAC study infant food diary for age 18 months with further 
examples and guidance on foods now available for infants (16).
Food diaries were coded by trained Dietary Assessment Assistants using our in-house 
program DINO (Diet in Nutrients out). Household measures (teaspoon, cup etc.), if specifi ed, 
or age appropriate portion sizes were assigned to each food. Home-made foods with recipes 
supplied by parents were entered as individual ingredients. Th e output generated a food 
code and weight for each food item recorded. Checking of the coded data was carried out by 
nutritionally qualifi ed editors. Programs within DINO were used to analyse the coded data 
to output food and nutrient intakes. Th e in-house food composition database is based on 
McCance and Widdowson “Th e Composition of Foods” 6th Edition (17). Foods that were not 
on the database were matched to existing foods with a similar composition. A new food code 
was created if the food was commonly consumed or contributed signifi cantly to a respondent’s 
intake, in which case that food item was added to the database, with nutrients as listed on the 
packaging and other micronutrients calculated from listed ingredients. Th us a large number of 
currently available commercial infant and baby products have been added to the database.
Calculations
BMI was calculated as weight / height2 (kg/m2). Age and sex-appropriate standard deviation 
scores (SDS) for weight, height and BMI at each visit were calculated using internal means 
and standard deviations, including adjustment for precise age at each visit. Measurements of 
skinfolds at each anatomical site were used to derive separate internal SDS, adjusted for age and 
gender, and an overall skinfold SDS was calculated as the mean SDS of the 4 sites as an indicator 
of adiposity. 
Statistics
Diff erences in clinical characteristics between boys and girls were calculated with an independent 
t-test and chi-square test. Th e relationships between nutritional data and anthropometric data 
were analysed by linear regression models. In Model 1, adjustments were made for age, sex, 
maternal BMI and infant length, weight, BMI or adiposity, respectively at age 3 months. In 
Model 2 additional adjustments were made for other nutritional factors: type of milk feeding 
at 3 months (breast-fed, mixed-fed or bottle-fed) and total energy intake at 12 months (except 
when this was the exposure variable). Statistical package SPSS version 16.0 (SPSS, Inc., Chicago, 
IL) was used for analysis. Results were regarded statistically signifi cant if p was < 0.05.
Results
Th e characteristics of the study population are shown in Table 1. Th e overall average total energy 
intake was 0.44 MJ/kg/d, which is comparable to current UK recommendations (18). Almost 
all infants received some dairy protein-based milk (dairy protein-based infant formula or cow’s 
milk) at 12 months and this comprised around one third of the daily energy intake.
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Total energy, protein and fat intakes
Total energy intake was positively associated with length (P<0.001), weight (P<0.001) and BMI 
(p= 0.01), but not adiposity at 12 months (Model 1: adjusted for age, sex, maternal BMI and 
infant length, weight, BMI or adiposity respectively at age 3 months). Th e associations with 
length (P= 0.001), weight (P< 0.001) and BMI (p= 0.01) persisted aft er further adjustment for 
type of milk feeding at 3 months.
Table 1. Characteristics of the study population by gender. Means (SD) or percentages. 
Boys (n= 208) Girls (n= 188) p-value
Birth weight (kg) 3.61 (0.51) 3.38 (0.52) <0.005
Gestational age (wk) 39.9 (1.6) 39.8 (1.5) 0.6
Milk feeding at 3 months (%)
breast −
bottle & breast −
bottle −
38.7
28.9
32.4
51.4
29.5
19.1 0.007
Size at 12 months
Length (cm) 76.9 (2.4) 74.8 (2.8) <0.005
Weight (kg) 10.3 (1.0) 9.5 (1.1) <0.005
BMI (kg/m2) 17.3 (1.2) 16.9 (1.3) 0.001
Mean skinfolds SDS –0.09 (0.73) 0.04 (0.79) 0.1
% receiving breast milk at 12 months 21.2 22.3 0.8
% receiving dairy milk at 12 months 93.8 91.0 0.3
% receiving formula milk − 70.1 71.2 0.8
% receiving cow’s milk − 63.5 58.0 0.3
Dietary intakes at 12 months
Total energy (MJ/d) 4.48 (0.81) 4.19 (0.80) <0.005
Total protein (g/d) 38.9 (9.5) 35.7 (9.9) 0.002
Total fat (g/d) 44.0 (10.7) 41.8 (10.6) 0.04
Dairy milk protein (MJ/d) 11.3 (7.5) 9.7 (6.5) 0.03
Formula milk protein (MJ/d) − 5.6 (4.7) 5.8 (5.0) 0.7
Cow’s milk protein (MJ/d) − 5.7 (7.8) 3.9 (5.9) 0.01
Formula milk energy (g/d) − 0.89 (0.75) 0.92 (0.76) 0.7
Cow’s milk energy (g/d) − 0.45 (0.62) 0.31 (0.48) 0.02
Cow’s milk fat (g/d) − 6.3 (8.7) 4.4 (6.9) 0.02
Total protein intake at 12 months appeared to be positively associated with length (P< 0.001), 
weight (P< 0.001) and BMI (P= 0.04), however these associations disappeared aft er adjustment 
for other nutritional factors. Total protein intake was not associated with adiposity. 
Similarly, total fat intake appeared to be positively associated with length (P= 0.02), weight 
(P< 0.001) and BMI (P= 0.02) at 12 months, but these associations disappeared aft er adjusting 
for other nutritional factors. Total fat intake was not associated with adiposity.
Table 2. Daily total energy, total protein and total fat intakes related to length, weight, BMI and adiposity 
at 12 months. Partial regression coeffi  cients (β± SE).
Model 1 Model 2*
β SE p-value β SE p-value
Total energy (per MJ)
Length (SDS) 0.18 0.05 <0.001 0.17* 0.05 0.001
Weight (SDS) 0.22 0.05 <0.001 0.21* 0.05 <0.001
BMI (SDS) 0.14 0.05 0.01 0.14* 0.05 0.01
Adiposity (SDS)** –0.08 0.05 0.1 –0.08* 0.05 0.1
Total protein (per 10g)
Length (SDS) 0.16 0.04 <0.001 0.09 0.05 0.1
Weight (SDS) 0.17 0.04 <0.001 0.07 0.05 0.2
BMI (SDS) 0.09 0.04 0.04 0.01 0.06 0.8
Adiposity (SDS)** –0.04 0.054 0.3 –0.01 0.05 0.8
Total fat (per 10g)
Length (SDS) 0.09 0.04 0.02 –0.10 0.07 0.1
Weight (SDS) 0.14 0.04 <0.001 –0.03 0.07 0.7
BMI (SDS) 0.10 0.04 0.02 0.02 0.08 0.8
Adiposity (SDS)** –0.03 0.04 0.4 0.06 0.07 0.4
Model 1: adjusted for sex, age, maternal BMI and also infant length, weight, BMI or adiposity, respectively at age 3 
months. 
Model 2: further adjusted for nutritional factors (type of milk feeding at 3 months and total energy intake at 12 
months, except where this was the exposure variable*).
**Adiposity was also adjusted for length at 12 months
Dairy milk protein intake
Specifi cally, dairy milk protein intake was positively associated with length (P= 0.003), weight 
(P< 0.001), BMI (P= 0.04) and also adiposity (P= 0.005); the association with adiposity persisted 
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aft er further adjustment for other nutritional factors (P= 0.02). In fully adjusted models, both 
protein from dairy protein-based infant formula milk (0.21 ± 0.08 SDS per 10g; P= 0.02) and 
protein from cow’s milk (0.11 ± 0.06; P= 0.08) showed positive trends with adiposity.
Table 3. Daily dairy milk protein intake (from dairy protein-based infant formula and cow’s milk) related 
to length, weight, BMI and adiposity at 12 months. Partial regression coeffi  cients (β ± SE).
Total protein (per 10g)
Model 1 Model 2
β SE p-value β SE p-value
Dairy milk protein (per 10g)
Length (SDS) 0.17 0.06 0.003 0.07 0.06 0.2
Weight (SDS) 0.20 0.06 <0.001 0.10 0.06 0.1
BMI (SDS) 0.13 0.06 0.04 0.08 0.07 0.2
Adiposity (SDS)* 0.16 0.06 0.005 0.13 0.06 0.02
Model 1: adjusted for sex, age, maternal BMI and also infant length, weight, BMI or adiposity, respectively at age 3 
months.
Model 2: further adjusted for nutritional factors (type of milk feeding at 3 months and total energy intake at 12 
months). 
*Adiposity was also adjusted for length at 12 months
Discussion
In this UK birth cohort study, higher infant intakes of dairy milk protein (from dairy protein-
based infant formula and cow’s milk) were related to increased adiposity at 12 months. In 
contrast, length, weight and BMI in the fi rst year of life appeared to be associated with total 
energy intake rather than to any specifi c nutrient or nutrient source. 
A link between early total protein intake and childhood adiposity, assessed by skinfolds, was 
fi rst suggested by Rolland-Cachera et al. (12). Protein intakes in infants tend to be far greater 
than is required for growth and metabolism (13,19). Th e mean protein intake in our study, 3.8 
g/kg/day, was far greater than the Reference Nutrient Intake at this age (1.4 g/kg/d) (20). Such 
observations have lead to the hypothesis that higher protein intakes in early life might causally 
increase fat mass by stimulating the secretion of IGF-I and/or insulin, which in turn promote 
adipocyte maturation and lipid uptake storage (21-23). Repeated follow-up reports from the 
DONALD study have also described consistent positive associations between early protein 
intakes and adiposity in childhood in German children (15,19,24). In that study, total protein, 
animal protein and dairy protein intakes at ages 1 year and 5-6 years were positively associated 
with BMI and % body fat, measured by skinfolds at age 7 years (15,24) and with higher BMI at 
the start of adiposity rebound (19). However, Hoppe et al. did not fi nd an association between 
total protein intake at 9 months and fat mass at age 10 years, measured by DXA, in 105 Danish 
children (13), and in the UK ALSPAC study, total protein intake at 18 months was not associated 
with early adiposity rebound in 772 children (14). Furthermore, Skinner et al. showed that total 
fat intake (% energy), but not total protein intake (% energy), at 2 years was positively associated 
with BMI at 8 years (25). Th e DONALD study also reported a positive relationship between fat 
intake at 2 years and % body fat at 5 years, although this has been questioned by other studies 
(12,26-28). 
Our fi ndings suggest that diff erent sources of infant nutrients might contribute to the 
heterogeneity in results between studies. We found no associations between total energy, total 
protein or total fat intakes and adiposity at age 1 year, but rather specifi cally dairy milk protein 
intake appeared to correlate with infant adiposity, independent of various demographic and 
nutritional potential confounders. Too few infants were taking soya milk, or other milks, to be 
able to assess whether similar associations were seen with this source of protein. Our fi ndings 
are consistent with a recent observation in 203 German children from the DONALD study that 
infant diary protein intake was associated with adiposity at age 7 years, although this specifi c 
association reached only borderline statistical signifi cance in that study (15).
Our study population was larger than most previous studies investigating the association 
between infant nutrient intakes and adiposity. Moreover we had very detailed dietary data, of 
3 days duration, and carefully coded for all foods consumed with a large food composition 
database. We acknowledge that the sample was not designed to be representative of UK infants, 
although our population had similar birth weights to the British reference, and total energy 
intakes were almost identical to current UK recommendations. We were able to adjust for 
various potential confounding factors, including mother’s BMI, and type of milk feeding and 
body size and adiposity earlier in infancy at age 3 months, however, the reported associations 
are essentially cross-sectional. Furthermore, it is possible that the observations are residually 
confounded by other nutritional factors, including other components of infant milk formula 
and cow’s milk, or by parenting patterns associated with the use of these milks. Th e European 
Childhood Obesity Project (EARNEST) is trialling a novel infant milk formula with reduced 
protein content (29) and that study will hopefully eventually clarify the specifi c role of dairy 
milk protein on infant adiposity.
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In addition to lower milk protein contents, reductions in overall intake of infant milk 
formula or cow’s milk may be an eff ective and alternative strategy to avoid excess infant gains 
in weight and adiposity. Higher intakes of formula milk at 4 months have been related to 
larger body weight and BMI at ages 1 to 5 year in 582 children in the UK ALSPAC study (8). 
Th e UK Department of Health recommends that 500–600 ml of either breast milk or infant 
formula should be given each day between the ages of 6 and 12 months (30). However, recently 
revised international guidance on energy intakes recommend substantially lower intakes in 
infants (0.33 MJ/kg/d at age 12 months) (31). Furthermore, current UK and European guidance 
recommends parents to avoid introducing unmodifi ed cow’s milk to infant diets before age 
12 months due to the risk of iron defi ciency (32). However, data from a large UK study and an 
Icelandic study show that this recommendation is poorly adhered to, with 14-40% of infants 
receiving predominantly cow’s milk even at age 6-8 months (16,33). Our study indicates that 
increased adiposity in early life might be another reason to postpone and/or limit the use of 
cow’s milk in settings with a high prevalence of childhood obesity.
In conclusion, dairy milk protein intake was positively associated with adiposity at age 
12 months. Th ese fi ndings highlight potential future strategies to reduce infant adiposity and 
childhood obesity.
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Th e present thesis describes in a large group of young adults, the infl uence of diff erent 
growth patterns during childhood on determinants of cardiovascular disease (CVD), type 2 
diabetes mellitus and osteoporosis. Th e fi rst part reports the fi ndings of six studies in which 
the infl uence of size at birth and postnatal growth on insulin sensitivity, beta cell function, 
body composition, serum lipid and acylation stimulating protein levels, blood pressure, carotid 
intima media thickness and bone mineral density were investigated. In addition, the diff erences 
in determinants of adult diseases are described between four clinically relevant subgroups with 
diff erent growth patterns. 
Th e second part describes two studies, one study in young adults and one study in infants. 
Th e study in young adults describes which period of fi rst year growth is related to determinants 
of CVD and type 2 diabetes in early adulthood. In addition, the tempo of fi rst year growth was 
investigated in relation to these determinants. Th e study in infants shows the relation between 
nutrients and body size and body composition at 12 months of age.
Statistical Approach
Several studies investigated the association between birth size and determinants of adult disease, 
but there is a great heterogeneity in the statistical approach. Adjustments for gestational age and 
adult size were not always made, and results were interpreted in diff erent ways. To determine 
the association between birth size and determinants of adult disease, we used the multiple 
regression models as suggested by Lucas et al (1). First, birth weight was added to the model, to 
investigate the infl uence of birth size on the outcomes (model A). Secondly, birth weight was 
replaced by adult weight, to relate adult size to the outcomes. Th irdly, birth weight was added 
to the model. When birth size and adult size are shown in one model, this indirectly shows 
the change in weight (centile crossing) between birth and adulthood. Th erefore, it is possible 
to investigate whether weight gain from birth to early adulthood is related to the outcomes. 
Finally, the interaction term birth weight * adult weight was added to the model to investigate 
whether birth weight modifi es the eff ect of adult weight on outcome. Th is interaction term 
evaluated whether being growth retarded at birth and having weight gain during childhood 
is more serious in terms of outcome than having a normal birth size and an equivalent weight 
gain during childhood.
Part 1: Birth size, adult size and determinants of adult diseases
Insulin Sensitivity
Low birth weight has been associated with an increased risk for adult diseases, such as diabetes 
mellitus type II and CVD (2-5). Th is might indicate that malnutrition in fetal life could result in 
permanent endocrinologic and metabolic changes in the fetus with adverse eff ects in later life. 
However, rapid growth in childhood has also been related to increased insulin secretion and 
reduced insulin sensitivity (6).
We evaluated the contribution of birth size, adult size and body composition to insulin 
sensitivity and disposition index, measured by the frequently sampled intravenous tolerance 
(FSIGT) test, in 136 young adults. In addition, we evaluated if there were diff erences with regard 
to insulin sensitivity, insulin secretion and disposition index between 4 clinically recognizable 
subgroups of young adults. 
Birth weight was positively associated with insulin sensitivity, but the association disappeared 
when adult weight and waist/hip ratio were taken into account. Adult weight, particularly when 
specifi ed as current fat mass, was the only signifi cant determinant of insulin sensitivity, whereas 
birth size was not related. As adjustments were made for birth size, these results indirectly 
show that weight gain, specifi ed as fat accumulation, from birth to early adulthood was related 
to reduced insulin sensitivity. None of the variables were related to disposition index at early 
adulthood. 
SGA-CU subjects had lower insulin sensitivity and higher insulin secretion than controls, 
which attenuated aft er adjustment for current fat mass, but remained signifi cantly diff erent. 
Th ere were no other diff erences in insulin sensitivity between the subgroups, but SGA-S subjects 
had higher insulin secretion than controls, even aft er adjustment for fat mass. Th e disposition 
index did not diff er between the subgroups.
Only one other study has found a positive relationship between weight gain during childhood 
and insulin sensitivity in young adults, independent of birth weight (7). However, this study did 
not specify whether lean body or fat mass was responsible for this relationship. Our results 
show that fat mass was robustly and inversely related to insulin sensitivity. Th ese results are in 
accordance with the growth acceleration hypothesis, indicating that fetal growth restriction 
relative to genetic growth potential could result in growth acceleration postnatally, which has 
potentially deleterious eff ects on the development of adult diseases in later life (8,9). Based on 
our data, we suggest to take this hypothesis a step further: i.e. that an increased accumulation 
of fat during childhood, independent of birth size, will result in reduced insulin sensitivity. 
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Generally, an increase in fat mass has been related to metabolic and endocrinologic changes, 
which might have deleterious eff ects in later life with regard to an increased risk for CVD and 
type 2 diabetes (10).
Reduced insulin sensitivity in SGA-CU subjects has been reported before, but only in children 
(11). Our results show that this persists into early adulthood. Fat mass did not completely explain 
this relationship, so other factors seem to be involved as well. Genetic factors, like a higher 
frequency of carriers of the 22/23EK allele of a glucocorticoid receptor gene polymorphism and 
environmental factors, such as physical activity, might also infl uence the relationship (12,13). 
Th e disposition index was similar between the subgroups, which indicates that all subgroups 
had normal functioning β-cells and were therefore able to maintain glucose tolerance. To be 
able to maintain glucose tolerance when subjects are less insulin sensitive, the β-cells have to 
produce more insulin. However, when β-cells start to fail, the disposition index will decline. 
Th is will lead to impaired glucose tolerance and eventually type 2 diabetes. Our data showed 
that in early adulthood, SGA-CU are able to maintain their glucose tolerance, as shown by their 
increased insulin secretion compared to controls. 
In prepubertal SGA-S children, reduced insulin sensitivity has been reported before, but 
this could not be confi rmed in young adults (14-16). Th is might have changed during puberty, 
when insulin sensitivity physiologically decreases in all subjects (17), but maybe less in SGA-S 
subjects. SGA-S subjects had increased insulin secretion, which is hard to explain. Possible 
explanation are an increased sensitivity of the beta cells for glucose or an increased clearance of 
insulin by the liver. Th e higher insulin secretion did not aff ect their glucose tolerance, because 
it was similar to the other subgroups. 
Conclusions
Our data show that fat accumulation during childhood is the main predictor of insulin sensitivity 
in early adulthood. Prenatal growth, refl ected by birth size, was not related to insulin sensitivity. 
In early adulthood, SGA-CU subjects had reduced insulin sensitivity compared to controls, 
while all other subgroups had similar insulin sensitivity as controls. Reduced insulin sensitivity 
was found in only one of the two SGA subgroups, which enhances our conclusion that birth size 
is not related to insulin sensitivity in later life.
Body Composition
We investigated the infl uence of birth length and birth weight on fat mass (FM) and lean body 
mass (LBM), measured by Dual Energy X-ray Absorptiometry (DXA), in 312 young adults. 
Additionally, we investigated if there were diff erences in FM and LBM between four subgroups 
of young adults. Birth length was not related to FM (kg) or LBM (kg), while lower birth weight 
tended to be weakly related to higher FM and weakly with lower LBM. However, adult weight as 
well as weight gain during childhood were strongly related to FM and LBM, next to age, gender 
and adult height. SGA-CU subjects had a signifi cantly higher %FM and a signifi cantly lower 
%LBM than controls. 
Our study shows that birth weight has opposite eff ects on FM and LBM. One explanation 
might be that subjects who were born aft er fetal growth retardation use their energy for their 
vital organs and do not use their spare energy for accumulation of LBM, but rather for FM 
as a buff er for diffi  cult periods later in life. With regard to LBM, our results are in line with 
other reports showing a positive association with birth weight (4,18-25). Recent studies did not 
fi nd a conclusive answer with regard to the relation between birth weight and FM (4,20-25). 
Th is might be explained by the diff erent ways of measuring body composition, diff erent study 
populations and diff erent statistical approaches. We used DXA to measure body composition 
and analyzed our data with and without adjustments for adult size. When adult height was 
taken into account, attained adult weight had the strongest association with FM, indicating that 
relatively more weight gain than height gain during childhood is related to FM. Birth weight 
only showed a weak negative association with FM, while adult weight was strongly positively 
related. Th is suggests that prenatal growth has little infl uence on later FM, in contrast to weight 
gain during childhood.
SGA-S subjects showed similar body composition as controls, which is in contrast to two 
reports showing less FM in SGA-S children (26,27). Th is diff erence might be due to a diff erent 
statistical approach or SGA-S subjects might accumulate more fat than controls during puberty. 
Th e SGA-CU group had relatively more FM and less LBM than controls, indicating that not 
birth size, but especially postnatal weight gain explains the diff erences in body composition. 
Previously, higher %FM and less %LBM have been reported in children and older adults 
with low birth weight, but no data existed for young adults (11,28,29). Th e results of the ISS 
subgroup showed that growth retardation during childhood was not related to a diff erent body 
composition in early adulthood. Högler found a lower amount of LBM in growth retarded 
children, but this might be due to the absence of corrections for current height (30). Our results 
showed less LBM in ISS subjects, which disappeared aft er adjustment for adult height.
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Conclusions
Prenatal growth had a weak relationship with body composition in early adulthood, while 
weight gain was strongly associated with adult FM and LBM. SGA born subjects with catch-
up growth had relatively more fat and less LBM than controls, while SGA born subjects with 
short stature had a similar body composition as controls. Th erefore, body composition in early 
adulthood is mainly determined by postnatal growth, particularly gain in weight, instead of 
prenatal growth. 
Lipid Profi les
Th e infl uence of birth size, adult size, body composition and ApoE genotype on fasting serum 
levels of total cholesterol (TC), triglycerides (TG), HDLc, LDLc, ApoA-1, ApoB and Lp(a) was 
investigated in 297 young adults. We also investigated if there were diff erences in serum lipid 
levels between the 4 subgroups. Birth length and birth weight were not related to any of the lipid 
levels in early adulthood. However, weight gain from birth to early adulthood, specifi ed as fat 
accumulation, was positively related to serum levels of TC, TG, LDLc and ApoB. In addition, 
ApoE genotype was a strong predictor of TC, LDLc and ApoB, explaining on average 7% of the 
variance. In the subgroup analyses, no diff erences in ApoE genotype or lipid levels were found, 
except for SGA-S, who had higher serum levels of LDLc and ApoB than controls. However, 
the diff erence in LDLc disappeared aft er adjustment for %body fat and ApoE genotype. Th e 
diff erence in ApoB between SGA-S and controls attenuated aft er these adjustments, but 
remained signifi cantly diff erent from controls. Th ere were no diff erences in ApoE genotype 
prevalence between the subgroups.
Our results are in line with two studies, which reported that birth weight was not related 
with serum lipid profi les in later life (31,32). Th e literature is less consistent with regard to the 
relationship between birth length and lipid profi les (33-35). An inverse relation was found in 
children and male adults, but not in adolescents. Some reports take adult size into account 
and others do not, which may account for these diff erences. Previously, a positive relationship 
between weight gain and lipid levels in later life has been shown (36,37). However, prior to our 
study, no one was able to substantiate whether this was due to a higher % body fat, as fat mass 
was not measured.
We expected an adverse lipid profi le in SGA-CU subjects as they have a higher % body fat, 
but this was not found. An explanation for the similar lipid levels between SGA-CU subjects 
and controls might be that the diff erence in %body fat is not large enough to result in diff erent 
lipid levels. SGA-S subjects had higher serum levels of LDLc and ApoB than controls. Only 
ApoB levels remained higher than controls aft er adjustment for % body fat and ApoE genotype. 
Th e reason for these higher levels remains unknown, but a reduced number of LDLc receptor 
in the liver might explain this diff erence. Th ese results are in line with reported lipid levels 
in children born SGA, although previous studies did not diff erentiate between SGA with and 
without catch-up growth (6,14,38-40). Only Jaquet et al. investigated lipid levels in a mixed group 
of SGA young adults. Th ey found slightly but signifi cantly lower levels of HDLc and higher TG 
levels in 734 SGA subjects versus 886 controls (41). 
Conclusions
Our study shows that birth size is not related to serum lipid levels in early adulthood, while 
weight gain during childhood, specifi ed as fat accumulation, is. Genetic factors, like ApoE 
genotype, have a strong infl uence on lipid levels. Our subgroup analyses showed that not SGA-
CU subjects, but SGA-S subjects had higher levels of LDLc and ApoB, but this disappeared or 
attenuated aft er adjustment for %body fat and ApoE genotype. 
Acylation Stimulating Protein (ASP)
Acylation stimulating protein (ASP) is an adipose tissue-derived hormone, which stimulates 
glucose and free fatty acid (FFA) uptake into adipocytes (42-44). ASP levels might predict an early 
stage of dyslipidemia because fasting ASP is a predictor of triglyceride (TG) clearance (45,46). 
Postnatal catch-up growth might be associated with dyslipidemia in later life, and dyslipidemia 
might, in time, contribute to CVD. We therefore investigated the relationship between ASP and 
diff erent growth patterns during childhood. In addition, diff erences in serum ASP levels were 
investigated between the 4 subgroups.
Weight gain during childhood, particularly fat accumulation, was positively related to serum 
ASP levels in early adulthood. Size at birth was not related to ASP levels. ASP was positively 
related to TG, TC, ApoB and insulin secretion and negatively to insulin sensitivity. Between the 
subgroups, no diff erences in ASP were found, but SGA-CU and ISS subjects had signifi cantly 
higher levels of FFA.
ASP resistance is characterised by increased levels of both ASP and TG (42,45). Th is refl exes 
reduced free fatty acid (FFA) trapping into adipocytes because ASP is less active. Th is results 
in an increased FFA infl ux in the liver, which will lead to increased levels of LDLc and ApoB, 
as seen in dyslipidemia. ASP levels were positively related to TG levels, and both levels were 
related to fat accumulation during childhood. Th is might indicate that fat accumulation during 
childhood is related to ASP resistance. Th ese results are in line with recent reports, which 
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showed that higher levels of ASP and TG are related to obesity and %body fat in children, 
adolescents and adults (42,47,48).
ASP levels were negatively related to insulin sensitivity and positively to insulin secretion. 
Th is might suggest a link between ASP and insulin secretion as insulin stimulates C3 production, 
which is an ASP precursor (49). Higher levels of ASP were also found in lean subjects who were 
less insulin sensitive, like lean patients with diabetes mellitus type II or women with polycystic 
ovary syndrome (50,51), which strengthens the postulation there is a link between ASP and 
insulin metabolism. Th e eff ects of ASP on FFA metabolism are independent and additive to the 
eff ects of insulin (43), so a direct link was not yet found.
ASP levels were similar among the four subgroups, while we expected higher levels of ASP in 
SGA-CU subjects because they had a higher %body fat. Th is might be due to the relatively small 
variance in %body fat, as other studies only showed diff erences in ASP levels in obese subjects 
and not in controls (48,52). SGA-CU and ISS subjects had higher FFA levels than controls. Only 
in SGA-CU subjects this might be explained by an increased activity of hormone-sensitive-
lipase, because they are less insulin sensitive. In ISS subjects, FFA trapping might be reduced as 
ASP was non-signifi cantly lower. 
Conclusions
Exaggerated weight gain during childhood should be prevented as this might lead to ASP 
resistance, characterised by higher levels of ASP and TG. In time, this might lead to postprandial 
hypertriglyceridemia, which has been associated with early dyslipidemia. 
Blood Pressure and Carotid Intima Media Th ickness (IMT)
Both blood pressure and carotid IMT are accurate predictors of cardiovascular events later in 
life (53-56). We, therefore, evaluated the infl uence of birth size, adult size and body composition 
on systolic (SBP), diastolic blood pressure (DBP) and carotid IMT in 243 young adults. We 
also investigated if there were diff erences in SBP, DBP and carotid IMT between the four 
clinically recognizable subgroups. Both blood pressure and carotid IMT were not related to 
birth length or birth weight. Fat accumulation during childhood was related to higher systolic 
and higher diastolic blood pressure in early adulthood, but not to carotid IMT. Comparison 
of the subgroups showed no diff erence in SBP or DBP, but carotid IMT was larger in SGA-CU 
than in controls. 
Th e relationship between birth size and subsequent blood pressure is probably the most 
investigated association based on the ‘fetal origin’ hypothesis (57-61). Nevertheless, clarity is 
still lacking due to the impact of random error, selective emphasis of particular results and 
inappropriate adjustment for current weight and confounding factors (62). To correctly evaluate 
this association, we used the statistical approach as suggested by Lucas et al and adjusted for 
several important confounders (1). Our results showed that fat accumulation during childhood 
infl uenced SBP and DBP in early adulthood, while birth size was not related. Th is is in line with 
other studies, which previously showed that weight gain in early life or childhood was positively 
related to subsequent blood pressure (63,64), although no specifi cation was made between lean 
body mass or fat mass.
Carotid IMT showed no association with birth size, but in contrast to our expectations, also 
no association was found with adult weight, weight gain or % body fat. Previous studies reported 
that an increase in BMI during childhood was associated with carotid IMT in adulthood, but 
they were unable to investigate whether there was a direct relation between carotid IMT and fat 
mass (65,66). We did not fi nd a relation between carotid IMT and fat mass and that might be due 
to the small range of fat mass or relatively young age in our study population. We also found a 
correlation between artery diameter and carotid IMT, so we adjusted for artery diameter. No 
previous studies have taken artery diameter into account. Th is could explain the diff erences in 
study results.
Both subgroups born SGA did not have a higher blood pressure, which is in line with the 
multiple regression analyses showing that a lower birth weight does not increase the risk for 
higher blood pressure. No diff erences in SBP and DBP were seen between the four subgroups. 
Th is is probably due to the relatively small diff erences in fat mass between the subgroups, 
as the multiple regression analyses showed that fat mass was a predictor of blood pressure. 
Diff erences were seen in carotid IMT between the subgroups; SGA-CU had larger carotid IMT 
than controls. Oren et al previously reported that young adults with the lowest birth weight and 
the highest postnatal growth had a larger carotid IMT than young adults with normal birth size 
and postnatal growth (67). Our results indicate that prenatal growth does not infl uence carotid 
IMT in adulthood. If prenatal growth had an infl uence on carotid IMT, both SGA-S and SGA-
CU subjects would have had a larger carotid IMT in early adulthood, instead of only SGA-CU 
subjects. Th is also indicates that other factors might infl uence carotid IMT in SGA-U subjects, 
like infl ammatory factors or oxidative stress (68,69).
Conclusions
More fat accumulation during childhood leads to a higher blood pressure in early adulthood, 
while size at birth is not related to blood pressure. SGA-CU subjects had a larger carotid IMT 
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than controls, while SGA-S subjects had similar carotid IMT as controls. Th erefore, postnatal 
weight gain is more important than prenatal growth in the development of a thicker intima 
media of the carotid arterial wall. 
Bone Mineral Density (BMD) 
We investigated in 312 young adults whether birth size, adult size and body composition, 
determined by DXA, were related to bone mineral density (BMD) in early adulthood. Current 
weight, specifi ed as lean body mass and fat mass, and weight gain during childhood were 
positively related to BMD of the total body(TB) and the lumbar spine(LS). Birth length was not 
related to BMD(TB+LS) and birth weight was inversely related to BMD(LS), which disappeared 
aft er adjustment of weight gain. Comparison of the subgroups showed that aft er adjustments 
for adult size and body composition, ISS subjects had a lower BMD(TB) than controls. Th ere 
were no diff erences in BMD(LS) and bone mineral apparent density (BMAD) between the 
subgroups.
Several reports showed that birth weight has no relationship with BMD(TB) (20,70-73), but 
no study investigated the relationship between birth length and BMD(TB), while it has been 
reported that shorter birth length might be related to a higher fracture risk (74). Birth weight 
was inversely related to BMD(LS) but this relationship disappeared aft er adjustment for weight 
gain during childhood. Th erefore, weight gain has a greater infl uence on BMD(LS) than birth 
weight, which is in line with the literature (70,71,73,75). 
Previously, Arends et al. reported lower BMD(TB) in 3-8 years old SGA-S children (76), but 
did not take current weight into account. Our results did not show any diff erence in BMD(TB+LS) 
between SGA-S and controls, but this diff erence might be due to the fact that we did correct for 
adult weight. 
Th e SGA-CU subjects had also a similar BMD(TB+LS) as controls. Whereas SGA-CU subjects 
remained somewhat shorter than controls, their weight was the same as that of controls. 
Because weight is such a signifi cant determinant of BMD, it might explain why we did not fi nd 
a diff erence between the 2 groups. To our knowledge no study on BMD has been performed in 
SGA-CU subjects. 
Our results showed that ISS subjects had lower BMD(TB) than controls. Aft er correction 
for height and bone age, two studies showed lower BMD(LS) in ISS subjects, while no data were 
given about BMAD (77,78). Th e lower BMD(TB) might be due to a reduced bone turnover in ISS 
subjects (77). Th ese results are in line with a report showing increased fracture risk in subjects 
with a reduced growth rate during childhood, which occurs in ISS subjects (74). 
Conclusions
Postnatal growth, especially weight gain during childhood, determines BMD(TB+LS) in early 
adulthood, independent of birth size. Subjects with a reduced growth rate during childhood are 
at risk for lower BMD(TB), what might result in increased fracture risk in later life.
Part 2: Growth in early life and determinants of adult diseases
Timing and Tempo of Catch-up Growth in Early Life
It has been debated whether weight gain in early life, or poor growth in early life followed by 
catch-up growth between 2 and 10 years is related to increased risk for cardiovascular and 
metabolic diseases in later life (9,79-86). We investigated in 217 young adults whether a certain 
period in the fi rst year of life was related to determinants of CVD and type 2 diabetes in early 
adulthood. Additionally, we evaluated whether the tempo of catch-up growth in weight was 
related to these determinants.
Our results showed that increased weight gain relative to height gain in the fi rst three 
months of life associates with reduced insulin sensitivity and serum HDL, and an increased 
waist circumference, acute insulin response, cholesterol / HDL ratio and serum triglyceride in 
early adulthood, which are all important determinants of CVD and type 2 diabetes in later life. 
A subgroup analysis showed that of all subjects with fi rst year catch-up in weight (> 0.67 SDS), 
those with fast catch-up growth in weight in the fi rst three months of life had a signifi cantly 
higher % body fat, more central adiposity and reduced insulin sensitivity in early adulthood 
than those with a more gradual catch-up growth. Th e diff erences in fat distribution and insulin 
sensitivity between the subgroups were explained by the % body fat.
Barker et al. postulated the fetal origin hypothesis, suggesting that an unfavourable fetal 
environment might lead to re-programming of the endocrine and metabolic pathways of the 
fetus, leading to the development of CVD and type 2 diabetes in later life (87,88). Recently, an 
increasing number of studies show a positive relationship between postnatal catch-up growth 
in early life and risk factors of CVD and type 2 diabetes in childhood and early adulthood 
(9,58,80-82,86,89). Previously, we showed that SGA born subjects with catch-up growth in 
weight had a higher risk for CVD or type 2 diabetes, while SGA born subjects without catch-up 
growth in weight did not have an increased risk. Th is indicates that having a low birth weight 
for gestational age is not directly related with an unfavourable cardiovascular and metabolic 
profi le, but increased weight gain relative to height gain during early childhood is.
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Our results show that particularly very early weight gain is positively related to several 
determinants of CVD in early adulthood, but other periods in life might be important as 
well. Previous studies showed that subjects with a slow gain in weight from birth to two years 
followed by catch-up in weight during childhood also had an increased risk for development 
of CVD and type 2 diabetes (79,90-92). Just like our subjects, who showed growth retardation 
in fetal life, these subjects also experienced catch-up in weight aft er a period of slow growth. 
As both groups showed catch-up growth in weight, this might indicate that catch-up in weight 
aft er a period of growth retardation, either during intra-uterine or early life, increases the risk 
for the development of CVD and type 2 diabetes in later life, independently of the period of 
catch-up growth.
As tempo of catch-up growth might be more important than the actual time period, factors 
infl uencing rapid weight gain in early life warrant investigation. So far, breast-fed infants appear 
to have slower weight gain than bottle-fed infants and infants with nutrient-enriched diets even 
have increased weight gain (9,36,93-95). Th e exact mechanism how nutrients infl uence growth 
and weight gain needs to be unravelled.
Conclusions
Weight gain relative to height gain in the fi rst three months of life is related to an unfavourable 
cardiovascular and metabolic profi le in early adulthood. Th ereby, fast catch-up growth in the 
fi rst three months of life appears to be more detrimental than a more gradual catch-up growth 
over 1 year. Th is implicates that rapid weight gain during the fi rst three months should be 
prevented. 
Nutrient Intake and Body Size at 12 Months of Age
In 396 infants of the Cambridge Baby Growth Study, aged 12 months, we investigated the 
associations between infant energy, protein and fat intakes on body size and adiposity, measured 
by skinfolds, at age 12 months. In particular we tested the hypothesis that dairy milk protein 
intake (from dairy protein-based infant formula milk and cow’s milk) might be specifi cally 
associated with infant adiposity. Nutrient intakes were assessed by three-day diet records. Total 
energy intake at 12 months was positively related to length, weight, and BMI at 12 months, 
but not to adiposity. Total protein and total fat intakes were not related to any anthropometric 
outcome. However, dairy milk protein intake was positively related to adiposity at 12 months, 
and this association persisted aft er adjustment for other nutritional factors. Both protein from 
dairy protein-based infant formula milk and protein from cow’s milk showed similar trends 
with adiposity at 12 months.
Previously, Rolland-Cachera et al postulated a hypothesis that higher protein intakes in 
early life might causally increase fat mass by stimulating the secretion of IGF-I and insulin, 
which in turn promote adipocyte maturation and lipid uptake storage (96-99). Several reports of 
the DONALD study have repeatedly shown a positive association between protein intake and 
adiposity in childhood in 203 German children (100-102). However, other studies did not fi nd 
a relationship between total protein intakes in early life and fat mass at age 10 years or early 
adiposity rebound (103,104). Furthermore, Skinner et al. showed that total fat intake, but not 
total protein intake, at 2 years was positively associated with BMI at 8 years (105). However, this 
could not be confi rmed by other studies (97,106-108).
Although we found that dairy milk protein intake was positively related to adiposity at 12 
months, we must recognize that it is possible that the observations are residually confounded by 
other nutritional factors, including other components of infant milk formula and cow’s milk, or 
by parenting patterns associated with the use of these milks. Only one previous study reported 
an apparent positive association between infant dairy milk protein intake and adiposity, but 
they did not account for potential confounding by other related dairy nutrients (102).
 
Conclusions
Infant dairy milk protein intake, from both infant formula and cow’s milk sources, was positively 
associated with adiposity at age 12 months.
Higher intakes of formula milk at 4 months have also been related to larger body weight and 
BMI at ages 1 to 5y (81). Together with our data, this suggests that reduction of dairy milk intake 
might lead to less weight gain and less adiposity in early life. 
General conclusions, implications and directions for future research
In the early 1990s, Barker et al. opened a new fi eld of research by reporting a relationship 
between low birth weight and CVD and type 2 diabetes (2,5,87,88). Since, many studies have 
investigated this relationship and showed confl icting results. Singhal and Lucas formulated a new 
hypothesis in 2004, postulating that fetal growth restriction relative to genetic growth potential 
could result in growth acceleration during childhood, which is responsible for the increased 
risk for adult diseases in later life (8). In the PROGRAM-study, a cohort of 322 young adults, 
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we found that fat accumulation during childhood was related to reduced insulin sensitivity, 
an increase in serum levels of TC, TG, LDLc, ApoB and ASP, and systolic and diastolic blood 
pressure in early adulthood, independent of size at birth. We were therefore able to specify 
the hypothesis of Singhal and Lucas and postulated that increased accumulation of fat during 
childhood, independent of birth size, will result in an increased risk for development of CVD 
and type 2 diabetes (Figure 1). Weight gain during childhood was related to higher fat mass, 
lean body mass and bone mineral density(TB+LS) in early adulthood. Size at birth was not related 
to bone mineral density, but lower birth weight was moderately related to lower lean body mass 
and higher fat mass in early adulthood. However, the eff ect of weight gain during childhood 
was greater, indicating its importance. In conclusion, prenatal growth, refl ected by size at birth 
seems to be of less infl uence compared to weight gain during childhood.
Fetal growth restriction
Development of adult disease
Fat accumulation during childhood
Relative to their 
growth potential
Nutrient-enriched diets
+
Weight gain during childhood
Figure 1. Specifi ed growth acceleration model of Singhal et al.
Additionally, we investigated whether there was a sensitive time-window for weight gain in 
early life infl uencing determinants of CVD and type 2 diabetes, because this might be an option 
to intervene and start prevention programs. Our results show that more weight gain in the fi rst 
three months of life related to reduced insulin sensitivity and serum HDL, and an increased 
waist circumference, acute insulin response, cholesterol / HDL ratio and serum triglyceride in 
early adulthood. Additionally, our results showed that of all subjects with fi rst year catch-up in 
weight (> 0.67 SDS), those with fast catch-up in weight in the fi rst three months of life had a 
signifi cantly higher % body fat, more central adiposity and reduced insulin sensitivity in early 
adulthood than those with slower catch-up in weight. Th erefore, rapid weight gain in early life 
should be prevented to reduce the risk for CVD and type 2 diabetes in later life. Future research 
should focus on which factors infl uence rapid infant weight gain. Secondly, intervention trails 
are required to investigate which intervention might prevent this rapid early weight gain.
It is clear that nutrition is a contributor to rapid weight gain, as breast-fed infants gain slower 
weight than formula-fed infants (93,94). Although it has been thought that this is due to the high 
protein content of formula milk, evidence is not conclusive. In our population-based cohort of 
396 infants, higher intakes of dairy milk protein, cow’s milk protein and formula milk protein, 
were related to higher adiposity at 12 months. Th is indicates that reduced intakes of dairy milk 
might prevent rapid infant weight gain. Breast milk would be a good alternative for dairy milk. 
Th e observations might be residually confounded by other nutritional factors, including other 
components of infant milk formula and cow’s milk, so it would be very interesting to perform 
intervention study to confi rm whether intakes of dairy milk protein or intakes of other nutrients 
are responsible for this association.
Although we investigated the relation between nutrient intake and body composition in 
early infancy, this relationship needs to be investigated into childhood or even into adulthood. 
Food patterns may change throughout life and could therefore change the risk for adiposity in 
life. Another important factor infl uencing the risk for CVD and diabetes type 2 is the level of 
physical activity (109,110). Unfortunately, no data was collected with regard to physical activity, 
which might be considered as a limitation of the study. Another limitation is that there were 
no data on family history of cardiovascular disease and diabetes type 2 as well as maternal 
characteristics during pregnancy. 
For clinical relevance, we assigned the study participants into four subgroups, based on 
growth during their fetal life and childhood. Although studies in SGA-S children showed that 
they might have an increased risk for CVD and type 2 diabetes (14), we could not confi rm 
these results in young adults. We only found higher levels of ApoB compared to controls, while 
other lipid levels, insulin sensitivity, blood pressure and carotid IMT were similar to controls. 
Th erefore, we conclude that subjects with a small size at birth who remain relatively short into 
adulthood do not have an increased risk for development of CVD or type 2 diabetes. On the 
other hand, we acknowledge that we investigated a relatively small group of SGA-S subjects 
and therefore other studies have to be performed to confi rm our results. In addition, follow-up 
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studies need to investigate if the risk factors alter diff erently in SGA-S subjects compared to 
controls in later life, as we investigated these subjects at a relatively young age. 
Th e results were diff erent for subjects born SGA with catch-up growth during childhood. 
Th ey had reduced insulin sensitivity, higher %body fat and greater carotid IMT than controls. 
Th is indicates that SGA-CU subjects might be at risk for cardiovascular events and type 2 diabetes 
in later life. Lipid levels and blood pressure were similar to controls, but these risk factors might 
start to diff er from controls in the years to come. Recently, a study in a large French cohort of 
SGA adults showed a larger increase in BMI from 22 to 30 years in SGA born adults compared 
to AGA born adults (111). Th erefore, follow-up studies have to be performed to investigate how 
these risk factors develop and whether these subjects have more cardiovascular events in later 
life. Th e diff erences in insulin sensitivity and carotid IMT with controls were independent of 
%body fat, suggesting that other factors or mechanisms are responsible for these diff erences. It 
would be of interest to investigate which factors, genetic or environmental, could explain these 
diff erences.
Subjects born appropriate for gestational age with idiopathic growth retardation during 
childhood had only a lower BMD than controls, but other risk factors for adult disease were 
similar to controls. Th ese results might be reassuring for the risk of CVD, however, not for the 
risk of osteoporosis. Our ISS subjects have been investigated in their early twenties, when BMD 
is highest in life. As BMD deteriorates in later life, ISS subjects might need to be evaluated in 
later life to determine if osteoporosis begins sooner and is more severe than in controls.
Although we investigated a wide range of determinants of adult disease, it would be 
interesting to investigate additional determinants. With regard to cardiovascular disease, 
alterations in coagulation, fi brinolysis and infl ammation might infl uence the development of 
CVD (10). Whether these determinants already diff er between SGA-CU subjects and controls 
in early adulthood is yet unknown. Previously, low birth weight has been related to impaired 
lung and immune function and lower risk of cancer in later life (112).Th erefore, relationships 
between growth patterns and adult disease needs further investigation as it might lead to specifi c 
interventions, which help to reduce the risk of adult disease.
Finally, we have made a new hypothetical model based on the existing literature and the 
results of the studies described in this thesis (Figure 2). 
Fetal growth restrictionRelative to their 
growth potential
Maternal factors
Fetal factors
Placental factors
Environmental factors
Growth acceleration in weight
(especially in the first three months of life) 
Low normal growth
or reduced growth
Development of adult disease
Fat accumulation during childhood
Dairy milk intake
+
Insulin sensitivity
Unfavourable
body composition
Unfavourable
lipid profile
Blood pressure
Short adult stature
Figure 2. Hypothetical model showing the diff erent growth patterns and their linkage with adult disease.
Th e model in Figure 2 shows that subjects who experienced fetal growth restriction are born 
relatively small for their growth potential. About 90% of them will show catch-up growth in the 
fi rst two years of life and those who experience fast catch-up in weight in the fi rst three months 
of life accumulate more fat mass and have a higher risk for development of reduced insulin 
sensitivity, unfavourable body composition and lipid profi le and increased blood pressure in 
later life. Th ese factors are all important determinants of cardiovascular disease and diabetes 
type 2. Th is model is not complete, but might be seen as a starting point for additional research. 
Future research should try to focus on which factors determine the growth acceleration and 
infl uence fat accumulation during childhood to complement this model.
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Chapter 1
Th is chapter provides an introduction in the diff erent hypotheses with regard to the infl uence 
of birth size and childhood growth on adult diseases and their determinants. Th e relationships 
between birth size and several determinants of adult diseases are explained, like insulin sensitivity, 
body composition, serum lipid profi les, acylation stimulating protein (ASP), blood pressure, 
carotid intima media thickness (IMT) and bone mineral density (BMD). Th e relationship 
between growth in early life and cardiovascular and metabolic profi le is discussed, together 
with the infl uence of nutrition on body size and body composition in infancy. In addition, the 
defi nitions, prevalence and etiologies of small for gestational age (SGA) and idiopathic short 
stature (ISS) are described together with the study design. Finally, the aims and outline of the 
thesis are presented.
Chapter 2
Low birth weight has been related to reduced insulin sensitivity, but it was unknown whether 
this was due to prenatal or postnatal factors. Th ere was very limited information whether 
subjects born SGA who remain short (SGA-S) or subjects born SGA with catch-up growth 
(SGA-CU) were at risk for type 2 diabetes in later life. We therefore investigated in 136 young 
adults the relative contribution of birth size, adult size, body composition and waist-to-hip 
ratio on insulin sensitivity and disposition index, measured by Frequently Sampled Intravenous 
Glucose Tolerance test (FSIGT). In addition, we investigated if there were diff erences between 
four clinically relevant subgroups, subjects born SGA who remain short (SGA-S), and those 
with postnatal catch-up growth (SGA-CU), subjects with idiopathic short stature (ISS) and 
controls.
Neither birth length nor birth weight, but the accumulation of fat mass from birth to early 
adulthood appeared to be the main predictor of insulin sensitivity in early adulthood. Aft er 
correction for age, gender, and adult body size, insulin sensitivity was signifi cantly lower in 
subjects born SGA with catch-up growth than in controls. None of the variables had a signifi cant 
infl uence on disposition index, and there was no signifi cant diff erence in disposition index 
between the subgroups.
In conclusion, fat accumulation during childhood predicts insulin sensitivity in early 
adulthood. Prenatal growth, refl ected by birth size, was not signifi cantly related to insulin 
sensitivity. In early adulthood, SGA-CU subjects had reduced insulin sensitivity compared to 
controls, while all other subgroups had similar insulin sensitivity as controls. Reduced insulin 
sensitivity was found in only one of the two SGA subgroups, which supports our conclusion 
that fat mass accumulation during childhood is a major determinant of insulin sensitivity in 
later life.
Chapter 3
Several studies investigated the relationship between birth size and later body composition, 
but due to great diff erences in measuring body composition, diff erent study populations and 
diff erent statistical approaches, it remained hard to compare these studies. Short children born 
SGA have a typical lean appearance, while other reports showed that subjects born SGA with 
catch-up growth developed adiposity in early life. It was unknown if these diff erences in body 
composition persisted into adulthood. We investigated the relationship between birth size, adult 
size and body composition in 312 young adults. Body composition was measured by DXA.
Birth weight was inversely related to fat mass, but was not related to lean body mass. However, 
the infl uence of adult weight on fat mass and lean body mass was greater than birth weight, 
indicating that weight gain from birth to early adulthood was the main determinant of body 
composition in early adulthood. Th ese results were confi rmed by the results of the subgroup 
analyses, showing that SGA-CU subjects had relatively greater fat mass and less lean body mass 
than controls. SGA subjects who remained short as adults had a similar body composition as 
controls. Our results indicate that too much weight gain during childhood should be prevented 
as it may lead to an unfavorable body composition in later life. Intervention programs should 
focus on postnatal growth in weight as its eff ect on body composition is greater than that of 
prenatal growth.
Chapter 4
An unfavorable lipid profi le increases the risk for cardiovascular disease and cardiovascular 
events in later life. No consistency was found with regard to the relationship between low birth 
weight and serum lipid profi les. If low birth weight would aff ect lipid levels in later life, this 
should be present in SGA subjects. No study found increased serum lipid levels in subjects 
born SGA, but no study diff erentiated between subjects born SGA with and without catch-up 
growth. Th is chapter describes the infl uence of birth size, adult size, body composition and ApoE 
genotype on fasting serum levels of total cholesterol (TC), triglycerides (TG), HDLc, LDLc, 
ApoA-1, ApoB and Lp(a) in 297 young adults. We also investigated if there were diff erences in 
serum lipid levels between the 4 subgroups.
Gender, ApoE genotype, adult height and adult weight, specifi ed as fat mass, were signifi cant 
determinants of serum lipid levels in early adulthood, while prenatal growth, refl ected by birth 
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length and birth weight, was not. Our subgroup analyses showed that short adults born SGA 
had higher levels of ApoB than controls. Th ere were no diff erences in other serum lipid levels 
or ApoE genotype between the subgroups. Th ese data imply that fat accumulation during 
childhood might result in unfavorable serum lipid levels in early adulthood and therefore 
enhance the development of cardiovascular disease in early life. Parents and their children need 
to be informed about the risk of fat accumulation during childhood. 
Chapter 5 
Acylation stimulating protein (ASP) is hormone produced by adipocytes, which enhances the 
uptake of glucose and chylomicron-derived free fatty acid (FFA) in adipocytes. ASP infl uences 
the metabolism of FFA by increasing the uptake of FFA and reducing the release of FFA by 
adipocytes. Normally, higher serum ASP levels lead to lower serum FFA levels. However, high 
fasting levels of TG and ASP have been associated with obesity, insulin resistance, cardiovascular 
disease and dyslipidemia. Th is resulted in the hypothesis that higher ASP levels in the presence 
of higher TG might indicate ASP resistance. Serum ASP is considered as a predictor of delayed 
TG clearance and might therefore predict postprandial hypertriglyceridemia, which is an early 
stage of dyslipidemia. We investigated which factors are related to fasting ASP levels in early 
adulthood and whether diff erent growth patterns during childhood are related to a diff erent 
fasting ASP level in early adulthood.
Weight gain during childhood, particularly fat accumulation, was positively related 
to serum ASP levels in early adulthood. Birth size was not related. Serum ASP levels were 
positively related to TG, TC, ApoB and insulin secretion and negatively to insulin sensitivity. 
Th e subgroup analyses showed no diff erences in serum ASP levels, but the SGA-CU subjects 
and the ISS subjects had higher levels of serum FFA than controls. 
In conclusion, exaggerated weight gain during childhood might lead to changes in ASP 
regulation and therefore FFA metabolism. ASP metabolism is positively related to insulin 
regulation and lipid metabolism. In early adulthood ASP metabolism was similar between the 
four clinically relevant subgroups.
Chapter 6
Th is chapter describes the relationship between birth size and blood pressure as well as carotid 
intima media thickness (IMT) in early adulthood. Blood pressure and carotid IMT are both 
highly correlated with cardiovascular events in later life. Development of higher blood pressure 
and greater carotid IMT in early life might increase the risk for cardiovascular events in later 
life. Th e relationship between birth size and blood pressure is one of the most investigated 
relationship within the ‘fetal origin hypothesis’, but controversy still remained. In SGA subjects, 
no study investigated carotid IMT. As SGA-CU subjects have reduced insulin sensitivity and an 
unfavourable body composition compared to controls, diff erences might be found in carotid 
IMT between SGA-CU subjects and controls. We investigated the relationship between growth 
patterns and blood pressure and carotid IMT in 243 young adults.
Birth size was not related to systolic blood pressure, diastolic blood pressure or carotid IMT. 
However, accumulation of fat mass from birth to early adulthood was related to systolic and 
diastolic blood pressure, but not to carotid IMT. Comparison of subgroups showed no diff erences 
in blood pressure between the four subgroups, but SGA-CU subjects had a greater carotid 
IMT than controls. Th is indicates that postnatal catch-up growth, and not prenatal growth, 
infl uences development of greater carotid IMT as SGA-CU subjects and not SGA-S subjects had 
higher carotid IMT. To diminish the risk for hypertension in later life, fat accumulation during 
childhood should be prevented.
Chapter 7
Osteoporosis is a condition characterized by reduced bone mineralization, resulting in an 
increased fracture risk. Although some studies showed a positive association between birth 
weight and bone mineral density (BMD), hardly any study had taken adult size into account and 
most of the subjects being studied were elderly. We therefore investigated in 312 young adults 
whether birth size, adult size and body composition were related to BMD in early adulthood.
 Current weight, specifi ed as lean body mass and fat mass, and weight gain during 
childhood were positively related to BMD of the total body(TB) and the lumbar spine(LS). Birth 
length was not related to BMD(TB+LS) and birth weight was inversely related to BMD(LS), which 
disappeared aft er adjustment for childhood weight gain. Th is indicates that the infl uence of 
weight gain during childhood is greater than the infl uence of prenatal growth, refl ected by birth 
weight. Comparison of the subgroups showed that aft er adjustments for adult size and body 
composition, ISS subjects had a lower BMD(TB) than controls. Th ere were no diff erences in 
BMD(LS) and bone mineral apparent density (BMAD) between the subgroups. 
In conclusion, weight gain during childhood determines BMD(TB+LS) in early adulthood, 
while birth weight hardly infl uences BMD(TB+LS). Birth length was not related to BMD(TB+LS) 
in early adulthood. In addition, subjects with a reduced growth rate during childhood are at risk 
for lower BMD(TB), what might result in increased fracture risk in later life. 
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Chapter 8
First year growth seems to be an important period in the development of cardiovascular disease 
and type 2 diabetes. Some even suggested that in this period a special ‘time window’ might 
be applicable. However, it remained unclear whether slow or fast growth in early life has an 
adverse eff ect on determinants of CVD. Some studies showed that slow growth in the fi rst two 
years followed by rapid growth in childhood was related to an increased risk for cardiovascular 
events. Other studies showed that rapid weight gain in the fi rst 3 to 6 months was related to 
increased fat mass in childhood and a disadvantageous metabolic profi le in early adulthood. 
We investigated the relation between fi rst year growth and an extensive set of cardiovascular 
and metabolic determinants in 217 young adults. In addition, we investigated whether tempo of 
catch-up growth was related to these determinants of CVD and type 2 diabetes.
Our data showed that increased weight gain relative to height gain in the fi rst three months 
of life was associated with reduced insulin sensitivity and serum HDL, and an increased waist 
circumference, acute insulin response, cholesterol / HDL ratio and serum triglyceride in early 
adulthood. To investigate whether tempo of catch-up growth in the fi rst year infl uenced the 
determinants, we made two subgroups out of all subjects with fi rst year catch-up growth (> 
0.67 SDS). Th ose with fast catch-up growth in the fi rst three months of life (> 0.5 SDS) had a 
signifi cantly higher % body fat, more central adiposity and reduced insulin sensitivity in early 
adulthood than those with a more gradual catch-up growth. Th e diff erences in fat distribution 
and insulin sensitivity between the subgroups were explained by the % body fat.
In conclusion, exaggerated weight gain relatively to height gain in the fi st three months 
should be prevented as it is related to several determinants of CVD and type 2 diabetes in early 
adulthood. In addition, slower weight gain in the fi rst three months results in a more favorable 
metabolic profi le than rapid weight gain in the fi rst three months. 
Chapter 9
Catch-up growth in early life seems to result in an increased fat mass in childhood, which 
is being tracked into adulthood. Factors infl uencing catch-up growth in early life need to be 
established and nutrition is one of these factors. Breast-fed infants have a slower weight gain 
than formula-fed infants and suggestions were made that this might be due to the higher protein 
content of formula milk. Others suggested that higher intakes of dairy milk, which is also high 
in protein content, were associated with increased weight gain and adiposity in childhood. We 
investigated in 396 infants of the Cambridge Baby Growth Study, the associations between 
infant energy, protein and fat intakes on body size and adiposity, measured by skin folds, at age 
12 months. In particular we tested the hypothesis that dairy milk protein intake (from dairy 
protein-based infant formula milk and cow’s milk) might be specifi cally associated with infant 
adiposity.
Higher total energy intakes were related to higher length, weight and BMI at 12 months 
aft er adjustment for demographic and nutritional factors. Th ere was no relation with adiposity. 
However, dairy milk protein intake was positively related to adiposity at 12 months, and this 
association persisted aft er adjustment for other nutritional factors. Both protein from dairy 
protein-based infant formula milk and protein from cow’s milk showed similar trends with 
adiposity at 12 months. Despite these associations, we must recognize that it is possible that the 
observations are residually confounded by other nutritional factors, including other components 
of infant milk formula and cow’s milk, or by parenting patterns associated with the use of these 
milks. Th ese results indicate that reduction of dairy milk intake, from both infant formula and 
cow’s milk sources, might lead to less weight gain and less adiposity in early life.
Chapter 10
In the general discussion, our fi ndings are discussed in relation to the current literature. Finally, 
our conclusions are described together with general considerations and directions for future 
research.
Chapter 12
Samenvatting
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Hoofdstuk 1
In dit hoofdstuk worden verschillende hypotheses uitgelegd met betrekking tot de invloed van 
intra-uteriene groei en groei tijdens de kindertijd op ziekten die op oudere leeft ijd optreden. 
Er wordt ingegaan op de relatie tussen grootte bij de geboorte en verschillende determinanten 
van deze ziekten, zoals insulinegevoeligheid, lichaamsamenstelling, serum lipiden profi elen, 
acylation stimulating protein (ASP), bloeddruk, de intima media dikte (IMT) van de arteria 
carotis en de botdichtheid (BMD). Vervolgens wordt de relatie tussen groei in het eerste jaar 
en het cardiovasculaire en metabole profi el op jong volwassen leeft ijd besproken, samen met 
de invloed van voeding op de lichaamsgrootte en lichaamsamenstelling in het eerste jaar. De 
defi nities, prevalenties en etiologie van te klein zijn bij de geboorte (small for gestational age 
(SGA)) en idiopatische kleine gestalte (ISS) worden besproken, net als de studie opzet. Als laatste 
worden de doelstellingen van de studies vermeld, zoals die in dit proefschrift  zijn beschreven.
Hoofdstuk 2
Verschillende studies lieten een relatie zien tussen een laag geboortegewicht en verminderde 
gevoeligheid voor insuline. Echter, het bleef onduidelijk of dit kwam door prenatale of postnatale 
factoren. Bij de start van de studie was het nog onduidelijk of SGA geboren mensen met een 
te kleine volwassen lengte (SGA-S) of juist SGA geboren mensen met inhaalgroei (SGA-CU) 
een verhoogde kans hadden op diabetes type 2 in het latere leven. Daarom werd in 136 jong 
volwassen onderzocht wat de bijdrage is van de lengte en het gewicht bij de geboorte, lengte 
en gewicht op de volwassen leeft ijd, alsmede de lichaamsamenstelling en buik-heup ratio op 
insulinegevoeligheid en dispositie index (een maat voor de glucose homeostase), gemeten 
m.b.v. de Frequently Sampled Intravenous Glucose Tolerance test (FSIGT). Vervolgens werd 
onderzocht of er verschillen waren in vier klinisch relevante subgroepen, SGA-S, SGA-CU, ISS 
en controles.
De resultaten laten zien dat niet de grootte bij de geboorte, maar de hoeveelheid 
vetaccumulatie tijdens de kindertijd de belangrijkste determinant is van insulineongevoeligheid 
op de jong volwassen leeft ijd. Na correctie voor leeft ijd, geslacht en volwassen lichaamsgrootte, 
hadden SGA-CU mensen een verlaagde insulinegevoeligheid ten opzichte van controles. De 
dispositie index werd echter niet voorspeld door een van de variabelen en er was ook geen 
verschil in dispositie index tussen de vier subgroepen.
De conclusie is dat meer vetaccumulatie van de geboorte tot aan jong volwassenheid is 
geassocieerd met een lagere gevoeligheid voor insuline op jong volwassen leeft ijd. Prenatale 
groei, gerefl ecteerd door lengte en gewicht bij de geboorte, heeft  geen signifi cante invloed op 
de insulinegevoeligheid. Op jong volwassen leeft ijd hadden SGA-CU mensen een verlaagde 
gevoeligheid voor insuline ten opzichte van controles en de andere subgroepen hadden een 
vergelijkbare insulinegevoeligheid dan de controles. Verminderde insulinegevoeligheid werd 
alleen aangetoond in een van de twee SGA subgroepen, hetgeen onze conclusie ondersteunt dat 
de grootte bij de geboorte niet geassocieerd is met de insulinegevoeligheid in het latere leven.
Hoofdstuk 3
De relatie tussen grootte bij de geboorte en de lichaamsamenstelling later in het leven is 
herhaaldelijk onderzocht. Maar door de grote verschillen in de manier van meten, verschillende 
studie populaties en verschillende statistische benaderingen blijft  het moeilijk deze studies met 
elkaar te vergelijken en zodoende een conclusie te vormen over deze relatie. In SGA geboren 
kinderen die klein blijven word aangetoond dat ze een typisch mager voorkomen hebben, 
terwijl in SGA geboren kinderen met inhaalgroei werd aangetoond dat ze relatief vet zijn, zelfs 
al op jonge leeft ijd. Voor de start van de studie was het nog onduidelijk of deze verschillen 
in lichaamsamenstelling blijvend zouden zijn tot in volwassenheid. Wij hebben de relatie 
tussen lengte en het gewicht bij de geboorte, lengte en gewicht op de volwassen leeft ijd en 
de lichaamsamenstelling onderzocht in 312 jong volwassenen. De lichaamsamenstelling werd 
gemeten met behulp van Dual energy X-ray Absorptiometry (DXA).
Geboortegewicht was negatief gerelateerd met vetmassa, maar was niet gerelateerd aan 
spiermassa. Echter, de associatie tussen het volwassen gewicht en de vetmassa en spiermassa 
was groter dan die tussen het geboortegewicht en lichaamsamenstelling, wat laat zien dat de 
gewichtstoename van geboorte tot jong volwassen leeft ijd de belangrijkste determinant is 
van de lichaamsamenstelling op jong volwassen leeft ijd. De resultaten werden bevestigd door 
de resultaten in de subgroep analyse. Deze lieten zien dat SGA-CU mensen relatief meer 
vetmassa en minder spiermassa hebben dan controles. SGA-S jong volwassenen bleken een 
vergelijkbare lichaamsamenstelling te hebben als controles. Deze resultaten impliceren dat teveel 
gewichtstoename tijdens de kindertijd voorkomen dient te worden, aangezien dit kan leiden tot 
een ongunstige lichaamsamenstelling op jong volwassen leeft ijd. Interventie programma’s om 
een ongunstige lichaamsamenstelling te voorkomen zouden zich voornamelijk op de postnatale 
gewichtstoename moeten focussen in plaats van op de prenatale groei, aangezien daar meer 
preventief eff ect te verwachten valt.
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Hoofdstuk 4
Een ongunstig lipiden profi el verhoogt het risico van hart- en vaatziekten alsmede het risico 
van een hartaanval of een beroerte in het latere leven. Momenteel is er nog geen consensus 
bereikt over het feit of de grootte bij de geboorte invloed heeft  op het lipiden profi el. Als een laag 
geboortegewicht een eff ect zou hebben op het lipiden profi el, dan zou men een ongunstig lipiden 
profi el verwachten bij mensen die SGA geboren zijn. Geen enkele studie heeft  afwijkende lipiden 
spiegels gevonden bij SGA geboren mensen, maar deze studies hebben ook geen onderscheid 
gemaakt tussen SGA-S en SGA-CU. Dit hoofdstuk beschrijft  de invloed van geboortelengte en 
-gewicht, volwassen lengte en gewicht, lichaamsamenstelling en ApoE genotype op nuchtere 
serum waarden van totaal cholesterol (TC), triglyceriden (TG), HDLc, LDLc, ApoA-1, ApoB 
en Lp(a) in 297 jong volwassenen. Tevens werd onderzocht of er verschillen waren in serum 
lipiden spiegels tussen de vier klinisch relevante subgroepen. 
Geslacht, ApoE genotype, volwassen lengte en gewicht, gespecifi ceerd als vetmassa, waren 
signifi cante determinanten van serum lipiden spiegels op de jong volwassen leeft ijd, terwijl 
prenatale groei, gerefl ecteerd door grootte bij de geboorte, niet signifi cant was. De subgroep 
analyse wees uit dat SGA-S jong volwassenen hogere ApoB spiegels hadden dan controles. 
Er waren geen andere verschillen in serum lipiden spiegels of ApoE genotype tussen de 
subgroepen. Deze data laten zien dat vetaccumulatie tijdens de kindertijd kan resulteren in 
ongunstige serum lipiden spiegels op jong volwassen leeft ijd en op deze manier de ontwikkeling 
van hart- en vaatziekten kan versterken. Ouders en hun kinderen moeten geïnformeerd worden 
over het risico van vetaccumulatie tijdens de kindertijd. 
 Hoofdstuk 5
Acylation stimulating protein (ASP) is een door vetcellen geproduceerd hormoon dat de 
opname van glucose en vrije vetzuren (afk omstig van triglyceriden) in vetcellen bevordert. In 
fysiologische condities leidt een hogere serum ASP waarde tot een verlaging van de vrije vetzuur 
spiegel. Echter, in geval van obesitas, insuline resistentie, dyslipidemie en cardiovasculaire 
ziekten worden zowel hoger serum waarden van ASP als triglyceriden gevonden. Dit heeft  
geresulteerd in de hypothese dat hoge ASP waarden in combinatie met normale of hogere TG 
waarden ASP resistentie refl ecteert. Aangezien serum ASP wordt gezien als een voorspeller van 
een vertraagde TG klaring, kan de ASP spiegel postprandiale hypertriglyceridemie voorspellen. 
Postprandiale hypertriglyceridemie wordt gezien als een beginstadium van dyslipidemie. Wij 
hebben onderzocht welke factoren gerelateerd zijn nuchtere ASP waarden op de jong volwassen 
leeft ijd en of verschillende groeipatronen tijdens de kindertijd zijn gerelateerd aan nuchtere 
ASP waarden in jong volwassenheid.
Relatief meer toename in gewicht dan in lengte tijdens de kindertijd, vooral vetaccumulatie, 
was positief gerelateerd aan de serum ASP spiegels in jong volwassenen. Grootte bij de geboorte 
had geen relatie met de serum ASP spiegels. Serum ASP was verder positief gecorreleerd met 
TG, TC, ApoB en de insuline secretie en negatief gecorreleerd met insulinegevoeligheid. De 
subgroep analyse liet geen verschil in ASP spiegels zien tussen de subgroepen, maar de SGA-
CU mensen en de ISS mensen hadden wel een verhoogd vrije vetzuur waarde t.o.v. controles. 
De conclusie is dat relatief teveel gewichtstoename tijdens de kindertijd kan leiden tot 
veranderingen in de ASP regulatie en vervolgens ook tot veranderingen in het vrije vetzuur 
metabolisme. ASP blijkt gerelateerd aan insuline secretie en –gevoeligheid alsmede aan het 
lipiden metabolisme. Er waren geen verschillen in ASP waarden tussen de vier verschillende 
subgroepen. 
Hoofdstuk 6
Dit hoofdstuk beschrijft  de relatie tussen grootte bij de geboorte en de bloeddruk alsmede de 
intima media dikte van de carotis (cIMT) op jong volwassen leeft ijd. Systolische bloeddruk, 
diastolische bloeddruk en cIMT zijn sterk gecorreleerd met cardiovasculaire events op oudere 
leeft ijd. Het ontwikkelen van een hogere bloeddruk en een dikkere cIMT op jonge leeft ijd kan 
het risico van een cardiovasculair event in het latere leven verhogen. De relatie tussen grootte 
bij de geboorte en bloeddruk is een van de meest onderzochte relaties binnen de “fetal origin 
hypothesis’, maar er is nog steeds geen consensus bereikt. In SGA geboren mensen was nog geen 
studie verricht naar de cIMT. Aangezien SGA-CU mensen een verlaagde insulinegevoeligheid 
en een ongunstigere lichaamsamenstelling hebben dan controles, zou men wellicht een dikkere 
cIMT bij SGA-CU mensen kunnen aantreff en ten opzichte van controles. We hebben de relatie 
tussen groeipatronen en bloeddruk en cIMT onderzocht in 243 jong volwassenen. 
Grootte bij de geboorte was niet gerelateerd aan systolische bloeddruk, diastolische 
bloeddruk, of cIMT. Vetaccumulatie gedurende de kindertijd was gerelateerd aan een hogere 
systolische en diastolische bloeddruk, maar niet met cIMT. De subgroep analyse liet geen 
verschillen in bloeddruk zien, maar de cIMT van de SGA-CU mensen was groter dan die van 
de controles. Dit suggereert dat postnatale inhaalgroei, en niet prenatale groei, de ontwikkeling 
van een grotere cIMT versterkt, aangezien de SGA-CU mensen maar niet de SGA-S mensen 
een grotere cIMT hadden. Om het risico op een hogere bloeddruk op jong volwassen leeft ijd te 
verminderen zal vetaccumulatie tijdens de kinderjaren moeten worden voorkomen. 
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Hoofdstuk 7
Osteoporose is een aandoening die wordt gekarakteriseerd door een verminderde bot 
mineralisatie. Dit resulteert in een verhoogd risico op botbreuken. Enkele studies hebben een 
positieve relatie aangetoond tussen grootte bij de geboorte en botdichtheid op latere leeft ijd. 
Echter, veel van deze studies hielden geen rekening met de grootte van de volwassenen en de 
meeste studies werden verricht in ouderen. Daarom onderzochten wij bij 312 jong volwassenen 
of lengte en het gewicht bij de geboorte, lengte en gewicht op de volwassen leeft ijd en de 
lichaamsamenstelling gerelateerd waren aan botdichtheid in jong volwassenheid.
Huidig gewicht, zowel spiermassa als vetmassa, en gewichtstoename gedurende de 
kindertijd waren positief gecorreleerd met de botdichtheid van het hele lichaam (BMD(TB)) en 
van de lumbale wervelkolom (BMD(LS)). Geboortelengte was niet gerelateerd aan BMD(TB+LS), 
maar geboortegewicht was negatief gerelateerd aan BMD(LS). Deze associatie verdween na 
correctie voor gewichtstoename. Dit suggereert dat de invloed van gewichtstoename gedurende 
de kindertijd een grotere invloed heeft  dan de invloed van prenatale groei, gerefl ecteerd door 
geboortelengte en -gewicht. Vergelijking van de subgroepen liet zien dat na correctie voor 
volwassen lengte, volwassen gewicht en de lichaamsamenstelling, ISS mensen een lagere 
BMD(TB) hadden dan controles. Er waren tussen de subgroepen geen verschillen in BMD(LS) en 
BMD(LS) gecorrigeerd voor lengte. 
De conclusie is dat gewichtstoename tijdens de kindertijd de BMD(TB+LS) op jong volwassen 
leeft ijd beïnvloedt, terwijl de invloed van geboortegewicht klein is. Geboortelengte is niet 
gerelateerd aan BMD(TB+LS) op jong volwassen leeft ijd. Vervolgens blijkt dat kinderen met een 
verminderde lengtegroei een verhoogde kans hebben op een lagere BMD(TB), wat kan resulteren 
in een verhoogde kans op botbreuken op latere leeft ijd.
Hoofdstuk 8
Groei in het eerste levensjaar blijkt een belangrijke periode te zijn in de ontwikkeling van 
hart- en vaatziekten en diabetes type 2. Echter, het was onduidelijk of langzame of juist snelle 
groei in deze periode een negatief eff ect had op de determinanten van deze aandoeningen. 
Enkele studies lieten zien dat langzame groei in de eerste 2 jaar gevolgd door snelle groei in 
de kindertijd gerelateerd was aan een verhoogde kans op een cardiovasculair event op latere 
leeft ijd. Anderen vermeldden dat juist snelle groei in de eerste 3 tot 6 maanden gerelateerd 
was aan een toename van de vetmassa tijdens de kindertijd en een ongunstig metabool profi el 
op de jong volwassen leeft ijd. Wij onderzochten daarom de relatie tussen groei in het eerste 
levensjaar en een uitgebreide selectie van cardiovasculaire en metabole determinanten in 217 
jong volwassenen. Vervolgens onderzochten we ook of de snelheid van inhaalgroei gerelateerd 
was aan deze determinanten van hart- en vaatziekten en diabetes type 2. 
Onze data laten zien dat een relatieve gewichtstoename ten opzichte van lengtetoename in 
de eerste drie maanden van het leven was gerelateerd aan een verminderde insulinegevoeligheid 
en serum HDLc spiegel, en een toename in buikomtrek, insulinesecretie, cholesterol/HDLc 
ratio en serum TG waarden op jong volwassen leeft ijd. Om te onderzoeken of de snelheid van 
de inhaalgroei in het eerste levensjaar deze determinanten beïnvloedt, werden 2 subgroepen 
gemaakt van alle mensen die inhaalgroei hadden vertoond in deze periode (> 0.67 SDS). De 
mensen met snelle inhaalgroei in de eerste 3 maanden (> 0.5 SDS) hadden een signifi cant hoger 
vetpercentage, een meer centrale vetdistributie en verminderde insulinegevoeligheid op jong 
volwassen leeft ijd ten opzichte van de mensen met een langzame inhaalgroei in de eerste 3 
maanden. De verschillen in insulinegevoeligheid en vetdistributie konden verklaard worden 
door het verschil in vetpercentage op jong volwassen leeft ijd. 
Teveel gewichtstoename ten opzichte van lengtetoename in de eerste drie maanden 
moet worden voorkomen omdat dit gerelateerd is aan meerdere determinanten van hart- en 
vaatziekten en diabetes type 2 in jong volwassenen. Gematigde inhaalgroei in gewicht in de 
eerste 3 maanden is gerelateerd aan een gunstiger metabool profi el dan snelle inhaalgroei in 
deze periode.
Hoofdstuk 9
Vroege inhaalgroei in gewicht lijkt te resulteren in een toegenomen vetmassa in de kindertijd, 
die persisteert in volwassenheid. De invloed van verschillende factoren die de vroege inhaalgroei 
beïnvloeden word daarom toenemend onderzocht. Een van die factoren is al bekend en dat 
is voeding. Kinderen die borstvoeding krijgen hebben een langzamere gewichtstoename dan 
kinderen met fl esvoeding en er is geopperd dat dit verklaard zou kunnen worden door de 
verhoogde eiwit hoeveelheid in fl esvoeding. Anderen suggereren dat een verhoogde inname van 
zuivelmelk, dat relatief veel eiwit bevat, is gerelateerd aan een toename in gewicht en adipositas 
in kinderen. In Cambridge, onderzochten wij 396 kinderen van de Baby Growth Study met de 
vraagstelling of energie, eiwit of vet inname op 1 jaar gerelateerd was aan lichaamsgrootte en 
vethoeveelheid op 1 jaar. Er werd specifi ek gekeken of de inname van koemelk-eiwitten, uit 
fl esvoeding en koemelk, gerelateerd was aan de vethoeveelheid op 1 jaar, gemeten met behulp 
van huidplooimetingen. 
Hogere energie inname was positief gerelateerd aan lengte, gewicht en BMI op 1 jaar, na 
correctie voor demografi sche factoren en andere voedingsparameters. Er was geen relatie 
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met de hoeveelheid vet. Echter, een hogere inname van koemelk-eiwitten was wel gerelateerd 
aan meer lichaamsvet op 1 jaar en deze relatie bleef signifi cant na correctie voor mogelijke 
confounders zoals totale energie inname. Zowel koemelk-eiwit van fl esvoeding als van koemelk 
lieten dezelfde trend zien met betrekking tot lichaamsvet. Ondanks het feit dat deze associatie 
werd gevonden, kan deze associatie vertekend zijn door andere voedingsfactoren, inclusief 
andere voedingscomponenten uit fl esvoeding en koemelk, of voedingspatronen van ouders 
die geassocieerd zijn met de inname van koemelk-eiwitten. De resultaten geven aan dat een 
verminderde inname van koemelk-eiwitten via fl esvoeding en koemelk kan leiden tot een 
verminderde gewichtstoename en minder vetmassa in het vroege leven.
Hoofdstuk 10
In de algemene discussie worden de resultaten van de studies in relatie met de huidige 
literatuur besproken. Dit hoofdstuk wordt afgesloten met onze conclusies, algemene 
overwegingen en suggesties voor toekomstig onderzoek.
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